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collagenase at 2.5mg /ml, injected into the 
common bile duct just below the bifurcation, at a 
rate of 1.8m1 /min, until even the mesenteric 
pancreatic lobules are well distended; left to digest 
for 20 minutes, with digestion halted by ice -cold 
2mM EDTA; washed in cold HBSS, and separated 
with low spin at 100g; returned to warm RPMI and 
stained with dithizone, 
ABSTRACT 
The studies undertaken in this research project characterised as fully as possible the 
antigen identified by the monoclonal antibody BOB78. Earlier studies (Hart, Ross et al. 
2000) have linked BOB78 to the identification of apoptotic cells. The present project 
extended this finding by further studies utilising various antibody -based techniques on 
cancer -derived cell lines in different stages of apoptosis. 
The BOB78 antigen was confirmed to be present in normal cells and to be multi -lineage. 
BOB78 antigen is normally expressed within the cytosol of nucleated cells, but absent in 
anucleated red blood cells which do not undergo apoptosis. Following depolarisation of 
mitochondrial transmembrane potential, a key event in the initiation of apoptosis, 
BOB78 antigen is detected on the surface of the outer cell membrane. This surfacing of 
the BOB78 antigen parallels that of phosphatidylserine residues, presently the most well 
characterised marker for apoptosis in analysis with flow cytometry. 
Immunocytochemistry corroborated this finding by showing the translocation of the 
BOB78 antigen to membrane blebs of apoptotic cells. Observations using agents which 
disrupt the endomembrane synthetic pathways suggest that BOB78 is probably not 
trafficked through the Golgi apparatus or processed for secretion. Although BOB78 is 
an IgM antibody, it does not identify a carbohydrate epitope and is therefore likely to be 
specific for a multi -lineage protein. 
Membrane blebbing in apoptotic cells appears to share certain characteristics with the 
budding of platelets from megakaryocytes. For example, the production of platelets 
during the terminal differentiation of megakaryocytes involves activation of caspases. 
Interestingly, BOB78 was found by flow cytometric analysis to be present in platelets as 
they develop from the membranes of the MEG -01 megakaryocytes. BOB78 was also 
expressed on the surface of senescent platelets. These MEG -01 platelets were therefore 
used for purification of BOB78 through immunoprecipitation. The captured BOB78 
antigen was sequenced using MALDI -TOF, which identified it as chaperonin, also 
known as heat shock protein 60 (hsp60). 
Heat shock protein 60 is a highly conserved stress protein which has chaperone 
functions in prokaryotes as well mammalian cells. Expression of hsp60 on the surface of 
apoptotic cells may serve novel functions or purposes akin to molecular chaperoning. 
Mechanisms underlying the translocation of hsp60 to the cell membrane have been 
characterised in various prokaryotes. Homologous pathways of movement for this 
highly conserved entity are likely to exist in mammalian cells. The observation that 
hsp60 is expressed on the surface of senescent platelets suggests a possible role as a 
recognition signal in phagocytosis. Platelets are equipped with caspases and when 
senescent display membrane changes typical of apoptotic cells. Like apoptotic cells, 
platelets are normally cleared from tissues by macrophages. Surface expression of hsp60 
is probably an essential change marking cellular entities for uptake by phagocytes. It 
remains to be studied if engulfment of bodies displaying an endogenous moiety like 
hsp60 might play a key role in mediating a non -inflammatory response observed in 
apoptosis. It may also be speculated that hsp60 serves the function of molecular 
mimicry as many intracellular bacteria display surface hsp60, the expression of which 
has been linked to pathogenic invasiveness. The ability of these microbes to evade 
immune clearance may be linked to the non -inflammatory apoptotic disguise which 
surface hsp60 confers on them. 
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CHAPTER 1 
INTRODUCTION 
The life of a cell may be terminated under a variety of circumstances. Within a 
multicellular organism the context of cell death may be physiological or pathological. 
Thus, the loss of a cell may be physiological as it is essential to the restoration of 
homeostasis; or it may be pathological where a vital equilibrium may be threatened by 
the death of the cell. Alternatively, cells may be conferred inappropriate longevity, 
leading to significant perturbations of physiology or the emergence of serious 
pathologies. Observations on cell death have therefore linked it to many diseases. In a 
multicellular organism cell death needs to be accurately balanced. The past three 
decades have witnessed illuminating studies generating a new level of understanding of 
the events underpinning and regulating cell death. Understanding cell death promises 
greater insights into developmental processes, degenerative diseases, inflammatory 
conditions, autoimmune diseases and cancers. Tremendous potential exists for targeted 
manipulation of cell death and clearance of cells which may translate into significant 
therapeutic benefits. 
Apoptosis: a form of programmed cell death 
Clinical specimens featuring overwhelming infections or physico -chemical damage 
have presented classic examples for pathological cell death. The destruction of cells 
typically occurs through a process termed necrosis. Necrosis describes the death of 
cells which occurs when environmental stresses have been overwhelming, too extreme 
in degree and rapidity, resulting in a direct, contemporaneous and contiguous pattern of 
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cell loss. The energy- dependent machineries maintaining functional and anatomical 
compartmentalisation, such as organelles, are destroyed. Membranes lose their selective 
permeability allowing the ingress of ions and molecules leading to swelling of 
organelles and cytoplasm. Eventually the cell is lost through uncontrolled physical 
changes rupturing the cell membrane with haphazard spillage of cellular contents. The 
microscopic features of necrosis are typical. The tissues involved show a collection of 
indistinct cellular outlines within which organelles are not discernible and the nuclei 
usually appear compacted and small. 
In contrast to this pathological form of cell death a cell may die through apoptosis. 
Apoptosis occurs specifically in groups of cells or in a single cell. As implied by its 
Greek root (falling leaves, as from a tree) apoptosis is not dramatic under the 
microscope (Kerr, Wyllie & Currie, 1972). Typically, the dying cells are scanty and 
discrete within the tissues. A single apoptotic cell is usually found amongst normal 
neighbouring cells. The apoptotic cell itself however shows remarkably consistent 
changes especially in the nuclei. Since being first described apoptosis has been 
extensively studied and much is now known about the initiation and completion of the 
process. The nature of apoptosis which is the striking opposite of necrosis is that the 
cell mobilises from within the very tools required to deconstruct itself in a controlled 
and orderly manner. Death through apoptosis is a form of turnover crafted into normal 
physiology (Wyllie, Kerr & Currie, 1980). It is a form of programmed cell death and is 
the commonest form of cell death. It is an essential phenomenon in embryogenesis, 
metamorphosis, endocrine -controlled tissue atrophy, and normal tissue turnover (Meier, 
Evan et al., 2000; (Vaux and Korsmeyer, 1999). 
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The end -point of apoptotic cell death consists of specific manifestations of cell 
morphology and biochemistry. The sequence of events leading to apoptosis follows a 
genetic programme which is highly conserved (Ellis et al., 1991). The many cellular 
factors enrolled into the act of deconstruction of the cell are therefore conserved 
throughout evolution. The most enlightening observations have in fact derived from 
studies of the nematode Caenorhabditis elegans (Jacobson, 1997). Many of the genes 
encoding products which participate in cell deletion during the development of C. 
elegans have been matched to their mammalian homologues. The apoptotic pathways at 
its initiation, execution and regulatory phases have counterparts matched to various 
products in the mammalian system. For example CED -4 is an adaptor protein which 
transduces the signal for initiation of apoptosis and its mammalian homologue is Apaf- 
1 (Apoptosis protease activating factor -1); CED -3 is a cysteine protease (known as 
caspase in mammalian cells) which activates downstream substrates leading to typical 
changes in apoptosis; whilst CED -9 is a regulator, binding to CED -3 to prevent its 
activation, similar in action to the anti -apoptotic members of the Bc1-2 family of 
proteins (Ashkenazi and Dixit, 1998; Vaux and Korsmeyer, 1999) 
Apoptosis: morphological changes 
During apoptosis a cell undergoes dramatic changes in its morphology (Kerr, Wyllie & 
Currie, 1972). The cell first shrinks and condenses in size, vacuoles then develop in the 
cytoplasm, nuclear condensation follows; later the nucleus fragments into clumps. The 
cell then develops evaginations of the plasma membrane described as blebbing, and 
pockets of cytoplasm get packaged into the membrane blebs. Other membrane changes 
seen include echinoidal projections (Willingham, 1999). Ultrastructurally the organelles 
in the cytoplasm maintain their gross integrity whilst the execution phase of apoptosis 
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proceeds. Compartmentalisation of cytosolic organisation appears to be maintained. 
Due to the condensed cytoplasm an increased granularity of the apoptotic cell is usually 
discerned. The chromatin is degraded into neat multiples of internucleosomal slices of 
around 200 base pairs and the nuclear partition is broken down. The chromosomal 
materials and the organelles are then trafficked to the plasma membranes, channelled 
into the blebs and these pinch off from the plasma membrane. The blebbing apoptotic 
cell presents one of the most dramatic pictures of cell termination and is in stark 
contrast to the necrotic process. In a word, these changes reflect how a cell committed 
to apoptosis would lose contact with its neighbouring cells, shut down most cellular 
maintenance activities such as DNA repair and synthesis, rearrange the organelles, 
disrupt the nuclear envelope, digest genomic DNA, reorganise the cytoskeleton, and 
distribute cellular remnants into manageable packages, which would be ready for 
disposal by other cells. 
Whereas necrosis is typically attended by an inflammatory reaction to the disorderly 
array of dying cells and their contents, apoptosis is non -inflammatory (Huynh et al., 
2002; Savill et al., 2002). This is an important hallmark of apoptosis. Although the 
phagocytosis of apoptotic cells may be attended by `immunological neutrality', as in 
the failure to stimulate release of pro -inflammatory cytokines; it had been demonstrated 
that the uptake of apoptotic cells results in active immunosuppressive responses with 
induced upregulation of anti- inflammatory cytokine eg. TGF -ß (transforming growth 
factor -ß) in the phagocytes (Fadok et al., 1998). Apoptosis is particularly important in 
the immune system (Krammer, 2000). It is the commonest form of cell removal in 
clonal deletion in the thymus, and in resolution of inflammation (Craxton et al., 1999; 
Krammer, 1999). Non -phlogistic immune reaction to apoptosis is also pivotal to the 
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quiet resolution of inflammation and clearance of dead cellular components (Maderna 
and Godson, 2003). Imbalances in the clearance of immune cells or apoptotic cells play 
critical roles in the generation of immunological disorders. Appropriate disposal of 
apoptotic cells avoids inappropriate inflammatory responses and the development of 
pathology. 
Apoptosis: biochemistry of programmed cell death 
The primary signal for the termination of a cell may arise from within the cell or the 
external environment (Hengartner, 2000). These separate pathways can be seen as 
intrinsic or extrinsic induction of apoptosis (illustrated in figure 1.1 and 1.2). The key 
initiator in the intrinsic pathway lies with the mitochondria (Loeffler & Kroemer, 2000; 
Bratton & Cohen, 2001). The transducer in the extrinsic initiation is a membrane 
molecule called the death receptor (Nagata, 1997). A classic example of death receptor 
is CD95 also known as Fas /Apo -1, a member of the superfamily of tumour necrosis 
factor receptors. Both the intrinsic and extrinsic pathways converge on caspase -3, 
which drives the enzymatic cascade of activation of further caspases instrumental in 
splitting the cell into membrane -bound parcels. The caspases (cysteinated aspartate 
specific proteases) are proteolytic enzymes which carry out the cellular disassembly 
( Thornberry & Lazebnik, 1998; Thornberry, Chapman & Nicholson 2000). To cleave 
procaspase -3 into its active form, the intrinsic pathway assembles a complex called 
apoptosome, whilst the extrinsic pathway activates the upstream enzyme caspase -8. 
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Figure 1.1 Biochemistry of Apoptosis. The intrinsic pathway 
is dependent on the mitochondria whilst the extrinsic pathway 
is initiated by the death receptor. 
DISC 










DISC: Death Inducing Signal Complex; 
FADD: Fas-associated Death Domain; 
Apaf: Apoptosis protease activating 
factor 
Apoptosis: the intrinsic pathway 
When a cell is no longer enduring the stresses placed on it, the energy -generating 
mitochondria initiates the key event in committing the cell to controlled deconstruction 
(Hengartner, 2000). Mitochondria lose the electrical potential they maintain between 
their membranes, the mitochondrial membrane potential (MMP). This potential is 
maintained through an energy- dependent process. The membrane potential of the 
mitochondrion is lost whereupon proteins contained in the intermembrane space are 
released into the cytosol. The prime initiator of apoptosis normally restricted to this 
space, cytochrome -c, is then released into the cytosol. Other pro -apoptotic factors 
which are released include caspase -2 and caspase -9. In the cytosol, cytochrome -c 
interacts with another factor Apaf (apoptosis protease activating factor). Cytochrome -c 
binds to monomers of Apaf -1 allowing these to assemble into the heptameric 
apoptosome (Li et al., 1997). Apoptosome recruits procaspase -9 into the complex to 
cleave and activate it. Apoptosome complexes then cleave procaspase -3, at the 
convergent point in the initiation of apoptosis (Adams and Cory, 2002). Procaspase -9 
requires both cytochrome -c and Apaf -1 for its activation (Cain et al., 1999). 
Cytochrome -c release is a universal feature in apoptotic cell death (Green and Reed, 
1998). In apoptosis which is initiated extrinsically the release of cytochrome-c is a later 
event and occurs after the caspases have been activated. 
Apoptosis: the extrinsic pathway 
This system of apoptosis which results from transduction of the death signal through 
the death receptor also relies on the formation of a complex of molecules (Krammer, 
2000); Nagata, 1997). Members of the death receptors family share a similar scheme of 
substrate activation in the sequence of (1) ligand binding (2) receptor oligomerisation 
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and formation of DISC (death inducing signal complex) (3) recruitment of the adaptor 
molecule FADD onto the DISC (4) interaction of DISC with procaspase -8 and (5) 
cleavage and activation of procaspase -8. This cascade of activation is exemplified by 
the binding of ligand to Fas /Apo -1 (Baker and Reddy, 1998). This member of the 
tumour necrosis factor (TNF) receptor family is usually constitutively expressed on 
cells of the immune system. Its expression can however be induced in other cells as 
well, especially in inflammatory states. The ligand for CD95 /Fas had been identified 
(Suda & Nagata, 1994). Most members of the death receptor family have corresponding 
receptors similar to those of TNF -RI and TNF -RII for tumour necrosis factor. Fas- 
ligand is naturally occurring and may exist as a soluble factor exerting effects distally 
as well as proximally, or can be expressed on the surface of cells of the immune 
system, for example, lymphocytes exerting a direct cytotoxic effect upon encounter 
with a target cell. Upon engagement of the corresponding ligand at the cell- surface Fas 
oligomerises into a trimer (Ashkenazi and Dixit, 1998). Trimerization is essential for 
activity and the Fas- trimer engages the FADD (Fas- associated death domain) protein. 
This interaction happens between the corresponding death domains of Fas and FADD. 
These then incorporate procaspase -8 into the complex of DISC (death- inducing 
signalling complex). Procaspase -8 is then cleaved to form the active caspase -8 which is 
then released into the cytosol, where it will through proteolysis and activate 
procaspase -3, the convergent point in the initiation of apoptosis. Caspase -8 is the key 
initiator in the death -receptor pathway. When death -receptors are oligomerised through 
binding to their ligands, for example, three Fas- ligands to trimerise the Fas /Apo -1, the 
resulting trimer is thought provide a focal point for several pro -caspase 8 molecules to 
aggregate. It is predicted that the proximity of the procaspases, with their inherent 
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catalytic property, might eventually set off enzymatic cleavage of these into active 
caspases. However the exact activation event of procaspase -8 remains unknown. 
Apoptosis is the most common route of disposal for cells of the immune system. The 
circumstances where the expression of CD95 /Fas is most relevant are inflammatory 
conditions and clonal deletion of cells in the development of immune system. 
Moreover, as other cells may be induced to upregulate expression of CD95 /Fas, such as 
virus- infected cells, this death -signalling pathway is also the most common form of 
cytotoxic killing by lymphocytes and natural killer cells. 
Executors of apoptosis: caspases 
Caspases are the executors of apoptosis (Cryns & Yuan, 1998). They are deployed to 
bring about the dramatic morphological changes in a cell during apoptosis. Caspases 
are conserved through evolution and are found in insects, nematodes and hydra 
(Budihardjo et al., 1999; Cikala et al., 1999; Earnshaw et al., 1999). All enzymes of this 
family possess an activity specific cysteine, and cleave the Asp -Xxx bonds (i.e. after 
aspartic acid residues) of the substrates, hence the common name caspases (cysteinated 
aspartate specific activated proteases). Caspases are involved from the initiation 
through to the packaging of apoptotic cells. Genes coding for caspases in mammals 
have been matched to their counterparts in C elegans. Caspases act in a cascade where 
an upstream activated enzyme will, through proteolysis, activate the precursor 
downstream in a predetermined sequence (Nicholson & Thronberry, 1997). Several 
properties of caspases appear to be the key to the mobilisation of this cascade upon 
entry into apoptosis (Thornberry & Lazebnik, 1998). Proteolytic modification of 
caspases cannot be reversed. This ensures a unidirectional progress along the apoptotic 
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pathway. However, as expected of a highly regulated process, there are inhibitors of 
activated caspases at various levels of the cascade (Salvesen & Duckett, 2002). The 
rapidity with which apoptosis can be effected is linked to a pool of caspases ready for 
functional mobilisation, as most of the caspases already exist in precursor forms in 
living cells. The cascade of activation is facilitated by autocatalytic proteolysis caspases 
have upon themselves. The activation of caspases therefore can proceed exponentially. 
As cellular disassembly is an ordered sequence of catalytic events, with subcellular 
compartments undergoing varying degrees of modification, the caspases retains high 
specificity for the substrates involved. Since most of their actions render shutdown of 
many of the maintenance machineries in a cell, caspases generally render their 
substrates inactivated. 
Caspases exist in inactive precursor forms in the cell. In this zymogen state they consist 
of three domains, an N- terminal prodomain, and the p20 ( -20kD) and p10 ( -10kD) 
domains. The caspases are cleaved between the domains. The p20 subunit and p10 
subunit then associate to form a heterodimer which further associate to form a tetramer 
with active sites. The active site of each p20/p10 dimer comprises of residues from both 
subunits and both are essential for substrate binding and catalysis (Walker et al., 1994; 
Wilson et al., 1994). The active sites uniformly have the residue sequence of Asp -Xxx 
which enables caspases to effect autocatalytic activation. This positive feedback loop is 
probably pivotal to the amplification of the cascade. Such sequences of activation 
group caspases as initiators and effectors. 
The caspases are targeted toward specific substrates within the cell. The substrates may 
either lose their functions or gain new functions. Gain of function results from removal 
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of regulatory or inhibitory units. In apoptosis most of the caspase substrates are 
inactivated through proteolysis. Many of these substrates are nuclear related proteins. 
One of these is a nuclease (known as caspase activated DNAse, CAD) which cuts the 
genomic DNA at internucleosomal segments generating DNA fragments in multiples of 
roughly 200 base pairs (Nagata et al., 2000). In non -apoptotic cells CAD exists coupled 
to ICAD in an inactive precursor form. Activation of CAD occurs through caspase- 
cleavage release of the inhibitory unit it carries (ICAD) (Enari et al., 1998). The DNA 
repair enzyme PARP (poly(ADP- ribose) polymerase is disabled through cleavage by 
the caspases. The changes in the nucleus with attendant shrinkage and clumping are 
mediated by caspase acting on nuclear lamins (intermediate filament proteins) 
(Takahashi et al., 1996; Orth et al., 1996). Nuclear lamins which polymerise to form the 
limiting partition ie. nuclear lamina are cleaved by the caspases, leading to collapse of 
this structure which contributes to chromatin condensation. The changes in cell shape 
also result from action of caspases on their substrates (Coleman et al., 2001). These act 
on the cytoskeleton bringing about cytoplasmic condensation. Caspase -3 acts directly 
on the cytoskeleton kinases and one of the effect is the phosphorylation of myosin light 
chain (MLC) which is associated with the formation of blebs from the plasma 
membrane (Wen et al., 1997; Rudel & Bokoch, 1997). 
Caspase -3 is the convergent point of the intrinsic and extrinsic pathways of apoptosis 
initiation. Occurring as an inactive precursor procaspase -3 it resides in the cytosol 
within access by the initiators. When cleaved by caspase -8 or the apoptosome as 
described earlier, the active enzyme catalyses several reactions which initiate the 
changes in the cytoskeletal structure of the cell and the breakdown of nucleus into 
oligonucleosomal packets. 
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Regulatory points in the apoptotic pathways 
The patterns of caspase activation involve amplification loops and positive feedbacks 
which would culminate in a quick death for the cell. Actions of caspases however are 
subject to regulation. Controls occur at key activation points. Antagonists and agonists 
for the caspases exist and it may be the integration of the overall effects of these which 
determine if apoptosis will proceed. This is an interesting area of studies where new 
factors which inhibit or regulate the caspases are frequently being reported. The 
following brief review of the better characterised systems will serve to illustrate some 
known interactions. In the intrinsic pathway at the level of the initiator caspase -9 are 
the Bc1 -2 family of proteins. This is a very large family of proteins the members of 
which have either anti -apoptotic or pro -apoptotic properties. The various members are 
involved in balancing apoptotic signals within the cytoplasm, the net of which may 
depolarise the mitochondrial membrane potential to initiate apoptosis (Adams & Cory, 
1998). 
Regulators at mitochondria: Bcl -2 family proteins 
The proto -oncogene Bcl -2 was first discovered at the chromosomal breakpoint of 
t(14;18) in human B -cell lymphomas (hence bel) (Adams & Cory, 1998). To date at 
least 15 members of this huge family of modulators have been identified. The Bc1 -2 
proteins comprise of a large family of members which share certain sequence 
homology. However they have opposing functions and are divided into three groups. 
Group I members possess anti -apoptotic activity whilst members of groups II and III 
share pro- apoptotic activity. Prior to activation of apoptosis, the anti -apoptotic 
members reside on the cytoplasmic side of membranes of mitochondria, endoplasmic 
reticulum and the nuclear envelope. One of the reasons for such localisation may be 
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that these members register damage to these subcellular compartments, and effect 
changes to their functions, or effect cytoplasmic signalling eventually integrating these 
into the balance of apoptosis -related signals. On the other hand, the pro -apoptotic 
members localise predominantly to the cytoskeleton. The key function of anti -apoptotic 
Bc1-2 members appears to be resisting the release of pro -apoptotic signals from the 
mitochondria (Gross et al., 1999). The exact manner in which the opposing actions of 
the various Bcl -2 proteins balance out remains elusive. In Caenorhabditis elegans, the 
anti -apoptotic homologue CED -9 prevents the setting in of apoptosis through binding 
to and sequestering the Apaf -1 homologue CED -4 (Metzstein et al., 1998). 
The key regulatory point where anti -apoptotic Bcl -2 protein acts appears to be the 
release of apoptogenic cytochrome -c from the mitochondria (Antonsson & Martinou, 
2000). On the other hand it had been reported that cytochrome -c may be released 
through interaction with pro -apoptotic Bcl -2 with isolated mitochondria. It has not been 
fully elucidated as to how this can be effected but the following working hypotheses 
had been forwarded: 
1. Bcl -2 members form channels in the mitochondrial membrane facilitating protein 
transport. 
2. Bc1 -2 members interact with other proteins to form channels. Some members can 
interact with voltage dependent anion channel. 
3. Bcl -2 members induce rupture of the outer mitochondrial membrane. 
It is assumed that the overall balance of pro- and anti -apoptotic Bcl -2 members would 
determine if the caspases may proceed with apoptotic missions. An important 
characteristic of Bcl -2 members, lending support to this belief, is that these proteins can 
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form heterodimers which may render opposing actions neutralised. The inhibition of 
the intrinsic pathway by Bc1-2 is usually bypassed by the death receptor pathway. The 
effects of the anti -apoptotic members of Bc1-2 proteins have been confirmed in cancers 
and cell cultures studies. Protection afforded by the Bc1-2 members applies to a range 
of cytotoxic drugs, gamma and ultra -violet irradiation; cytokine withdrawal, 
dexamethasone and staurosporine (Kulkarni and McCulloch, 1994). 
Regulation at death receptor: FLIPs 
The activation of procaspase -8 may also be regulated through inhibition. A class of 
proteins called FLIPs (FADD -like ICE inhibitory proteins) have been discovered to 
share similar sequence with procaspase -8 but lack the essential residues involved in 
catalysis (Shu et al., 1997; Irmler et al., 1997). In some cases of death initiated through 
death receptors the exit of cytochrome -c into the cytosol is probably secondary to an 
overriding pro -apoptotic assembly of caspases and Bc1 -2 members. 
Regulation of apoptotic signals: IAP and caspase -3 
Recently a family of genes encoding for proteins which confer inhibitory effects on 
caspases had been discovered. First isolated in baculovirus (Crook, Clem & Miller, 
1993), homologues had been identified in humans (Roy et al., 1995; Rothe et al., 1995). 
These are the inhibitors of apoptosis IAP (Salvesen & Duckett, 2002). The IAP proteins 
act at the level of activated caspases eg. caspase -3 (Deveraux & Reed, 1999). IAPs 
exhibit high affinity binding to caspase -3 and mask the active site. Inhibition occurs 
through steric occlusion of the normal substrates of the caspase. This binding is 
reversible. 
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Regulation of apoptotic signalling prevents unwarranted cell death. Controls act at the 
level of signal integration via factors like the Bc1-2 proteins and FLIPs. These prevent 
the maturation of the initiator caspases, caspase -9 and caspase -8. Further downstream 
IAPs prevent the actions of the effector casnase -3. Apoptosis may therefore be 
modulated at its initiation as well as execution phases. It is hoped that with targeted 
manipulation at these points, death may be effected in cancer cells resistant to cytotoxic 
agents (Jansen et al., 1998; Waters et al., 2000); degenerative disorders such as 
cardiomyopathy may be delayed or reversed (Mocanu et al., 2000); severity of 
ischaemic injuries may be lessened (Endres et al., 1998); and sepsis and its systemic 
sequelae may be halted (Hotchkiss et al., 1999). 
Phosphatidylserine: a membrane marker of apoptosis 
In addition to the dramatic changes of pinching off through blebbing, the plasma 
membrane of an apoptotic cell also acquires distinct characteristics. Acquisition of 
some of these characteristics has been noted to be directly related to the activation of 
caspases (Martin et al., 1996; Naito et al., 1997). The best characterised change in the 
plasma membrane of an apoptotic cell is the externalisation of phosphatidylserine PS 
(Martin et al., 1995). Phosphatidylserine is an essential component of plasma 
membrane and probably serves to maintain membrane integrity. This anionic 
phospholipid is actively retained on the inner leaflet of the plasma membrane of normal 
cells through the actions of transporter -enzymes called translocases. The balance of 
inward and outward fluxes of PS is balanced by translocases and the equilibrium is 
tipped to this asymmetry in normal viable cells. During apoptosis additional activities 
of a protein called scramblase keeps the PS residues flipped to the outer leaflet of the 
plasma membrane (Frasch et al., 2000). Externalisation of PS is an event downstream 
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of activation of caspase -1, also known as interleukin -1 -beta converting enzyme (ICE). 
Exposure of PS was shown to be prevented by the pan- caspase inhibitor Z -VAD 
linking it intimately to caspase activation (Naito et al., 1997). This caspase- dependent 
event was also noted to be independent of nuclear events in apoptosis. Preparations of 
enucleated cytoplasts displayed PS on the membranes when caspase -1 within these was 
activated (Martin et al., 1996). The externalisation of PS has also been shown to be an 
early uniform feature of apoptosis regardless of the initiating stimulus. Over expression 
of anti -apoptotic Bc1 -2 members prevents the surfacing of PS externally (Martin et al., 
1995). This indicates the exposure of PS is effected only after a cell is committed to 
apoptosis. This event usually precedes the loss of plasma membrane integrity by 
several hours as observed with in vitro studies. 
Presently the exposure of PS on cell membranes is generally accepted as a feature of 
ongoing apoptosis (Martinez and Freyssinet, 2001). The exposed PS residues are 
marked by interaction with a molecule called Annexin -V. The binding of Annexin -V to 
cell membranes can be visualised through flow cytometry or immunofluorescent 
microscopy. Positive membrane binding for Annexin-V is one of the most commonly 
used criteria for identifying apoptotic cells. 
Clearance of apoptotic cells 
The restructuring of an apoptotic cell into membrane bound bodies sets the foundation 
for the next step in defining the apoptotic process. Apoptotic bodies necessitate 
disposal. It is generally accepted that this task may be undertaken by neighbouring cells 
or by tissue macrophages, in the capacity of non -professional and professional 
phagocytes respectively (Fadok, Bratton & Henson, 2001). In fact it has been proposed 
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that the crucial feature of apoptosis in vivo is that it leads to the recognition and 
engulfment of intact cells or membrane -bound apoptotic bodies by phagocytes (Savill 
et al., 2002). Observations in normal tissues typically find a paucity of apoptotic cells 
implying that apoptotic cells are normally expediently and efficiently cleared. The 
interface between an apoptotic cell and a macrophage is likely to implicate a host of 
reactions between signals and receptors (Hengartner, 2001; Ravichandran, 2003). There 
are probably several changes on the surface of a cell declaring apoptotic -self in contrast 
to normal -self (Savill, 2002; Krieser & White, 2002). Correspondingly there may be 
receptors on the macrophage specific for these alterations on apoptotic cells. The 
physiological milieu within which this interaction occurs may also supply factors in 
supplemental roles for this. It is generally accepted that following recognition and 
engulfment of apoptotic bodies, an immunosuppressive effect is elicited within 
macrophages (Savill, 1998; Savill & Fadok, 2000). Intense studies in the past decade 
have revealed much about the clearance of apoptotic cells and derangements in this 
process has been linked to many immunity and inflammatory disorders (Henson et al., 
2001). It is anticipated that uncleared apoptotic bodies would eventually undergo 
necrotic degradation exposing a multitude of hitherto excluded cellular antigens. The 
auto -antibodies in the autoimmune disease systemic lupus erythromatosus (SLE) reflect 
sensitisation of the adaptive immune system by auto -antigens like nucleic acids and 
other nucleoproteins (Casciola -Rosen et al., 1994; (Rosen and Casciola- Rosen, 1999). 
Interests in the factors that define the fate of apoptotic cells are immense, and it is 
hoped that some of the observations may soon translate to therapeutic principles. 
Among the signals on the apoptotic -self, some facilitate tethering to the phagocyte; 
some initiate engulfment, whilst others may mediate both attachment and engulfment 
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(Krieser & White, 2002). Several of these interactions have now been characterised. It 
appears that redundancy occurs with these interactions and no single signal possesses 
an overriding dominant effect. The central role of the macrophage as a professional 
tissue phagocyte has implicated the innate immune system as essential for this 
physiological outcome. This area of research is intense and new candidate ligand - 
receptor interactions are reported regularly. To date, several of the interface interactions 
have been well characterised. The examples elaborated below are not exhaustive but 
serve to illustrate the framework with which membranes on apoptotic cells are 
identifiable from normal membranes and how uptake of apoptotic cells is initiated. 
Recognition of apoptotic cells: PS and PS receptor 
Phosphatidylserine (PS) residues externalised on the plasma membrane is one of the 
most extensively studied characteristics which is central to the interaction between 
apoptotic cells and the macrophage (Fadok et al., 2001; Fadok et al., 1992) (Figure 
1.2). PS is recognised by both macrophages and non -professional phagocytes. A 
putative receptor on the macrophage has in fact been cloned (Fadok et al., 2000). This 
PS receptor was recently demonstrated to be pivotal in mediating engulfment (Hoffman 
et al., 2001). Ligation of PS receptors in macrophages to PS vesicles and PS- coated 
cells was crucial in stimulating uptake through macropinocytosis. However, PS did not 
appear to be significantly involved in tethering apoptotic particles to macrophages, as 
PS residues alone promoted poor binding of the particles to macrophages. Mere 
tethering was differentiated from engulfment by feeding red blood cells together with 
various antibodies and ligands to macrophages followed by lysing those which had not 
been ingested. Most of the other known putative receptors, when exposed to their 
respective ligands on the red blood cells did not result in engulfment. 
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Figure 1.2 Phagocytosis of apoptotic cell involving 
phosphatidylserine residues. The receptors on phagocytes are 
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The role of the PS receptor in phagocytosis is further supported by in vitro observations 
that reducing the expression of the PS receptor in phagocytes, by transfection ith 
small -interfering RNA, decreased phagocytosis of apoptotic targets (Wang et al., 2003). 
In vivo, however, the evidence is less conclusive (reviewed by Williamson and 
Schlegel, 2004). Murine knockouts of the PS receptor gene (psr) display various 
developmental defects in the lungs and brain (Li et al., 2003), as well as in 
erythropoietic and T- lymphocytic lineages (Kunisaki et al., 2004). These defects were 
attributed to reduced clearance of apoptotic cells by macrophages in in vivo assays. In 
contrast, Bose et al. (2004) observed no defect in apoptotic clearance in the psr 
knockout mouse. It has been suggested that the method of PS receptor isolation by 
Fadok et al. (2000) might have identified non -specific candidates (Williamson and 
Schlegel, 2004). The authors had used a phage display library probed with the PS 
receptor antibody, which could be sensitive to weakly- reacting epitopes. 
PS is also exposed on the cell membrances of necrotic cells, through membrane 
permeabilisation, and would be recognised and processed by phagocytes. It was 
observed that macrophages bound and engulfed necrotic and apoptotic cells to similar 
extents and with similar saturable kinetics (Cocco & Ucker, 2001). Binding and 
engulfment of both apoptotic and necrotic cells by macrophages appeared to be 
dependent on PS. This suggests that recognition of PS exposure by macrophages is a 
not a unique initiating event for phagocytosis of apoptotic cells, as necrotic cells also 
utilise this mechanism. 
In conclusion, the functions of the PS receptor in phagocytosis of apoptotic cells 
remain elusive. A further complicating observation localises the PS receptor in Hydra 
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to the nucleus instead of the cell surface (Cikala et al., 2004). Nuclear localisation 
signals in the receptor protein sequence appear to be conserved in several species, 
including those in mammalian, C. elegans and Drosophila homologues. This finding 
poses a challenge to the role of the PS receptor as a cell surface mediator of 
phagocytosis. 
Other receptors recognising PS 
Phosphatidylserine may also be recognised by other receptors (Figure 1.3). A member 
of the receptor tyrosine kinase family Mer has been reported to be involved in 
phagocytosis of apoptotic cells. It is expressed in phagocytes and this represents a 
novel function for the molecule. The phagocytic deficiency, on knockout of the Mer 
gene, was restricted to apoptotic cells whilst Fc receptor- mediated phagocytosis or 
particle ingestion was unaffected (Scott et al., 2001). It was found that whilst the 
macrophages from mer- knockout mice showed deficiency in the engulfment of 
apoptotic thymocytes. The macrophages were, however, equally competent in ingesting 
Listeria monocytogenes as compared to wild -type macrophages, pointing to a role for 
mer in the recognition of apoptotic cells. The mer tyrosine kinase probably uses GAS6 
(growth arrest specific protein 6) as a bridge to phosphatidylserine (Nakano et al., 
1997). Mer has been shown to bind to GAS6 whilst GAS6 has been demonstrated to 
bind to phophatidylserine residues on apoptotic cells. The ligand for mer might be 
phosphatidylserine on apoptotic cells via a bridging interaction between PS and GAS6 
to mer. It was suggested that the cytoplasmic domain of the mer receptor may trigger 
the engulfment mechanism in macrophages. 
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Figure 1.3 Interaction using non- phosphatidylserine 
residues. Receptors on the macrophages involved in 
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The secreted milk fat globule -EGF- factor 8 protein (MFGE -8) was reported to link 
apoptotic cells to phagocytes (Hanayama et al., 2002). It is produced and secreted by 
thioglycollate activated macrophages and binds to aminophospholipids such as 
phosphatidylserine. This binding competed with that of Annexin V. When added to 
fibroblasts expressing high level of alpha -v beta -3 integrin, phagocytosis of apoptotic 
cells was greatly promoted. Therefore it appears that MFGE -8 recognises PS residues 
on apoptotic cells and bridges these to phagocytes expressing the vitronectin receptor 
(av-ß3 integrin). The display of PS on the surface, a uniform feature on apoptotic cells, 
therefore seems to be recognised by several receptors thus enhancing the expedient 
identification of these by phagocytes. Whilst PSR appears to be specific in mediating 
engulfment many other receptors would appear to facilitate the process by maximising 
the juxtaposition and tethering of apoptotic bodies to phagocytes. 
CD36, a member of the class B scavenger receptors on macrophages, was one of the 
first to be implicated in recognition of apoptotic cells (Savill et al., 1990; Savill et al., 
1992). CD36 was shown to interact with the vitronectin receptor ( a,, -ß3 integrin ), 
expressed on the surface of leukocytes, and this cooperation employed thrombospondin 
as a molecular bridge to recognise apoptotic cells. The factor on the apoptotic cell 
being recognised has not been identified (Moodley et al., 2003). CD36 is also involved 
in endocytic clearance of oxidized low -density lipoprotein (oxLDL) present on the 
surfaces of apoptotic cells (Chang et al., 1999; Kagan et al., 2002). Apparently, 
oxidation of the membrane phospholipids results in oxLDL -like sites on apoptotic cells, 
which is required for recognition by macrophages. 
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Class A scavenger receptors on macrophages and other phagocytes have also been 
implicated in the recognition of apoptotic cells (Platt et al., 1996). The 
asialoglycoprotein receptor on hepatocytes can function in the ingestion of apoptotic 
cells (Dini et al., 1992). This is consistent with the observation that apoptotic cells lose 
sialic acid residues from complex carbohydrates on their surfaces (Duvall et al., 1985). 
Interestingly, apoptotic cells can switch repulsive signals which are recognised by 
receptors on phagocytes into non -repulsive signals. One such molecule involved in this 
switch is CD31, which has been reported to mediate binding and ingestion of apoptotic 
cells by macrophages (Brown et al., 2002). In viable leukocytes, CD31 mediates 
detachment from phagocytes in viable leukocytes. However, this CD31- dependent 
activity is absent in apoptotic leukocytes, promoting tethering of apoptotic cells to 
phagocytes and possibly aiding ingestion. 
Recognition of apoptotic cell: innate receptors 
A host of pattern recognition receptors are employed in the innate immune system to 
recognise non -self antigens such as those of microbes. There is evidence to suggest a 
role for these in the recognition of apoptotic cells. One such candidate is the 
lipopolysaccharide (LPS) receptor CD14 on macrophages utilised to bind gram 
negative bacterial antigens. It has been implicated in the recognition and engulfment of 
apoptotic cells (Devitt et al., 1998). Using a monoclonal antibody which binds to the 
surface of macrophages and specifically inhibits interaction with apoptotic cells, the 
authors confirmed the epitope recognised to be part of CD14. The region of CD14 
implicated was close to that which recognised LPS. The anti -inflammatory response to 
apoptotic cells however was preserved upon ligation of CD14. It was therefore 
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suggested that distinct downstream responses were possible with CD 14. The ligand for 
CD14 on apoptotic cells however has so far not been identified, though ICAM -3 is a 
possible candidate (Moffatt et al., 1999). 
The innate immune system with the employment of pattern recognition receptors seems 
well poised to play a major part in the clearance of apoptotic cells. The nonclonal 
system of recognition would fit well with the demand of a disposal system for cells 
undergoing physiological death (Medzhitov & Janeway 1997). This system is mainly 
executed by the evolutionary conserved family of Toll -like receptors on macrophages 
( Medzhitov, 2001), which recognize bacterial antigens and activate downstream pro - 
inflammatory events (Underhill & Ozinsky, 2002). However there has not been any 
conclusive evidence of the involvement of Toll -like receptors in the recognition and 
uptake of apoptotic cells. Toll -like receptors appear unlikely to be utilized in the 
recognition and phagocytosis of apoptotic cells (Blander & Medzhitov, 2004). 
However, the matter may be more complicated. The close associate of Toll -like 
receptor, CD14, which binds bacterial lipopolysaccharide (LPS) has been implicated in 
the recognition of apoptotic cells, albeit at a site not identical to the LPS -binding 
moiety (Devitt et al., 1998). 
Innate recognition: a role for serum factors 
The complement system of the innate immune system had also been shown to have a 
role in the clearance of apoptotic cells. A member of the first component in the classical 
pathway, Clq has been linked to uptake of apoptotic cells. Deficiency in this protein is 
associated with autoimmune diseases. Cl q knock -out mice demonstrate features of 
systemic lupus erythromatosus (SLE). The complement factor Cl q binds to the blebs 
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on apoptotic cells. Incubating Clq with apoptotic cells maintained in serum -free 
conditions facilitated uptake by phagocytes (Ogden et al., 2001).. It was found that C I q 
engaged surface calreticulin (CRT) on phagocytes. This surface CRT, a calcium 
sequestering chaperone is associated with CD91, an endocytic receptor protein on the 
phagocyte membrane. Upon interaction with C 1 q the complex initiated uptake of 
apoptotic cells through macropinocytosis. In the absence of C 1 q this targeting toward 
apoptotic cells would be less efficient. The apoptotic bodies would likely undergo 
necrotic lysis releasing self antigens which were normally excluded from the immune 
response. This therefore might be a key event in the initiation of autoimmune response. 
In the same study, Ogden et al. also reported similar observations with mannose- 
binding lectin (MBL). MBL is a member of the collectin family which binds specific 
pathogen- associated molecules such as those on bacteria. They concluded that uptake 
of apoptotic cells involved pattern recognition molecules of the innate immune system. 
The moiety on the blebbing membrane of apoptotic cells recognised by C 1 q or MBL 
had yet to be characterised. 
The antigen BOB78: a surface marker of apoptotic cells 
A novel monoclonal antibody called BOB78 isolated in the Lister Research Laboratory 
was found to identify apoptotic neutrophils through membrane binding. Following 
inoculation of mice with human leukaemic myeloid THP -1 cells, hybridomas using the 
splenic cells were cultured. From the panel of retrieved antibodies BOB78 was found 
through flow cytometry and indirect immunofluorescence to identify apoptotic cultured 
neutrophils. BOB78 is an IgM isotype antibody. The population of neutrophils 
identified was thought to be in late apoptosis (Hart et al., 2000). It was found that the 
BOB78 antigen was normally present in the cytoplasm of neutrophils. The quantity of 
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BOB78 antigen within neutrophils did not change dramatically upon apoptosis. It 
appears that BOB78 is a cytoplasmic antigen which translocates to the plasma 
membrane in apoptotic cells. 
There had been repeated attempts to purify the BOB78 antigen through immuno- 
precipitation; however, it had proved difficult. The proteolytic activities within 
apoptotic neutrophils might have contributed to this difficulty in spite of the fact that 
the BOB78 antigen is present in the cytoplasm normally. The titre of BOB78 antibody 
in the supernatants of cultured hybridomas might also have been a limiting factor. 
Aims of the project 
The studies undertaken were aimed at elucidating the nature of the antigen identified by 
the monoclonal antibody BOB78. 
With the knowledge that BOB78 identified a population of apoptotic neutrophils as 
reported earlier (Hart, Dransfield et al., 2000), further characteristics of BOB78 which 
attracted particular attention were: 
1. Is the BOB78 antigen a common feature on most apoptotic cells? 
2. At which stage of apoptotic changes does the antigen recognised by BOB78 appear 
on the membrane of cells? 
3. What is its normal turnover and location in cells 
4. The nature of the BOB78 antigen as determined through sequencing 
The studies I had carried out had been targeted to addressing these questions with the 





(see Appendix I for materials) 
Cell Culture & Maintenance 
In vitro cultures of various cell lines were maintained in standard conditions of 
commercial medium supplemented with 5 to 10 per cent by volume of foetal calf serum 
(FCS). The cultures were incubated at 37 °C in humidified air with 5% carbon dioxide. 
Leukaemic cell lines which included the monocytic THP -1 and megakaryocytic MEG- 
01 were maintained in RPMI (GibcoBrl); whilst epithelial cell lines hepatoma HUH -7 
and pancreatic Mia were maintained in DMEM (Dulbeco's Modified Eagle's Medium, 
GibcoBrl). THP -1 and MEG -1 cells were usually maintained in log -phase at a density 
of 8 - 10 x 105 cells /ml in medium, and subcultured by diluting 1/3 in fresh medium 
every 2 days or as indicated by the change in pH of the medium. HUH -7 and Mia cells 
which were grown in monolayers were subcultured after detachment through 
trypsinisation when the cells reached confluency. 0.05% trypsin in 2mm EDTA was 
added to the cell monolayers after 2 washes in PBS (phosphate buffered saline). After 
incubating with 10mis of trypsin per 75cm2 flask for 30 seconds at 37 °C, the trypsin 
was decanted leaving only a thin film. A further incubation of 5 minutes usually 
sufficed to detach the cells when these were easily dislodged with sharp taps to the side 
of the flasks. The activity of trypsin was aborted with fetal calf serum, and the detached 
cells were suspended in 10% FCS / DMEM. After two further washes in 10% 
FCS /DMEM the cells were plated 1/3 - 1/5 onto the flasks, which would usually keep 
the cells in log phase of growth. 
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A. Induction of apoptosis 
Human leukaemic THP -1 cells were diluted to 1 x 106 cells /ml in fresh medium, and 
synchronised through S -phase arrest by incubating with 2mM thymidine for 16 hours. 
The cells were released from the thymidine block by washing in large quantities of 
RPMI at least twice. The cells were then resuspended at 1 x 106 cells /ml in 
RPMI /10 %FCS. Apoptosis was induced with 31.LM camptothecin (CPT, Sigma) in 
culture, with typically 15 to 20 per cent of cells apoptotic by 6 hours. 
B. Measuring cellular DNA content with propidium iodide on flow 
cytometry 
Cells were collected from culture and washed in cold PBS through centrifugation at 
1000g for 5 minutes at room temperature. To each tube was pelleted 1 x 106 cells which 
were resuspended in 1ml of nuclear staining solution containing propidium iodide in 
sodium citrate and Nonidet 40 (refer to appendix for materials). To each tube was then 
added 1 ml of RNAse solution. The reaction was incubated in the dark for 30 minutes 
at room temperature. The tubes were then processed through cytometry using FL3 to 
read off fluorescence from propidium iodide bound to cellular DNA. 
C. Neuraminidase digestion of cells 
Human leukaemic THP -1 cells were harvested, washed and resuspended to a 
concentration of 10 x 106 cells /ml in normal saline (154mM NaC1). Neuraminidase -X, 
a deglycosylating agent isolated from Clostridium perfringens (Sigma), was added to 
the THP -1 cells to a concentration of 0.1U /ml. Cells were incubated for at least 30 
minutes at 37 °C with constant mixing. The cells were washed with PBS /BSA1% as 
before prior to immunostaining for flow cytometry. 
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D. Tunicamycin inhibition of N- linked glycosylation 
Human THP -1 cells were harvested and maintained in fresh culture medium of 
RPMI /10% FCS at a density of 1 x 106 cells /ml. Cells were incubated with 
neuraminidase -X (Clostridium perfringens, Sigma) at a concentration of 0.1 U /ml for at 
least 1 hour at 37 °C in 5% CO2 atmosphere. Cells were then washed in medium before 
returning to culture in tunicamycin concentrations ranging 0 - 1001ag /ml (Sigma) for 18 
hours. The cells were then harvested and washed and processed for immunolabelling 
for flow cytometry. 
E. Inhibition of biosyntheis- secretory pathway 
Human leukaemic THP -1, hepatoine HUH -7 and pancreatic Mia cells were cultured 
and treated with monensin or Brefeldin -A. Monensin is a Na+ ionophore which blocks 
glycoprotein secretion. Brefeldin -A is a fungal metabolite which disrupts the structure 
and function of the Golgi apparatus (Sigma catalogue). 
Immunocytochemistry 
Cells were either grown in chamber slides or centrifuged onto adhesive microscopic 
slides. Cells were washed in PBS and drained well. Fixation was achieved by 
immersion in a large volume of cold methanol (previously kept at -20 C) for 10 -15 
minutes on ice. Slides were either rinsed in PBS or washed in a PBS bath for 20 
minutes. Primary antibodies were added at 1O0111 per chamber or 50 - 100111 per slide, 
and incubated for about 60 minutes at room temperature. Slides were then washed in 
PBS for 10 minutes. A total of 3 washes were performed before the addition of 
secondary antibodies. Aliquots of l0411 per chamber, or 50 - l04.1 per slide, of 
secondary antibodies eg. FITC and TRITC- conjugated antibodies (DAKO) were added, 
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used at 1:20 and 1:50 dilution respectively. Slides were then incubated in the dark for 
60 minutes at room temperature, then washed 3 times in PBS as before. Nuclear 
counter -staining was performed with 1001l per slide of TO -PRO 3 (4111 /m1 dilution, 
Cambridge Bioscience) for 5 - 10 minutes at room temperature. Finally, slides were 
rinsed in distilled water, mounted with a cover slip using fluorescent mounting medium 
(DAKO) and kept in the dark until the mounting medium dried. 
Flow Cytometry 
A. Detection of surface antigens 
Cells grown in suspension eg. THP -1 were used. The cells were collected from 
suspension culture by centrifugation (room temp or 4 °C) at 550g for 5 minutes. Half to 
one million cells in a single tube were stained with l µg of primary antibodies. The cells 
were washed twice with phosphate buffered saline containing 1% bovine serum 
albumin (PBS / 1 %BSA) and collected into a pellet at 550g for 5 minutes. Blocking of 
non -specific background staining was effected with 20% normal rabbit serum in PBS 
for at least 20 minutes at room temperature (or 4 °C). Primary antibodies at 1 11g per 
50111 of PBS / 1 %BSA were added to 0.5 - 1 x 106 cells and incubated for at least 30 
minutes at room temperature (or 60 minutes at 4 °C). The cells were washed twice with 
lml of PBS / 1 %BSA per tube to remove the unreacted primary antibodies. Secondary 
antibodies (eg. PE and FITC -conjugated antibodies) at 0.5 11g / 50111 were added per 
tube and incubated for at least 30 minutes at room temperature (or 4 °C). After this the 
cells were washed twice as before and resuspended in 1% formaldehyde in PBS at 1 ml 
per tube (ie. 0.5 - 1 x 106 cells). 
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Cells were analysed by the Coulter EPICS XL Cytometer using the Exporn132 ADC 
Analysis program. FITC was excited by a 15mW argon laser at 488nm, and detected in 
the FL1 channel using a 525 bandpass fluter with a detection range of 505- 545nm. PE 
was detected in the FL2 channel using a 575 bandpass filter with a detection range of 
560- 590mn. 
B. Detection of intracellular antigens 
To permeabilise the cells for intracellular staining, cells were pelleted at 550g for 5 
minutes. The medium was decanted off carefully and completely, and cold 4% 
paraformaldehyde was added. Cells were kept in melting ice for at least 15 minutes and 
pelleted. Paraformaldehyde was decanted off and cold methanol (100% kept at -20 °C) 
was immediately added. Cells were kept in melting ice for 30 minutes, pelleted, and 
washed twice with PBS. The cells were then blocked in 20% rabbit serum as described 
above (Pollice et al., 1992; Tsan et al., 2000). 
C. Surface and nuclear staining of cells undergoing apoptosis 
For surface staining of cells undergoing apoptosis, staining and washings were 
performed at 4 °C. Fixation with 1% paraformaldehyde / PBS was ommited. Cells in 
each tube were resuspended in 100 µl of 0.02% propidium iodide (2 µg /ml) in PBS no 
more than 5 minutes before flow cytometry. Propidium iodide staining was detected in 
the FL3 channel using a 620 bandpass filter. 
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D. Fixation and immunolabelling of erythrocytes 
Fixation 
Erythrocytes were washed in PBS and resuspended in l00111 PBS. 1 ml PBS containing 
50µg /m1 sodium dodecyl sulphate (SDS) and 1mg /ml bovine serum albumin (BSA) 
was added. After 1 minute, 9.7ml PBS, 0.3ml formalin (37% formaldehyde in PBS) 
and 1011g /m1 SDS were added. After 90 minutes, 0.8ml formalin was added and left at 
room temperature overnight. The cells were washed in PBS and the procedure was 
repeated without the addition of BSA. The fixed cells were finally washed in PBS and 
resuspended in a concentration of 2 X 107 cells /ml PBS containing 5mg /m1 BSA and 
0.1% sodium azide. 
Immunolabelling 
50µ1 (106 cells) of fixed eryhrocytes was added to the FITC or R- PE- labelled antibody 
solution. Cells were incubated for 1 hour at room temperature in the dark and washed 
once in PBS containing 1% BSA before immunodetection by flow cytometry. 
Immunoprecipitation with BOB78 antibody 
A. Preparation of cell lysate 
Cells were washed once with cold PBS and pelleted by centrifugation. Cells were lysed 
by adding TENT lysis buffer (10mM Tris -HCL, 5mM EDTA, 150mM NaCI, I% 
Triton -X 100, and freshly added protease inhibitors cocktail), mixed well through 
pipetting and left to incubate for 30 minutes on melting ice in the cold room. The 
mixture was then centrifuged at 12,000g for 10 minutes to clarify the lysate, pelleting 
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out undigested membranes and nuclei. The supernatant was carefully harvested and 
passed through a 23G needle for 3 times to shear any DNA present in the lysate. 
Measurement of protein concentration was performed with the Biorad kit using 
albumin dilutions as standards, and absorbanc? at 590nm was measured using a Bio- 
Rad spectrophotometer. 
B. Immunoprecipitation: incubation of lysate with antibodies 
The cell lysate for immunoprecipitation was precleared of non -specific binding by 
incubating with protein A Sepharose beads for 1 hour on ice. Prior to this, the beads 
had been collected by centrifuging at 150g for 30 seconds and washed once with excess 
lysis buffer containing protease inhibitors. 10111 of beads was added to 1001A1 of cell 
lysate (about 500µg protein). Meanwhile fresh beads were washed as above and most 
of the washing lysis buffer was removed. These were then conjugated to a bridging 
antibody by adding 10111 ( =1011g) of rabbit anti mouse IgM (DAKO), and incubated on 
melting ice for 2 hours in the cold room. Next 20µ1 of the conjugated beads was 
incubated with 200µ1 of anti -BOB78 supernatant (IgM variety) on melting ice for 2 
hours to capture the IgMs. The IgM -loaded beads were then incubated with the 
precleared lysate overnight in the cold room on ice. 
C. Collecting the immunoprecipitates 
The beads were collected by centrifuging at 350g for 30 seconds. These were washed 3 
times, each time by pelleting at 350g for 30 seconds, resuspending in 500111 of lysis 
buffer containing protease inhibitors, and agitating for 10 minutes on a rotating 
platform. The immune complexes were released from the beads by incubation with 
24.1 of 5X loading buffer (2% SDS) and boiling at 95° C for 5 minutes. The proteins 
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were then separated on a 12% SDS polyacrylamide gel which was run at 200V for 
about 75 minutes. 
One half of the gel was stained with colloidal Coomassie Blue (Gelcode) while the 
duplicate half was blotted onto nitrocellulose membrane. Immunoreactions on the 
Western blots were performed as described below. The transferred antigens were 
probed with antibodies including BOB78 antibody. 
Western blotting 
A. Denaturing protein electrophoresis and blotting 
Protein samples were prepared to contain 1/4 volume of the 4X loading buffer which 
included 10% sodium dodecyl sulphate and 5% 2- beta -mercaptoethanol (see appendix 
under Protein electrophoresis and Western blotting). The samples were denatured by 
heating at 95 °C for 5 minutes. 14tg of protein and appropriate molecular weight 
markers were loaded in each lane of a 12% SDS -polyacrylamide gel. Electrophoresis 
was performed at 200V for approximately 75 minutes to attain good separation of the 
molecular weight markers. 
Nitrocellulose membrane and sandwich blotters (cut to size of the gel) were prepared 
for blotting by soaking in transfer buffer. The stacking portion of the SDS - 
polyacrylamide gel was cut away and discarded. The nitrocellulose membrane was 
applied onto the separating portion of the gel, sandwiched between 3 pieces of blotters 
on each side. Transfer was achieved with the membrane orientated towards the anode 
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end of a semi -dry transfer apparatus moistened with distilled water, run at a constant 
current of 80 mA. This typically took 55 minutes for effective and complete transfer. 
The transferred proteins were stained with Ponceau, and lanes as well as molecular 
weights were marked with carbon pencil. 
B. lmmunodetection of proteins on Western blot 
After blotting, the nitrocellulose membrane was incubated in blocking solution made of 
5% milk proteins (w /v) in TBS (Tris- buffered saline) for at least 20 minutes at room 
temperature. The membrane was transferred into solutions of primary antibodies 
diluted in TBS /0.025% Tween 20 with 5% milk proteins (eg. 1:100 dilution of 
BOB78), and incubated overnight at 4 °C with gentle rocking. It was then washed 3 
times in TBS /0.025% Tween 20, and incubated with peroxidase -conjugated secondary 
antibodies diluted in TBS /0.025% Tween 20 with 5% milk proteins (eg. rabbit anti - 
mouse at 1: 1500 dilution) for at least 1 hour at room temperature. This was followed 
by 3 washes with TBS /0.025% Tween 20 and 2 further washes with TBS. The 
immunoreaction was detected by enhanced chemiluminescence (ECL Western blotting 
analysis system, Amersham Pharmacia Biotech) using X -ray film. 
Mass Spectrometry Analysis 
Individual gel slices which were not present in control immunoprecipitations were cut 
from colloidal Coomassie Blue -stained gels, the protein eluted and then digested with 
trypsin (Promega). Peptides from the digested bands were then run on LC -MS and 
MALDI -MS mass spectrometers. The LC -MS consisted of a Famos autosampler, 
Switchos column switching unit and an Ultimate nanoLC (Dionex). 
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For the MALDI -TOF analysis aliquots of 0.5ml digests were mixed with 0.5ml a- 
cyano-4- hydroxy cinnamic acid (CHCA) matrix on a MALDI sample plate. The 
samples were then analysed on a Voyager DE -STR MALDI-TOF MS (Applied 
Biosystems) and the processed spectra searcher! against the NCBI non -redundant 
database using Protein Prospector. This analysis was carried out by Dr. Andy 
Cronshaw at the Edinburgh Protein Interaction Centre (EPIC) facility. 
Enzyme- Linked Immunosorbant Assay (ELISA) 
The titre of BOB78 antibody in culture supernatants was estimated with ELISA 
(enzyme -linked immunosorbant assay). This is essentially a chromogenic detection of 
antibody- antigen interaction, and can be used to measure the quantity of antigen 
present. ELISA was carried out using 96 well -plates. To each well was added l00111 of 
rabbit anti -IgM antibodies diluted to about 10mg /L with coating buffer. The plate was 
left to coat with the antibodies overnight. The plate was then washed with washing 
buffer three times. 100111 of the BOB78 supernatants and standards (5 dilutions) were 
added to each well to incubate for 2 hours at room temperature. The wells were then 
washed three times as before. To each well was then added 100111 of peroxidase- 
conjugated anti -mouse antibodies and incubated for 1 hour. The wells were washed and 
the chromogenic substrate 1,2- phenylenediamine dihydrochloride (tablets dissolved in 
0.08% hydrogen peroxide in distilled water) was added. The development of colour 
was halted by addition of 150111 1M H2SO4 to each well. The colour developed in the 
wells was then read with a photometer plate reader at 492nm. The quality of the 
estimation and the specificity of the colour development were checked from the curve 
generated with the standards, as well with blanks or standard dilutions loaded between 
supernatant- containing wells. 
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Replicates 
All experiments were repeated on at least three separate occasions before incorporation 
into the study. 
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CHAPTER 3 
CHARACTERISATION OF BOB78 ANTIGEN IN CELLS UNDERGOING 
APOPTOSIS 
INTRODUCTION 
Apoptosis and its progression in cells can be studied using a variety of techniques. 
Typical morphological changes associated with apoptosis are generally characterised 
by microscopy (Wyllie, Kerr & Currie, 1980; Willingham, 1999). DNA fragmentation 
is usually demonstrated by gel electrophoresis. Degradation of genomic DNA into 
internucleosomal segments results in residues of multiples of 200 base pairs rendering a 
typical ladder pattern on electrophoresis. Immunological -based techniques are widely 
used to identify membrane changes, as well as signalling pathways and other cytosolic 
events such as proteolysis of caspases. In addition, the analysis of several key 
parameters in apoptotic cells is possible through flow cytometry which has several 
advantages (Darzynkiewicz et al., 1992; Vermes et al., 2000). In particular, the 
dynamic state of apoptosis and cellular changes can be followed relatively easily. 
Cytoplasmic events such as the loss of mitochondrial transmembrane potential (MTP), 
release of cytochrome -c, and activation of caspases can be traced with specific ionic 
fluorochromes or fluorescent antibodies. When apoptotic cells are treated with nucleic 
acid -binding fluorescent dyes such as propidium iodide, a typical peak or plateau is 
detectable in the sub -G1 region. This corresponds to a hypo -diploid state as small DNA 
fragments leak out of cells during in vitro processing. Cell membrane changes such as 
the exposure of phosphatidylserine (PS) residues on the outer plasma membrane can be 
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identified with fluorochrome- conjugated Annexin -V (Vermes et al., 1995; van 
Engeland et al., 1998). Morphological changes in cells undergoing apoptosis, such as 
reduced size and increased granularity, are reflected by reduced forward angle scatter 
(FS) and increased side angle scatter (SS) respectively on flow cytometry. Apoptotic 
bodies which form as apoptosis progresses exhibit both reduced FS and SS. Cells 
which have ruptured would give rise to very small debris, detected as particles with 
extremely reduced FS. A proportion of cells in late apoptosis or cells which have 
undergone secondary necrosis would also be permeable to the fluorescent nuclear dye 
propidium iodide, enabling these to be separated from viable and apoptotic cells which 
maintain membrane integrity. This gives rise to populations of cells which are 
propidium negative (viable), propidium dim (apoptotic) and propidium bright 
(permeable /necrotic) (Nicoletti et al., 1991; Del Bino, 1999). 
This chapter describes the characterisation of BOB78 antigen as an early marker of 
apoptosis and its localisation to the membrane blebs of apoptotic cells. Studies were 
performed using flow cytometry and fluorescence microscopy. 
RESULTS 
3.1 Characterisation of BOB78 antigen in viable cells 
It has been reported that the BOB78 antigen is expressed on the surfaces of neutrophils 
in late apoptosis, where its detection is delayed temporally compared with other 
classical markers of neutrophil apoptosis eg. CD16. The BOB78 antigen has also been 
detected in in tracellular compartments of normal neutrophils, possibly localised in 
granular compartments (Hart et al, 2000). This pattern of expression of BOB78 antigen 
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in cells was investigated with cultured human leukaemic THP -1 cells. THP -1 cells 
cultured in standard conditions were harvested and processed for flow cytometry as 
described in Methods (chapter 2). Additionally the THP -1 cells were also fixed and 
permeabilised to allow detection of intracellular antigens. 
3.1.1 BOB78 antigen is expressed in the cytoplasm but not on the surface 
of viable THP -1 cells 
Flow cytometry analysis showed that viable THP -1 cells cultured in standard 
conditions did not express BOB78 antigen on the surface. The small percentage of 
naturally dying THP -1 cells in the cultures however expressed BOB78 antigen on the 
surface. These cells were distinguished by the smaller cell sizes, with either unchanged 
or increased granularity as reflected by the side angle scatter on flow cytometry (figure 
3.1). On fixation and permeabilisation to access intracellular antigens, BOB78 antigen 
was found to be expressed within normal THP -1 cells. It was interesting to note the 
positive fluorescence for BOB78 exhibited on the surface of dying THP -1 cells was to 
the same degree as that for intracellular BOB78 antigen. This however cannot be taken 
to infer that the pool of intracellular BOB78 antigen was mobilised onto the surface of 
dying THP -1 cells, as the process of fixation and permeabilisation may alter the 
quantity of the BOB78 antigen or the detection of it thereof. 
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Figure 3.1 Expression of BOB78 antigen within untreated 
cells. Human leukaemic THP -1 cells were processed for flow 
cytometry , for surface as well as intracellular expression of BOB78 
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The BOB78 antigen is expressed within untreated cells. The 
BOB78 antigen is expressed on the surface of dying cells. 
Viable cells however do not normally express BOB78 antigen on 
the surface The presence of BOB78 antigen within untreated 
cells is confirmed upon permeabilising untreated cells. The 
quantity of BOB78 antigen, reflected by the relative fluorescence, 
appears unchanged between viable cells and dying cells. 
3.2 Characterisation of BOB78 antigen in apoptotic THP -1 leukaemic 
cells by flow cytometry 
Method 1. Induction of apoptosis through treatment with camptothecin 
The binding of the monoclonal antibody BOB78 to apoptotic cells was investigated 
using the human leukaemic cell line THP -1. Apoptosis was induced in THP -1 cells 
with the DNA topo- isomerase inhibitor camptothecin. Camptothecin (CPT) acts in the 
S -phase of the cell cycle and induces apoptosis in susceptible cells (Del Bino, 1991). 
Titration of camptothecin over a dose range from 3 to 30µM showed that the 
proportions of cells undergoing apoptosis were relatively constant (figure 3.2). 
The proportion of THP -1 cells entering S -phase was increased using thymidine block. 
Thymidine acts through competitive quenching of other nuleic acids during DNA 
synthesis and leads to cessation of cell division. Arrest in S -phase of the cell cycle 
through 18 -hour incubation with 2mM thymidine increased the proportion of the cells 
in S- phase. After the 18 hour incubation the proportion of dying cells remained 
comparable to the untreated population (figure 3.3). Release of the cells from the 
thymidine block was done by washing in medium and returning to standard culture 
conditions of RPMI /10% foetal calf serum. 
When the S -phase synchronised THP -1 cells were treated with 3 µM camptothecin, cell 
death was apparent within 4 hours. Increasing the incubation times resulted in 
proportional increases in cell death (figures 3.4 & 3.5). Microscopic examination 
revealed that the number of necrotic cells was also increased as estimated by the 
proportion of lysed cells in culture. The expression of BOB78 among the treated and 
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Figure 3.2 Percentage cell death in THP -1 cells treated with 
camptothecin. Human leukaemic THP -1 cells were treated with 
varying concentrations of camptothecin for different periods as 
indicated. The cells were gated on morphology (dying in Bite A and 
viable in V) and cell death correlated with reduced cell size as analysed 
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Rate of cell killing is relatively constant when the 
concentration of camptothecin is above 3uM. When the 
concentration of camptothecin is above 311M the percentage of 
cell death (gated A) does not increase, indicating the rate of 
killing depends on the proportion of cells entering the DNA 
synthesis period (S- phase) of the cell cycle. The dose range 
selected appears to have lied on the plateau of a dose - 
response curve. 
Figure 3.3 Synchronisation of leukaemic THP -1 cells using 
thymidine block. THP -1 cells were cultured and blocked in S -phase by 
incubation in 2mM thymidine for 18 hours. The cells were released from 
the block with washing and returned to standard culture. Cells were 
washed, permeabilised and stained with propidium iodide (read on FL3) 
to quantify gnomic DNA. 
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Thymidine block increases proportion of cells in S -phase of 
cell cycle. The DNA quantity plots show about 60% of THP -1 
cells to be arrested in S -phase of cell cycle. Apoptosis, 
reflected by the sub -G1 peak (D) resulting from leakage of 
degraded genomic DNA, is not increased by treatment with 
thym idine. 
Wthin the cell cycle, G1 /G0 phase: diploid state; S phase, 
synthesis of DNA; G2/M phase: 2 sets of diploid DNA; A (or sub- 
Gil peak: result of DNA degradation during apoptosis. 
Figure 3.4 Cell death induced by camptothecin (CPT) 
treatment: a typical experimental result. Human leukaemic THP -1 
cells were gated by size on flow cytometry. Periods of incubation with 3 
CPT listed. Increasing the period of incubation resulted in higher 
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Figure 3.5 Cell death induced by camptothecin increases 
with period of incubation. Human leukaemic THP -1 cells were 
treated with 3µM camptothecin for 6, 12, 18 and 24 hours and sorted 
by morphology on flow cytometry, as shown in figure 3.4. The mean 
percentages of dying cells from replicate experiments were calculated 
from cells in gate A. Error bars represent standard errors calculated 
from the means of 3 experiments. 
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Figure 3.6 Degradation of cellular DNA in camptothecin 
treated THP -1 cells. THP -1 cells were cultured and blocked in S- 
phase by incubation in 2mM thymidine for 18 hours. The cells were 
released from the block with washing and returned to standard culture or 
incubated with 3pM camptothecin for 4 hours. The solvent DM SO was 
added as vehicle control. Cells were washed, permeabilised and stained 
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Camptothecin induces apoptosis in THP -1 cells. The DNA 
quantity plots show about 60% of THP -1 cells to be arrested in 
S -phase of cell cycle. Camptothecin acts on susceptible cells 
in this phase. Apoptosis, reflected by the sub -G1 peak resulting 
from leakage of degraded genomic DNA is increased 
compared with standard and DMSO conditioned cultures. 
Within the cell cycle, E: G1 phase with diploid state; C: S phase. 
DNA synthesized; B: M phase, 2 sets of diploid DNA D: sub -G1 
peak, result of DNA degradation. 
untreated THP -1 cells was characterised through flow cytometry. Analysis of DNA 
content showed the typical sub -G1 peak indicating a subpopulation of cells undergoing 
apoptosis (figure 3.6). 
Method 2. Induction of apoptosis through treatment with serum 
deprivation 
The other method used for the induction of apoptosis was serum deprivation. This is a 
common method and probably results in apoptosis via mechanisms akin to withdrawal 
of cytokines, as serum contains many putative growth factors (Chao et al., 2002). 
Apoptotic cells were detected within 2 hours of serum deprivation. These cells 
exhibited propidium iodide exclusion profiles similar to those treated with 
camptothecin (see figures 3.8 and 3.9). When analysed for DNA content the apoptotic 
THP -1 cells showed up as the typical sub -G1 peak as before (figure 3.7). As discussed 
below, apoptotic cells staining weakly for propidium iodide showed strong surface 
expression of BOB78 antigen. The results suggest BOB78 antigen appears on the 
external cell membrane when a cell is committed to apoptosis. BOB78 antigen may 
therefore be a marker of apoptotic cells. 
3.2.1 Apoptotic THP -1 cells express BOB78 on the external cell membrane 
Human leukaemic THP -1 cells were induced to undergo apoptosis as described briefly 
above and in Methods (chapter 2). Cell death was documented with propidium iodide 
(PI) as a vital dye where nuclear staining is indicative of necrosis /very late apoptosis 
and propidium dim cells are indicative of apoptosis (Nicoletti et al., 1991; Del Bino, 
1999). The cells were analysed by flow cytometry for the expression of BOB78 
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antigen. The results obtained by treatment with serum deprivation and camptothecin 
were similar (figures 3.8 and 3.9 respectively). 
Four subpopulations of cells with different staining characteristics for PI and BOB78 
were discernible. Viable cells did not stain for BOB78 antigen on the surface and 
excluded PI completely. Two subpopulations stained strongly for BOB78 antigen. One 
stained weakly for PI (PI dim) whilst the other stained strongly for PI (PI bright). The 
BOB78 antigen -positive /PI dim cells represent probably cells in early apoptosis. The 
BOB78 antigen -positive /PI bright cells would probably be in late apoptosis and losing 
membrane permeability. Lastly a population of PI bright cells were negative for 
BOB78 antigen staining. These were probably necrotic cells which were undergoing 
lysis. The apoptotic and necrotic cells fell into the same subpopulation based on size 
separation. It was not possible through gating to completely separate them into distinct 
populations. Shorter periods of camptothecin treatment or serum starvation resulted in 
more PI dim apoptotic cells, whilst longer treatment periods resulted in a greater 
collection of late apoptotic or necrotic cells. The observations from flow cytometry 
analysis suggest the BOB78 antigen appears on the plasma membrane when a cell 
undergoes apoptosis. Viable cells do not express BOB78 antigen on the surface at all. 
Necrotic cells which lose membrane integrity do not stain for BOB78 antigen on the 
surface. 
3.3 Correlating expression of BOB78 to key events in apoptosis by 
flow cytometry 
The specific appearance of BOB78 antigen on the surface coincided with two well 
characterized changes in apoptotic cells (Castedo et al., 1996; Vermes et al., 2000). 
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Figure 3.7 Degradation of cellular DNA in serum deprived 
THP -1 cells. THP -1 cells were synchronised through 18 -hour 
incubation in 2mM thy midine. The cells were released from the 
thymidine block by washing and returned to culture in serum free RPMI 
for 16 hours. Cells in the control population had also been synchronised 
and released in the same manner. The cells were permeabilised and 
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Figure 3.8 Staining THP -1 cells for surface expression of 
BOB78 antigen after serum starvation. Human leukaemic THP -1 
cells were cultured in serum free medium for periods of 2, 4, 6 and 16 
hours. The cells were stained for BOB78 antigen expression and isoty pe 
control IgM, with secondary detection by FITC -conjugated anti -mouse 
antibodies. Viability was assessed with propidium iodide (PI log) as 
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Apoptotic cells express BOB78 antigen on the surface. 
liable cell (in gate V) did not stain BOB78 on the surface at 
all. Apoptotic cells (in gate A) with weak PI staining showed 
strong surface expression of BOB78. This expression was 
also evident in PI bright cells* which would represent late 
apoptotic cells prior to membrane lysis. 
Figure 3.9 Staining THP -1 cells for surface expression of 
B0B78 after treatment with camptothecin. THP -1 cells were 
treated with 3µM camptothecin for periods of 6, 12, 16, 20 and 24 
hours. Cells were stained for BOB78 antigen surface expression, detected 
with FITC -conjugated secondary antibody and analysed on flow 
cytometry. Composite dot -plots of the total populations on propidium 
iodide (red) and FITC (green) fluorescences. Dying THP -1 cells showed 
surface staining for BOB78 from early to late apoptosis. This surface 















These were i) depolarisation of mitochondrial transmembrane potential (MTP), and ii) 
appearance of phosphatidylserine (PS) on the cell surface. Loss of MTP is an early 
event in cells committed to apoptosis (Crompton, 1999). The externalisation of PS 
residues onto the cell surface, detected through binding of Annexin -V, is another 
universal feature of apoptotic cells (Martin et al., 1995; van Engeland et al., 1998). The 
membrane expression of BOB78 antigen in apoptotic cells was tracked with these key 
events through dual staining and analysis by flow cytometry. 
Method 1: Dynamic tracking of dying cells through loss of 
mitochondrial transmembrane potential (MTP) 
When a cell loses the permeability barriers on the mitochondrial membranes, 
cytochrome -c is released and is incorporated into the complex of the apoptosome. This 
activates the initiator caspase, procaspase -9. This initiation phase of apoptosis is 
reflected by reduced staining for the dye DiOC6 (Overbeeke et al., 1998). This 
lipophilic cationic fluorochrome (green) is actively sequestered in the intermembranous 
space of mitochondria, and viable cells show strong uptake and maintain fluorescence 
when stained with this dye. Fluorescence is diminished when mitochondrial membranes 
lose their selective permeability and become leaky. This differential staining for DiOC6 
would therefore label viable cells distinctly from dying cells. Within the population of 
dying cells, apoptotic ones are differentiated from the necrotic ones through the strong 
nuclear staining for propidium iodide (PI) by the latter. These characteristics were 
confirmed with camptothecin treated leukaemic THP -1 cells. Dose titration revealed 
30mM DiOC6 was clearest in separating the various populations (figure 3.10). 
54 
Figure 3.10 Differentiation of viability by dual staining with 
DiOC6 and Pl. THP -1 cells synchronised with 2mM thymidine for 18 
hours and then treated with 3µM camptothecin for 6 hours. 
Mitochondrial fluorochrome DiOC6 (green) was added at room 
temperature to 30mM and reacted for 30 minutes. Propidium iodide (PI) 
was added immediately before analysis with flow cytometry. Viable cells 











































Composite dot -plot from vehicle control showing typical dual 
staining characteristics. 
Differentiation of cell viability. Viable cells maintain green 
fluorescence from sequestered Di0C6 (FITC) and exclude PI. 
Apoptotic cells demonstrate leakage of DiOC6 but exclude PI. 
Necrotic cells which have lost DiOC6 also stain with PI 
com pletely. 
3.3.1 Cells which lose MTP show surface expression of BOB78 antigen 
Human leukaemic THP -1 cells were induced to undergo apoptosis with 6 hours of 
camptothecin treatment in standard conditions as described earlier. Besides dual 
staining for BOB78 and PI, the same populations were also stained for BOB78 and 
DiOC6, and analysed by flow cytometry. Dying cells which shrank were gated 
according to size as reflected by reduced forward angle scatter (FS). Three 
subpopulations of cells were clearly distinguishable (figure 3.11). Viable cells stained 
strongly for DiOC6 and maintained the green fluorescence. These cells did not express 
BOB78 antigen on the surface. Another subpopulation which had lost MTP show 
marked surface expression of BOB78 antigen. A third subpopulation which was also 
dim in DiOC6 fluorescence did not express membrane BOB78 antigen. The cells which 
expressed BOB78 antigen on the surface also demonstrated two important 
characteristics. The cells were PI -dim and DiOC6 -dim. It may be inferred that PI -dim 
cells which expressed surface BOB78 antigen had initiated apoptosis through 
depolarisation of MTP (figure 3.12). The DiOC6 -dim population which did not stain 
for BOB78 antigen would represent late apoptotic or necrotic cells with membrane 
integrity being lost. These results indicate that cells in which irreversible initiation of 
apoptosis had occurred express BOB78 antigen on the surface. 
Method 2: Correlating exposure of phosphatidylserine (PS) residues 
with BOB78 antigen expression by staining with Annexin -V 
Presently, one of the best accepted features of apoptotic cells is their surface staining 
for Annexin -V (Martin et al., 1999; Martinez and Freyssinet, 2001). This soluble 
lipoprotein exhibits particular affinity for the PS residues displayed on the surface of 
apoptotic cells. In viable cells PS is restricted to the inner leaflet of the plasma 
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Figure 3.11 Expression of BOB78 antigen on DiOC6 dim cells. 
Human leukaemic THP -1 cells were treated with 31.tM camptothecin for 
6 hours and analysed with flow cytometry, for surface expression of 
BOB78 antigen, or CD44 (detected with anti -mouse PE- conjugated 
secondary antibodies) and integrity of mitochondrial transmembrane 





Cells gated by morphology. Isotype control and 
Mcable cells in V; apoptotic in A unstained for DiOC6 
DiOC6 DiOC6 
,o- I[ 
Surface expression of BOB78 antigen follows loss of the 
mitochondria! transmembrane potential (DiOC6 dim). A 
significant proportion of cells which have lost the mitochondria) 
transmembrane potential (MTP), reflected by the reduction in 
green DiOC6 fluorescence, express BOB78 antigen on the 
surface. The DiOC6 dim cells also lose the expression of 
surface adhesion molecule CD44. Surface expression of 
BOB78 antigen is an event which follows loss of MTP, a key 
event in the initiation of apoptosis. 
Figure 3.12 BOB78 antigen expression correlated with 
staining for propidium iodide. Human leukaemic THP -1 cells were 
treated with 3µM camptothecin for 6 hours and analysed with flow 
cytometry. The cells were stained with monoclonal BOB78 (detected 















Cam ptothecin treated 
THP -1 cells separated by 
size. Apoptotic cells 
(green, in gate A) are 
smaller than viable cells 





Apoptotic cells express BOB78 antigen on the surface. Dual 
staining with BOB78 and Pl. Viable cells exclude Pl and do not 
express BOB78 antigen. Apoptotic cells, early or late, express 
BOB78. Necrotic cells lose BOB78 antigen expression on 
membrane lysis. 
membrane (Devaux et al., 1991; Zachowski, 1993). There is movement of PS either 
way but enzymes called translocases maintain this asymmetric distribution (Diaz & 
Schroit, 1996). Externalisation of PS on apoptotic cells derives from a reversal of this 
traffic and is probably effected by the enzyme scramblase. In the presence of calcium 
ions, exposed PS binds strongly to Annexin -V. The same populations of cells from the 
experiments above stained for PI, BOB78 and DiOC6 were also examined for Annexin- 
V expression. 
3.3.2 Cells which externalise phosphatidylserine (PS) also express BOB78 
on the surface 
Viable cells did not stain for BOB78 antigen or Annexin -V, and excluded PI 
completely. Within the population of dying cells surface staining for BOB78 antigen 
paralleled that of Annexin -V (figures 3.13 & 3.14). Those which expressed BOB78 
antigen also stained for Annexin -V ie. expressed PS residues. Others which did not 
stain for Annexin -V also did not express surface BOB78 antigen. These probably 
represented cells which either had not yet exposed PS on the surface, or which had lost 
membrane integrity ie. undergone necrosis. This expression profile of BOB78 antigen 
indicates that surface expression of BOB78 antigen keeps pace with that of PS. 
Externalisation of PS, denoted by Annexin -V binding, had been suggested to be an 
early phenomenon in apoptotic cells. It precedes nuclear condensation and 
morphological changes. This implies the surface expression of BOB78 antigen may be 
an early feature in most apoptotic cells (Vermes et al., 1995; Martin et al., 1995) 
The findings obtained from flow cytometry suggest that expression of BOB78 antigen 
is not a terminal event before the cell disintegrates. Rather, once a cell proceeds with 
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Figure 3.13 BOB78 antigen expression coincident with 
positive staining for Annexin V. Human leukaemic THP -1 cells were 
treated with 3 iM camptothecin for 6 hours and analysed with flow 
cytometry. The cells were stained with monoclonal BOB78 (detected 





































Composite dot -plot Viable cells which are not 
showing viable (red) and positive for Annexin V do not 
apoptotic cells (green) express BOB78 antigen 
> BOB78-FITC 
Apoptotic cells express BOB78 antigen and 
phosphatidylserine on the surface. The coincident detection of 
BOB78 antigen and phophatidylserine PS (through Annexin V) 
suggests BOB78 antigen is expressed on the surface of plasma 
membrane early in apoptosis. 
Figure 3.14 Surface characteristics of viable cells vs. apoptotic 
cells with respect to BOB78 antigen, Annexin V and CD44 staining. 
Cells were treated with 3µM camptothecin for 6 hours, stained for BOB78 
antigen, phosphatidylserine (by Annexin V) or CD44 and analysed by flow 
cytometry (see figures 3.11 & 3.13). Percentages of cells in the viable 
population that were positive for BOB78 antigen, Annexin V and CD44 were 
compared to those in the apoptotic population. Cells were gated into viable 
and apoptotic populations based on morphology. Error bars represent 
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apoptosis BOB78 antigen appears on, or is translocated to, the surface, possibly as an 
early marker of cell death. 
3.4 Mapping BOB78 antigen expression on apoptotic cells with 
fluorescence microscopy 
The localisation of BOB78 antigen on apoptotic cells was also studied with 
fluorescence immunocytochemistry. Apoptosis was induced in THP -1 cells with 31A,M 
camptothecin for 16 hours, after having been first synchronised in the S -phase of cell 
cycle through incubation in 2mM thymidine for 18 hours (Del Bino et al., 1991). 
Apoptotic cells were harvested following a low g centrifuge. These cells were then 
cytocentrifuged onto microscopic slides and processed for immunocytochemistry as 
described in Methods (chapter 2). The cells were stained with IgM control negative and 
monoclonal BOB78 antibodies. Nuclear changes identifying apoptosis were followed 
with TO -PRO 3 staining. The staining was visualised with confocal microscopy. 
3.4.1 BOB78 localises to blebs of apoptotic cells 
Analysis by confocal microscopy revealed BOB78 to be concentrated in the blebs of 
apoptotic cells (figure 3.15). In apoptotic THP -1 cells with typical nuclear 
fragmentation BOB78 antigen was disproportionately distributed to the blebs. This 
pattern of distribution was apparent even though the cytoplasm in apoptotic cells was 
condensed. Cells which contained condensed nuclei (probably prior to fragmentation) 
showed BOB78 antigen to be concentrated nearer the periphery of the cytoplasm. 
Necrotic cells were discernible from apoptotic ones. These necrotic cells had nuclei 
which did not exhibit typical apoptotic clumping (figure 3.16). The nuclei were 
relatively amorphous and larger, and there was little or no cytoplasm. There was no 
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Figure 3.15 Microscopic localisation of BOB78 antigen in the 
membranes of apoptotic THP -1 cells. Human leukaemic THP -1 cells were 
treated with 311M camptothecin for 16 hours. The THP -1 cells were harvested on 
and cytocentrifuged onto microscopic slides. Fluorescence immunocytochemistry 
was performed with monoclonal BOB78 and IgM isotype control antibody. 
Primary reaction was detected with fluorescent TRITC (red) conjugated 
secondary rabbit anti -mouse antibody. Nuclear staining was effected with 
TOPRO -3 (blue). 
A 
B 
A: membrane blebs and BOB78. Apoptotic THP -1 cells with typical nuclear 
clumping appear to develop membrane blebbings (arrows). Those which 
are blebbing appear to have BOB78 antigen concentrated to the periphery of 
the cytoplasm or membranes. Naked nuclear materials probably result 
from lysis of late apoptotic or necrotic cells. (Bar: 151.1,m) 
B: membrane blebs and BOB78. The blebs within apoptotic cells appear to 
concentrate BOB78 antigen (red) within them (top arrows). The staining 
pattern seen with the bottom -arrowed cell maybe due to disintegration of 
the cell upon secondary necrosis. (Bar: 15µm) 
Figure 3.16 Microscopic comparison of BOB78 antigen expression in 
apoptotic and necrotic THP -1 cells. Human leukaemic THP1 cells were treated 
with 3µM camptothecin for 16 hours. The cells were harvested and cytocentrifuged 
onto microscopic slides. Fluorescent immunocytochemistry was performed with 
monoclonal BOB78 and IgM isotype control antibody. Primary reaction was detected 
with fluorescent TRITC (red) conjugated secondary rabbit anti -mouse antibody. 
Nuclear staining was effected with TOPRO -3 (blue). 
A 
B 
A: a mixture of apoptotic and necrotic cells. THP -1 cells with nuclear 
condensation and clumping typical of apoptosis show BOB78 antigen 
localising mainly to the periphery of the cytoplasm. These are 
distinguished from necrotic cells which appear as naked nuclei lacking 
typical apoptotic features. (Bar: 151,tm) 
B: membrane blebs and BOB78. Some apoptotic THP -1 cells with 
typical nuclear clumping appear to develop membrane blebbings 
(arrows). Those which are blebbing appear to have BOB78 antigen 
concentrated to the periphery of the cytoplasm or membranes. Naked 
nuclear materials probably result from lysis of late apoptotic or necrotic 
cells. (Bar: 1511m) 
positive staining for BOB78 antigen in necrotic cells. The findings suggest expression 
of BOB78 antigen on the surface is maintained only on apoptotic cells. Where 
membrane integrity had been lost upon secondary necrosis, this identifiable feature of 
apoptotic cells disappears. 
3.4.2 BOB78 antigen translocates from cytoplasm to membrane surface in 
apoptotic cells 
The localisation of BOB78 antigen to membrane blebs of apopotic cells was studied 
further in cells with abundant cytoplasm. The hepatoma -derived HUH -7 cells were 
treated with a toxic dose of monensin at 25µM for about 12 hours. Monensin interrupts 
protein traffic between Golgi and endoplasmic reticulum (Mollenhauer et al., 1990). It 
can be used to stress cells at low doses (in terms of protein traffic), and can cause death 
through apoptosis in susceptible cells (Park et al., 2002; Park et al., 2003). The BOB78 
antigen was observed to outline blebs on the membrane of apoptotic cells, as well as 
blebs which had been released (figure 3.17). Neighbouring cells which were not 
blebbing showed BOB78 antigen distributed throughout the cytoplasm. This suggests 
that in apoptotic cells BOB78 antigen relocates from the cytoplasm to the membrane 
blebs. Closer scrutiny revealed that BOB78 antigen collected close to where the plasma 
membrane began to evaginate, and blebs that appeared ready for budding off were 
filled with BOB78 antigen. The few blebs which budded off into the vicinity of 
neighbouring cells were lined with BOB78 antigen. 
This pattern of BOB78 antigen translocation was also observed when HUH -7 cells 
were treated with toxic doses of cycloheximide (figure 3.18). Cycloheximide interferes 
with protein biosynthesis. Membrane blebs accumulated BOB78 antigen whilst being 
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developed at the cell surface. Some BOB78- positive blebs were seen to ferry 
fragmented nuclear materials (figure 3.19). An incidental finding was that the 
cytoplasmic distribution of BOB78 antigen in those cells which did not undergo 
apoptosis did not differ from untreated cells (figure 3.18). This observation may 
suggest a low basal turnover of BOB78 antigen in the cells. A molecule which 
undergoes a higher turnover would show obvious disruption or deviation of 
immunostaining after treatment with cycloheximide. The main cytoplasmic pool of the 
BOB78 antigen may therefore be involved in this translocation to the cell surface. 
DISCUSSION 
The BOB78 antigen is normally present within the cytoplasm of cells and appears at 
the plasma membrane during apoptosis. The surface expression of BOB78 antigen on 
cells appears to be consistent regardless of the mechanism of apoptosis induction. This 
ability of the BOB78 antibody to identify apoptotic cells was first characterised in 
neutrophils (Hart et al., 2000) where surface expression of BOB78 antigen appeared to 
be a late marker of apoptosis. There appears to be no specific lineage confinement of 
BOB78 antigen in nucleated cells. Since apoptosis is run on a highly conserved 
programme, BOB78 antigen may be intimately linked with cell death. The kinetics and 
role of the BOB78 antigen in normal cells may elucidate this possible association with 
the apoptotic process. These are elaborated in Chapter 4. 
The surface staining of BOB78 detected with flow cytometry suggests that BOB78 
antigen localises to membranes of cells undergoing apoptosis. Since apoptotic cells 
develop membrane blebs, BOB78 antigen may be localising to these evaginations at the 
cell surface. Analysis with confocal microscopy has confirmed this association. The 
66 
Figure 3.17 Localising BOB78 antigen in apoptotic HUH -7 
hepatoma cells treated with monensin. Human hepatoma HUH -7 
cells were grown in monolayer and treated with 25µM monensin for 16 
hours. Immunocytochemistry was performed with monoclonal BOB78 
and IgM isotype control antibodies. Reaction was detected with TRITC- 
conjugated (red) rabbit anti -mouse antibodies. Nuclear counter- staining 
was effected with TO -PRO 3 (blue). 
Frame 1: An apoptotic cell is seen 
within a monolayer of HUH -7 cells 
(arrowed). The apoptotic HUH -7 
cell shows a condensed nucleus 
and blebs budding off the 
cytoplasm. The blebs show 
prominent BOB78 localisation. The 
nuclei within non -apoptotic cells 
appear larger and contain nucleoli. 
(Bar: 2511m) 
Frame 2: magnified view of frame 1 focussing on the apoptotic 
cell. Blebs are seen to be lined with BOB78. At the cytoplasm 
where the membrane blebs develop, BOB78 appear to be 
channelled into these, and adhere to the membrane of the blebs 
as these bud off. (Bar: 25µm) 
Figure 3.18 Microscopic characterisation of BOB78 antigen in 
apoptotic HUH -7 cells treated with cycloheximide. Human hepatoma HUH - 
7 cells were induced to undergo apoptosis with l0µgfnil cycloheximide for 6 hours. 
The cells were stained with primary monoclonal BOB78 and IgM isotype control. 
Reaction was detected with TRITC- conjugated (red) secondary rabbit anti -mouse 
antibodies and visualised using confocal microscopy. 
A 
B 
A: membrane blebs and BOB78. Apoptotic cells are identified with 
membrane blebbing. BOB78 antigen is seen to concentrate in the blebs. 
The nuclei in the apoptotic cells had fragmented and the clumps appear to 
be carried off in the blebs. Some cells showed prominent localisation of 
BOB78 antigen to the peripheral cytoplasm. These had nuclei which 
showed no clumping. These cells may represent early apoptotic ones. The 
streaming of BOB78 to the periphery and the concentration of it in the blebs 
in these cells would correlate with surface staining detected on flow 
cytometry. (Bar: 25µm) 
B: BOB78 antigen concentrated in blebs. Magnified view of A focussing on 
the blebbing cells. Concentration of BOB78 antigen to the blebs of the 
apoptotic cells can be seen. The fragmented nuclear materials appear to 
be contained within the blebs which are lined with BOB78 antigen. (Bar: 25p 
Figure 3.19 Microscopic localisation of BOB78 antigen in apoptotic 
bodies. Human hepatoma HUH -7 cells were induced to undergo apoptosis with 10 
lug/ml cycloheximide for 6 hours. The cells were stained with primary monoclonal 
BOB78 and IgM isotype control. Reaction was detected with TRITC -conjugated 
(red) secondary rabbit anti -mouse antibodies and visualised using confocal 
microscopy. Frame 2 was imaged at a focal plane lying above that of frame 1. 
Frame 1 
Frame 2 
Frame 1: Detaching apoptotic cell. Attached HUH -7 cells growing in 
monolayer. Some cells in apoptosis revealed blebbing of the 
membranes (arrows). The other cells with normal appearing nuclei 
showed typical cytoplasmic distribution of BOB78 antigen. (Bar: 251im) 
Frame 2: Detaching apoptotic bodies. The blebs coming off the cells 
were imaged at a level above the focal plane in frame 1. BOB78 
antigen can be seen localising to the blebs. Apoptotic bodies with 
fragmented nuclear materials detached from the monolayer and were 
lined with BOB78 antigen. (Bar: 25µm) 
apoptotic cells with BOB78 antigen localising to the periphery of the cytoplasm and 
membrane blebs would correspond with the smaller cells which were propidium iodide - 
dim and expressing BOB78 antigen on the surface. The bodies which stain strongly for 
propidium iodide but do not express BOB78 antigen would correspond with the naked 
nuclei seen on microscopy. These cells probably had undergone membrane lysis upon 
secondary necrosis. It appears that BOB78 antigen translocates from its normal 
cytoplasmic location to the plasma membrane and blebs during apoptosis. BOB78 
antigen is concentrated in apoptotic blebs and remains confined to the membranes of 
apoptotic bodies as these are released during cellular re- assembly in cell death. 
Treatment of human hepatoma HUH -7 cells with monensin or cycloheximide did not 
result in discernible changes of cytoplasmic BOB78 antigen expression. The global 
distribution of BOB78 within the cytoplasm of treated or untreated cells appeared to be 
similar. These observations suggest that the normal basal turnover of BOB78 antigen 
within cells is low. Since protein biosynthesis is generally halted during apoptosis 
(Hengartner, 2000), the strong expression of BOB78 antigen in the membranes and 
blebs indicate it is likely that BOB78 antigen is not actively synthesised during 
apoptosis. However, one may speculate that the movement of BOB78 antigen from 
cytoplasm to membrane may be an active process requiring energy input. 
It remains to investigate what role BOB78 antigen may have in lining the membranes 
of apoptotic blebs. Whether this expression is part of the apoptosis machinery, part of 
normal cellular machinery mobilised to maintain cellular integrity during cellular 
reassembly (or disassembly), or is part of important recognition signals for 
macrophages remain to be investigated. 
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Closer scrutiny of the staining pattern of BOB78 on immunocytochemistry suggests 
that the BOB78 antigen may be potentially expressed in the nuclei of cells. The staining 
within the nuclei has not, however, been consistent and might have been due to 
variability in the fixation of the cells, in spite of the same protocol having been used for 
all experiments. Nevertheless, this possibility needs further study and verification. It is 
interesting to note that heat shock protein 70 (hsp70) has been found to be expressed in 
the nuclei of stressed cells (Ramage and Guy, 2004). It is likely that hsp70 may be 
influencing transcription within the nucleus under certain conditions. It is possible 
therefore that hsp60, being another molecular chaperone, may be involved in similar 
activity within the nucleus. The potential of hsp60 being intimately linked to 
transcriptional activity within stressed cells warrants further investigation. 
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CHAPTER 4 
CHARACTERISATION OF THE BOB78 ANTIGEN WITHIN THE CELL 
INTRODUCTION 
The presence of BOB78 antigen in the human leukaemic THP -1 and hepatoma HUH -7 
cell lines suggests this antigen might not be lineage limited in expression. These cells 
demonstrate widely varying behaviour with respect to motility and biosynthetic 
capability. The cytoplasmic localisation of BOB78 antigen within these cells suggests it 
might be an entity vital to fundamental cellular functions. At the same time the nature 
of BOB78 antibody being of IgM subclass also raises the possibility that it might be 
recognising a carbohydrate moiety. This, if proven true, would mean that the antibody 
may not be localising to any specific protein antigen, and that isolating the BOB78 
antigen would be difficult. The abundant staining of BOB78 antigen within the 
cytoplasm of the cells studied so far prompted queries as to the location of BOB78 
within the biosynthetic- secretory pathway. The appearance of BOB78 antigen at the 
plasma membrane during apoptosis suggests that the dynamics of this phenomenon 
may be linked to the endomembrane systems of the cell. This chapter details the studies 
performed in an attempt to further evaluate the nature of BOB78 antigen. 
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RESULTS 
4.1 Verifying the lineage fidelity of BOB78 antigen 
Observations with fluorescence microscopy of BOB78 antigen have already indicated 
that it is normally present in the cytoplasm of the leukaemic (THP -1) and hepatoma 
(HUH -7) cells studied (refer Chapter 3, parts 3.1 and 3.4). Normal viable cells do not 
express BOB78 antigen on the surface. The surface expression of BOB78 antigen on 
apoptotic cells appears to be due to the translocation of the molecule from the 
cytoplasm to the plasma membrane. The presence of BOB78 antigen was thus tested in 
various normal human cells and human cancer cell lines. In addition, in order to 
investigate if it might be a highly conserved antigen, BOB78 antigen expression was 
also examined in the mouse myeloma cell line Sp2 /0. Analysis with flow cytometry 
was utilised to assess the cytoplasmic expression of the BOB78 antigen in these cells. 
Cells from various lineages, normal and cancer -derived, were cultured in standard 
culture conditions and harvested for immunostaining. The cells were fixed and 
permeabilised (Pollice et al., 1992), and stained with antibodies for analysis using flow 
cytometry as described in Materials & Methods (chapter 2). 
4.1.1 BOB78 is highly conserved and is normally present in the cytoplasm 
of nucleated cells 
When peripheral blood monocytes and lymphocytes were studied for expression of 
BOB78, it was found that these non -cancer cells also expressed BOB78 antigen on the 
surface when undergoing apoptosis. In addition, on permeabilising the monocytes, 
intracellular expression of BOB78 antigen was verified (figure 4.1). This property is 
consistent with observations in leukaemic THP -1 and hepatoma HUH -7 cells (refer 
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Chapter 3). It appears that BOB78 antigen is not lineage- restricted within nucleated 
human cells. These results suggest that the BOB78 antigen may be highly conserved 
and a murine cell line was therefore tested for expression of BOB78 antigen. The 
mouse cell line SP2 /0 was tested for the cytoplasmic presence of BOB78 antigen and 
the cells were confirmed as positive by flow cytometry (figure 4.2, A). It is interesting 
to note that dying SP2 /0 cells expressed BOB78 antigen on the surface (figure 4.2, B). 
These results suggest that the antigen recognised by the BOB78 antibody is a highly 
conserved cytoplasmic antigen which is present in all nucleated cells. Since BOB78 is 
of IgM isotype, there is a possibility that the BOB78 antigen is a carbohydrate. 
Carbohydrates are recognised through pattern recognition receptors (PRR) expressed 
on macrophages as part of the innate immune system, and the process does not involve 
presentation of antigens to T lymphocytes. The helper T cells which direct heavy chain 
isotype switching to IgG class are therefore not involved (Abbas, Lichtman & Pober, 
2000). 
4.2 Searching for a tissue negative for BOB78 antigen 
The ubiquitous distribution of BOB78 antigen within nucleated cells suggests that the 
molecule may serve certain highly conserved functions integral to the normal working 
of the cell. Moreover, the studies so far identify it as a surface feature of nucleated cells 
undergoing apoptosis. These observations suggest a possible dynamic role for BOB78 
antigen at a time when cells are undergoing ordered deconstruction initiated by a highly 
conserved genetic programme. A cellular model where apoptosis as prescribed for 
nucleated cells does not apply might provide further evidence that BOB78 antigen is 
closely linked to the machinery of apoptosis. Human red blood cells provide such a 
tissue model. Mature erythrocytes are anucleate and are not equipped to undergo 
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Figure 4.1 Verifying presence of BOB78 antigen in normal 
leucocytes. Serum starved lymphocytes and monocytes were stained 
with BOB78 and IgM isotype control antibodies, with secondary anti - 
mouse FITC -conjugated antibodies. Analysis for surface expression was 
performed through flow cytometry. Cells were gated by size into dying 
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BOB78 antigen is expressed on dying leucocytes. Serum 
starved lymphocytes and monocytes expressed BOB78 antigen 
on the surface. BOB78 antigen is also present as an 
intracellular antigen in normal monocytes. Nucleated cells, 
tumour -derived or normal, appear to carry BOB78 antigen as 
part of normal cellular constituents. 
Figure 4.2 Investigating the presence of BOB78 antigen in 
mouse SP2 /0 cells. Mouse SP2 /0 cells grown in standard medium were 
fixed and penineabilised, and stained for BOB78 (A). Another population 
of serum deprived SP20 cells were stained for surface BOB78 (B). 
Staining was detected with anti -mouse FITC -conjugated secondary 
antibodies and analysed through flow cytorrietry. 
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B: Surface staining of BOB78 (FITC) 
BOB78 is a multi -lineage antigen. Permeabilised mouse 
SP2 /0 cells reveal intracellular BOB78 antigen. The ability of 
anti -human BOB78 antibody to detect mouse antigens agrees 
well with the fact that BOB78 is an IgM raised against a highly 
conserved antigen. The antibody consistently identifies 
apoptotic cells, in this case even mouse cells. 
apoptosis per se like other nucleated cells (Weil et al., 1998). The presence or absence 
of the BOB78 antigen was therefore examined in erythrocytes. The red blood cells were 
fixed and permeabilised and stained for analysis by flow cytometry as described in 
Materials & Methods (chapter 2). Immunostaining was performed with anti - 
glycophorin as positive control, an IgM isotype negative control and BOB78. 
4.2.1 BOB78 antigen is absent from erythrocytes - a cellular model 
negative for apoptosis 
Normal erythrocytes expressed glycophorin on the cell surface but did not express 
BOB78 antigen. Upon permeabilisation, glycophorin within the erythrocytes was 
detected as before, there was however no staining for BOB78 (figure 4.3). The fixed 
and permeabilised cells had retained consistent morphology, and as the same 
permeabilisation techniques had been used to permit intracellular access of the IgM 
antibodies, the absence of BOB78 from erythrocytes was not likely to be artefactual. As 
the results obtained so far propose that the BOB78 antigen is highly conserved, the 
absence of the antigen from erythrocytes is of interest. Erythrocytes may thus qualify as 
a tissue negative for the BOB78 antigen although it is possible that a different isoform 
of the antigen exists, featuring a modified epitope not identified by the BOB78 
antibody. 
The findings so far propose that BOB78 is a highly conserved antigen which is 
ubiquitously expressed within the cytoplasm of nucleated cells. It becomes detectable at 
the surface of the plasma membrane when nucleated cells undergo apoptosis. It is 
possibly closely linked to the integral mechanisms of apoptosis. 
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Figure 4.3 Erythrocytes - a tissue model negative for 
apoptosis. Erythrocytes were fixed, permeabilised, and stained with 
IgM control negative, BOB78, and glycophorin A (control positive) 
antibodies. Reaction of the primary antibodies was detected with 
secondary antimouse antibodies conjugated with FITC, and analysed on 
flow cytometry. 
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The antigen BOB78 is not present in erythrocytes. The 
antigen BOB78 is absent from erythrocytes. As erythrocytes do 
not undergo apoptosis, this finding is consistent with the 
observation that BOB78 antigen is intimately linked to the 
orderly process of apoptosis. 
4.3 Excluding carbohydrate as the epitope identified by the BOB78 
antibody 
The BOB78 antibody was confirmed to be of IgM isotype in earlier studies in our 
laboratory. This raises the possibility that the BOB78 antibody might be identifying a 
carbohydrate moiety such as sialic acid. Carbohydrates in the form of oligosaccharides 
are added to a host of proteins as a post -translational process and account for some of 
the activity and signalling capacity of these glycoproteins (Varki, 1993). Many of these 
glycoproteins reside on surface membranes or are secreted to effect these functions 
(Lippincott- Schwartz et al., 2000). Sialic acid is a very common oligosaccharide side 
chain in a host of mammalian glycoproteins (Karlsson, 1991). If a carbohydrate epitope 
is identified by BOB78, the antigen identified by BOB78 may be multi -specific, ie not 
specific for an individual protein species. This would seriously undermine the 
interpretation of the findings so far. It would also imply purification of a single BOB78 
antigen with the antibody would be difficult. This issue was addressed with 
experiments using deglycosylating agents which remove oligosaccharide groups from 
glycoproteins. Removal of the oligosaccharide side chain would delete the positive 
detection of BOB78 if it is carbohydrate -specific. Positive antibody- antigen reaction 
however would not be affected if the BOB78 antibody is not identifying an 
oligosaccharide group. One of the most potent deglycosylating agents is 
neuraminidase -X from Clostridium perfringens. Reactivity of the BOB78 antibody 
before and after deglycosylation with neuraminidase -X was tested in the human 
leukaemic THP -1 cells, both in the intracellular site and when expressed on the surface. 
The dose of neuraminidase -X chosen was at a concentration whereby most major 
glycosylated groups especially sialic acid would be cleaved from glycoproteins. 
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4.3.1 BOB78 antigen within viable THP -1 cells remained detectable after 
deglycosylation 
THP -1 cells were incubated in normal saline for one hour and treated with 
neuraminidase -X for 45 minutes or 90 minutes and the control population was 
incubated in normal saline for the same time period. The cells were then harvested and 
washed, and processed for flow cytometry after fixation in paraformaldehyde and 
permeabilisation in methanol as previously described (Chapter 2). The relative 
fluorescence from the different cells following flow cytometry was compared, as the 
level of fluorescence on flow cytometry is related to the quantity of antigen present 
(Schuerwegh et al., 2001). This revealed no appreciable loss in the positive detection of 
BOB78 after deglycosylating treatment with neuraminidase -X for 45 or 90 minutes 
(figure 4.4). The epitope recognised by the BOB78 antibody therefore does not 
comprise sialic acid. Moreover when THP -1 cells were first fixed and then 
permeabilised, the intracellular BOB78 remained detectable after treatment with 
neuraminidase -X which would have cleaved carbohydrate groups from glycoproteins 
(figure 4.5). To corroborate this finding further surface expression of BOB78 antigen 
on apoptotic THP -1 cells was also similarly tested before and after treatment with 
neuraminidase -X. 
4.3.2. Surface expression of BOB78 antigen on apoptotic THP -1 cells 
remain detectable after deglycosylation with neuraminidase 
Human leukaemic THP -1 cells were synchronised in S -phase of cell cycle with 2mM 
thymidine for 18 hours and induced to undergo apoptosis with serum deprivation for 2 
hours (refer to Chapter 2). The cells were harvested, washed and incubated with 
neuraminidase -X in normal saline for one hour. The control population of apoptotic 
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Figure 4.4 Prevention of glycosylation in THP -1 cells with 
neuraminidase -X. Leukaemic THP -1 cells grown in standard medium 
were incubated in 154mM NaC1 for 45 or 90 minutes, with or without 
treatment with neuraminidase -X. The cells were permeabilised and 
stained with IgM isotype control and BOB78 primary antibodies. 
Fluorescence on FITC -conjugated secondary antibody was analysed on 
flow cytometry. 
BOB78 is not a 
carbohydrate moiety 
(sialic acid). There was no 
appreciable difference in 
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Figure 4.5 Deglycosylation of carbohydrate epitopes in THP- 
1 cells post- fixation. Fixed and permeabilised THP -1 cells were 
treated with neuraminidase -X for 90 minutes. The cells were then 
washed, stained with IgM isotype control and BOB78 primary 
antibodies. Fluorescence on FITC -conjugated secondary antibody was 
analysed on flow cy tometry . 
IgM control negative 
BOB78 antigen is not a 
carbohydrate moiety (sialic- 
acid). Treatment with 
neuraminidase -X would 
reduce the detection of 
intracellular BOB78 epitope if it 
were a carbohydrate (sialic 
acid). However BOB78 
staining is not significantly 
altered, indicating that the 
BOB78 antibody is likely 
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cells was incubated with normal saline. The cells were then stained for BOB78 and 
analysed for surface expression of BOB78 with flow cytometry as previously described 
(Chapter 2). Analysis with the flow cytometer showed that BOB78 reactvity on the 
surface of apoptotic THP -1 cells did not change after treatment with neuraminidase -X 
(figure 4.6). The apoptotic cells were thus identifiable, as previously noted, as 
propidium iodide -dim but BOB78- bright cells. In addition, the proportion of apoptotic 
cells did not differ between the treated and untreated populations, indicating that 
treatment with neuraminidase -X did not compromise the viability of the THP -1 cells. 
These results agreed with the earlier observation that detection of intracellular BOB78 
antigen was unchanged after deglycosylation. The BOB78 antibody is therefore not 
identifying sialic acid, a common carbohydrate moiety on mammalian glycoproteins. 
4.4 Excluding BOB78 antigen as a core oligosaccharide group 
Having excluded that BOB78 is not identifying sialic acid, further glycosylation- related 
analysis was performed to evaluate if BOB78 is identifying an epitope related to the 
core oligosaccharide group in glycoproteins. Core glycosylation is the attachment of N- 
acetylglucosamine residues to the asparagine residue on the protein at the N- terminal. 
This is the first and obligate step in protein glycosylation (Abeijon and Hirschberg, 
1992). Upon this carbohydrate structure are added other carbohydrate moieties specific 
to the glycoproteins. This core glycosylation step may be prevented by an antibiotic 
called tunicamycin (Chou et al., 1992). Tunicamycin is a hydrophobic analogue of 
UDP- N- acetylglucosamine. It blocks the addition of acetylglucosamine to dolichol 
phosphate, the first step in the formation of the core oligosaccharide. Incubating cells 
with tunicamycin would halt the maturation of glycoproteins, leading to breakdown in 
the normal biosynthetic- secretory pathway. If the epitope on BOB78 is related to core 
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Figure 4.6 Detection of BOB78 on apoptotic cells after de- 
glycosylation with neuraminidase -X. Human leukaemic THP -1 
cells were induced to undergo apoptosis with serum deprivation for 2 
hours. The cells were then treated with neuraminidase-X in normal 
saline, and processed for analysis of BOB78 surface expression on flow 
cytometry . Viable cells were separated from dying ones through 
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granular than viable cells (V). 
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the main apoptotic 
subpopulation (A) and the 
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Identification of BOB78 is unaffected after deglycosylation. 
The panels above illustrate how the detection of surface 
BOB78 on apoptotic cells was unaffected after deglycosylation 
with neuraminidase -X treatment. This confirmed BOB78 is not 
identified through sialic acid residue, an oligosaccharide side 
chain prevalent among glycosylated mammalian proteins. 
glycosylation, reactivity with the antibody would be reduced after incubation with 
tunicamycin. It is unlikely that detection of BOB78 antigen would be abrogated as the 
antigen appears to be present in abundant quantity inside the cells normally. However 
the shift in reactivity would be more pronounced if BOB78 antigen normally undergoes 
a high turnover rate. The effect of tunicamycin on intracellular BOB78 reactivity was 
investigated with human THP -1 cells using flow cytometry. 
4.4.1 The epitope recognised by BOB78 is not related to a core 
oligosaccharide group 
Human leukaeric THP -1 cells were cultured with tunicamycin over a dose range of 5 
to 101.1g /ml. The cells were then fixed and permeabilised, and processed for flow 
cytometry for detection of BOB78 as previously described (Chapter 2: Methods). 
Analysis with flow cytometry showed reactivity of the BOB78 antigen, reflected by the 
level of fluorescence, to be unchanged for cells cultured in tunicamycin when 
compared to untreated growing cells (figure 4.7). The peaks did not shift and had the 
same profiles as the untreated cells. This indicates that the BOB78 epitope is probably 
not related to the core oligosaccharide moiety. The incubation times would have 
affected biosynthesis of oligosaccharides on most glycoproteins, suggesting that 
BOB78 recognises a protein epitope. The antigen is not likely to undergo further 
processing within the ER -Golgi biosynthetic pathway. This possibility was examined 
further with Brefeldin -A, a Golgi disrupting agent. 
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Figure 4.7 Inhibition of core glycosylation with tunicamycin. 
THP -1 cells were incubated with 511g/m1 or lOug'ml tunicamyein for 18 
hours to inhibit core glycosylation of proteins. The cells were washed, 
fixed and permeabilised. Primary antibodies were IgM isotype control 
and BOB78, with FITC -conjugated secondary antibodies. Fluorescence 
was analysed on flow cy tometry . 
FITC 
IgM isotype control 
BOB78 epitope is not 
related to core 
oligosaccharides. 
Treatment with 
tunicamycin to inhibit core 
glycosylation did not 
reduce the detection of 
intracellular BOB78. This 
indicates the epitope 
detected by the BOB78 
antibody is not a 
carbohydrate moiety. 




4.5 Investigation of whether the BOB78 epitope matures within the 
Golgi apparatus 
The results obtained from the experiments with neuraminidase -X and tunicamycin 
indicated that the epitope recognised by the BOB78 antibody is not sialic acid and 
probably not an oligosaccharide. Further characterisation of the BOB78 epitope was 
carried out with Brefeldin -A to investigate if the BOB78 epitope matures in the Golgi 
apparatus of the cell. Brefeldin -A is a fungal macrolide lactone. It is a small 
hydrophobic compound and a potent inhibitor of protein trafficking in mammalian cells 
(Sciaky et al., 1997). The effect on Brefeldin -A is interference with the formation of 
transport vesicles which traffic between the membrane systems of endoplasmic 
reticulum ER and the Golgi apparatus (Nebenfuhr et al., 2002). Brefeldin -A inhibits the 
formation of the coats that are required for the budding of the transport vesicles. Within 
these membranes the system transport vesicles bud from one compartment and fuse 
with the membranes of the target compartments thereby transferring proteins from one 
area to the next in the line of processing. This traffic is two -way with ER and Golgi 
apparatus freely exchanging vesicles and membranes. Within minutes of treatment with 
Brefeldin -A the Golgi apparatus disassembles and redistributes into ER. The 
endoplasmic reticulum may be seen to swell at higher doses of Brefeldin -A. This 
dramatic effect, which is especially evident on microscopy, occurs because, whilst 
Brefeldin -A specifically prevents the forward movement of transport vesicles from ER 
to Golgi apparatus, the normal backward movement from Golgi to ER is not affected 
by Brefeldin -A. This effect makes it a potent inhibitor of secretion of most 
glycoproteins which undergo terminal processing in the Golgi apparatus. When treated 
with Brefeldin -A, staining of BOB78 within normal cells would be affected if BOB78 
antigen is an actively secreted entity or if the antigenic moiety on it depends on 
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modifications within the Golgi complex. Intracellular stores of BOB78 antigen before 
and after treatment with Brefeldin -A were analysed with immunoblotting, whilst the 
effects on cytoplasmic turnover and distribution of BOB78 antigen were studied 
through fluorescence microscopy. 
4.5.1. Brefeldin -A does not alter the epitope recognition of BOB78 
The human pancreatic cancer Mia cells were grown in monolayers in chamber slides 
and treated with Brefeldin -A, with an untreated population acting as control (as 
described in Materials & Methods; Chapter 2). The cells were then washed, fixed and 
processed for immunocytochemistry staining for BOB78 antigen. When compared with 
the untreated population, treatment with Brefeldin -A did not render any clearly 
demonstrable effect on the cytoplasmic staining of BOB78. The cytosolic localisation 
of BOB78 antigen was unchanged (figure 4.8). The intensity of staining also appeared 
unchanged. Within the cytoplasm of the treated cells, there appeared to be no 
differential concentration of staining to any particular location which suggested 
compartmentalisation of the BOB78 antigen. The exact localisation of BOB78 antigen 
was difficult to determine within the distorted cytoplasm which was probably occupied 
mainly by the swollen endoplasmic reticulum membranes. The treatment with 
Brefeldin -A was sublethal as there was no apoptosis detected. These observations 
suggest that the BOB78 epitope is matured without the participation of the Golgi 
apparatus. 
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Figure 4.8 Effects of Brefeldin -A on BOB78 in Mia cells. 
Human pancreatic cancer cells Mia were cultured in standard conditions 
and compared to incubations for 5 hours with Brefeldin -A at the 
annotated fmal concentrations. The cells were grown in monolayers in 
chamber slides, and were processed for inununocytochemistry with 
BOB78 and IgM isotype control primary antibodies. Secondary rabbit 
anti -mouse antibody was TRIT -C conjugated (red), with TOPRO -3 
(blue) for nuclear counter -staining 
RPMI/10%FCS 
BOB78 epitope is not 
matured in the Golgi 
apparatus. Staining for 
BOB78 persisted after 
treatment of Mia cells with 
Brefeldin -A which 
disassembles the Golgi 
apparatus. The pattern of 
cytoplasmic staining also 
appear unchanged. (Bar: 25p, 
m) 
Brefeldin-A0.5µg/m1 Brefeldin-A5µg/m1 
Another feature of the pattern of cytoplasmic staining of BOB78 also emerged from 
this study. Within both the untreated and treated populations of cells it appeared that 
BOB78 was not staining the Golgi apparatus. Whilst BOB78 was distributed 
throughout most of the cytoplasm there appeared to be a region relatively devoid of it 
(figure 4.8). This was the perinuclear zone of the Golgi apparatus (Hendricks et al., 
1992). The cytoplasmic staining of BOB78 appeared to leave a perinuclear halo with no 
staining. In addition cells treated woth higher concentrations of Brefeldin -A appeared 
to round up, which might be due to the effect of Brefeldin -A on cellular metabolism. 
The BOB78 antigen is therefore likely not a Golgi- related entity. 
4.5.2. Brefeldin -A did not appear to affect the quantity of BOB78 antigen 
within the cells 
An attempt was made to evaluate the possible effect of Brefeldin -A on the quantity of 
intracellular BOB78 antigen through the use of Western blotting. Human cells were 
treated as previously described (refer Chapter 2). The cells were then washed and lysed 
to yield protein lysate. The lysate was then subjected to Western blot as described in 
Materials & Methods (Chapter 2). The blots showed that the estimable quantity of 
BOB78 antigen as detected on Western blotting did not differ between the treated cells 
and the untreated ones (figure 4.9). The epitope detected by BOB78 antibody was 
probably not sensitive to Brefeldin -A treatment. This suggests maturation of the 
epitope does not occur within the Golgi apparatus. 
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Figure 4.9 Evaluating the expression of BOB78 after 
treatment with Brefeldin -A (a Golgi aisrupting agent). Human 
pancreatic Mia cells were cultured in standard conditions, and compared 
with vehicle control (DM SO) and treatment with Brefeldin -A. The cells 
were lysed and BOB78 antigen was detected through immunoblotting 
with BOB78. 
1 2 3 4 5 6 7 
,.., .,... r.....r.... .10=0.. 
Brefeldin -A treatment did not affect expression of BOB78 
antigen. The Western blot depicts the bands corresponding to 
BOB78 antigen. The density of the band is proportional to (but 
does not directly measure) the amount of antigen detected. 
There appears to be no dramatic change in the density of the 
bands, without or with treatment. 
Bands labelled: 
1: I -kB control positive 2: untreated cells 
3: DMSO (vehicle control) 4: untreated cells 
5: Brefeldin -A(BFA) 0.5 rrg /ml 
6: Brefeldin -A 5mg /m1 7: Brefeldin -A 25 ng /ml 
It appears however that this technique may not be the most suitable for quantitative 
determination of the expression of BOB78 antigen within cells. The antigen is normally 
abundantly present within cells. Disruption to the functions of cells with Brefeldin -A 
treatment, sufficient in degree and extent to affect the quantity of such a ubiquitous 
protein, may very likely lead to serious functional stress and cell death. At the same 
time it had not been possible to synchronise the growth cycles of these cells. These 
confounding factors suggest that estimation of quantity of BOB78 antigen using 
immunoblotting may be prone to errors. This is probably true even if the turnover of 
BOB78 antigen is very high indeed or if it is somehow intimately linked to the 
membrane traffic of the biosynthetic pathways with its synthesis and breakdown 
closely related to those of other glycoproteins. This experiment with Western blot was 
therefore performed with no prior assumptions of the effects which Brefeldin -A 
induced. 
4.6 Evaluating if movement of BOB78 antigen is affected by Monensin 
The appearance of BOB78 antigen on the plasma membrane suggests that a targeting 
mechanism exists for this movement. It might be transported along the membranes 
involved in the biosynthetic- secretory pathway. In addition there is a possibility that 
BOB78 antigen might be secreted, if the antigen is intimately involved within this 
traffic system. The abundant expression of BOB78 antigen within the cells also 
prompts the question whether a proportion of the cytoplasmic pool might be involved 
in constitutive export to the plasma membrane. In order to study whether the BOB78 
antigen might be exported by cells the fungal metabolite monensin was used. This 
antibiotic interferes with the export of glycoproteins. It has dramatic effect on the 
secretion of various cellular products including cytokines (Schuerwegh et al., 2001). 
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The effects of monensin on the turnover of glycoproteins may be studied through flow 
cytometry, where relative positive reactivities (mean fluorescence) may be compared 
(Schuerwegh et al., 2001). Should BOB78 normally be exported from the cell this 
disruption by monensin would manifest as increased signal on flow cytometry analysis 
(shift towards higher fluorescence). This glycoprotein export study was performed at 
the same time as the glycosylation studies with neuraminidase -X and tunicamycin. 
4.6.1. BOB78 antigen is probably not processed for secretion 
The effects of monensin on intracellular BOB78 antigen was studied with flow 
cytometry. Other possible effects on the cytoplasmic pool of BOB78 antigen was 
followed with fluorescence microscopy. The human leukaemic THP -1 cells were 
grown in standard culture conditions and incubated with monensin at doses titrated to 
interrupt glycoprotein export without inducing significant apoptosis among the cells. 
Monensin was added during the log -phase growth of the cells, when turnover of 
cellular functions is high, for enhanced effects. The cells were then harvested and 
processed for flow cytometry staining for BOB78 as described (refer Chapter 2). 
Positive detection of the BOB78 antigen remained unchanged after treatment with 
monensin. The relative fluorescences of both treated and untreated cells were similar 
(figure 4.10). The monensin treated cells did not exhibit a higher intensity of BOB78 
fluorescence. This result concurs well with the finding that the epitope detected is not 
sialic acid, derived from the neuraminidase -X deglycosylation studies, as one of the 
mechanisms through which monensin interrupts glycoprotein export is by its inhibitory 
action on sialotransferases. The maturation of the BOB78 epitope is therefore not likely 
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Figure 4.10 Effect of monensin on BOB78 detection. Leukaemic 
THP -1 cells, cultured in RPMI/10 %FCS at 1 x 106 cells /ml, were 
incubated with 25nM or 5OrtM monensin for 60 minutes or were 
untreated. The cells were fixed and permeabilised, and stained with 
primary IgM isotype control and BOB78 antibody, and FITC- 
conjugated secondary ant body . Fluorescence was analysed on flow 
cytometry. Control populations were compared with treated cells. 
Intracellular BOB78 antigen is 
probably not secreted. 
Incubation of the cells with 
monensin at the listed doses 
did not result in a dramatic 
change in the relative 
fluorescences (proportional to 
quantity intracellular BOB78). 
This suggests BOB78 antigen 
is not likely to be secreted in 
significant amounts under 
normal conditions. 
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to be related to the activity of this enzyme and the BOB78 antigen does not appear to 
be secreted under normal circumstances. 
4.6.2. Cytoplasmic distribution of BOB78 antigen appears unaffected by 
Monensin 
The possible effects of monensin on cytoplasmic distribution of BOB78 antigen was 
examined by fluorescent microscopy. It was anticipated that use of cells with high basal 
secretory capacity and abundant cytoplasm might make any effects more apparent. The 
human pancreatic cancer Mia cells were selected for this experiment. The cells were 
cultured as monolayers in chamber slides and were incubated with monensin at doses 
ranging from 0.11.tM to 1001,LM for 16 hours. Incubation with monensin was kept for a 
longer time period with the anticipation that dynamic changes within the Mia cells 
might be more evident. As Mia cells had been noted to be rather resilient to various 
forms of stress in culture, this amount of monensin was chosen even though doses 
within this range had been reported to induce apoptosis. The cells were then fixed and 
processed for immunocytochemistry as described previously (Chapter 2). 
On immunocytochemical investigation the BOB78 antigen typically occupies most of 
the cytoplasm of normal cells. There is often a very thin rim of increased abundance of 
the BOB78 antigen at the nuclear envelope. There is no particular association with the 
edge of the cytoplasm or any cytoplasmic projections such as there is with some 
cytoskeletal proteins eg. cofilin (Bamburg and Bray, 1987). This pattern is reminiscent 
of the distribution of endoplasmic reticulum. The translocation of BOB78 antigen to the 
membrane blebs of apoptotic cells has been previously discussed in Chapter 3. There 
appears to be significantly less staining of BOB78 antigen within the nuclei of cells 
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studied so far compared to the cytoplasm of live cells and the cell membranes of 
apoptotic cells (figures 3.13 - 3.17 and 4.8). On treatment with monensin as outlined 
above there appeared to be no dramatic effect on the cytopasmic staining and 
distribution of BOB78 antigen (figure 4.11). The treated cells showed no dramatic 
change in the cytoplasmic localisation of BOB78 antigen even at high doses of 
monensin (figure 4.12). There appeared to be no particular concentration of BOB78 
antigen to any area within the cytoplasm. The intensity of staining also appeared 
unaffected although this is not taken to infer an absence of change in the quantity of the 
BOB78 antigen. Apoptosis was not a significant feature of the treated cells. 
An incidental finding with the inherently fast -growing Mia cells was that BOB78 was 
present in dividing cells (figure 4.11). The smaller cytoplasm of the dividing cells 
showed definite and rather intense staining for BOB78. It is not possible to comment 
whether the intense staining had any direct relation to the quantity of BOB78 as the 
cellular morphology and volume had changed. 
DISCUSSION 
The results of the experiments detailed in this chapter allow a few conclusions about 
BOB78 to be made. It is evident that the epitope recognised by the BOB78 antibody is 
not sialic acid. The BOB78 antigen is also unlikely to be a oligosaccahride. There 
appears to be no demonstrable secretion of BOB78 from the cells under normal 
conditions. The antigenic site on BOB78 is very likely a peptide. Nevertheless it is still 
possible that the whole BOB78 molecule is a glycoprotein. Whilst tunicamycin may 
halt core glycosylation of the hypothetical "BOB78- glycoprotein" this does not change 
the antigenic recognition of the antigen by the BOB78 antibody. Tunicamycin would 
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Figure 4.11 Effects of monensin on BOB78 antigen in Mia 
cells. Human pancreatic cancer Mia cells cultured in standard conditions 
and compared with 16 -hour incubation with DMSO (volume adjusted 
vehicle control) and monensin at the final concentrations indicated in the 
legends. The cells were grown in monolay ers in chamber slides and 
processed for immunocytochemistry with BOB78 and IgM isotype 
control primary antibodies. Secondary rabbit anti -mouse was TRITC- 
conjugated (red) with TOPRO -3 (blue) for nuclear counter -staining (Bar: 
25µm) 
RPMI/10% FCS 
Monensin 0.1 µM 
DMSO (vehicle control) 
Monensin 1 µM 
Figure 4.12 Effects of higher doses of monensin. Human 
pancreatic cancer cells were cultured with increasing concentrations of 
monensin as indicated in the legends and processed as described in figure 
4.11.(Bar:25µm) 
Monensin 51,LM Monensin 25µM 
Monensin 50µM Monensin 100µM 
Titration of monensin concentrations does not affect 
cytoplasmic distribution of BOB78 antigen in Mia cells. 
Cytoplasmic distribution of BOB78 antigen appeared 
unchanged even at high levels of monensin. 
however interrupt the onward traffic of this "BOB78- glycoprotein ". Since most 
glycoproteins are products of the biosynthetic- secretory pathway, interruption of this 
traffic would induce a change in the quantity and possibly cytoplasmic localisation of 
any glycoprotein. These effects are usually obvious on flow cytometry and microscopic 
analysis. If BOB78 is truly a part of a glycoprotein it is likely that its turnover within 
the cells is very low. This suggestion would not agree well with the likelihood of it 
being a glycoprotein. 
Similarly treatment with monensin which inhibits glycoprotein movement and export 
should have a dramatic effect on BOB78 antigen if it truly is a processed for secretion. 
The abundant cytoplasmic pool of BOB78 antigen might account for the major 
proportion of the antigen detected, thus making any effects derived from incubation 
with monensin less apparent than anticipated. If this is the case, again as argued 
previously, the turnover of the hypothetical "BOB78- glycoprotein" had to be low. This 
appears rather incompatible with most secreted glycoproteins. Moreover the abundant 
cytoplasmic store of BOB78 antigen would probably be distributed into membrane - 
limited packages such as zymogens sensitive to signal- driven dynamics. 
The results from Brefeldin -A treatment suggest that BOB78 antigen is probably not 
recruited into the Golgi apparatus under normal conditions in the cells. With its 
expression in the cytoplasm unchanged by Brefeldin -A it is very probable that the 
localisation of BOB78 antigen is closely related to the endoplasmic reticulum. Taken 
together with the studies with tunicamycin, monensin and neuraminidase -X, it can be 
tentatively concluded that BOB78 is a protein or a peptide. It undergoes very low 
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turnover and is not linked to the membrane transport of the biosynthetic- secretory 
pathway. 
The pattern of cytoplasmic expression of BOB78 antigen on closer scrutiny with 
microscopy would propose that BOB78 may be an entity involved in the integral 
house -keeping functions in a cell. This proposal is borne out by the argument so far that 
it undergoes very little turnover and that it appears to be abundantly expressed at all 
times. Its presence within dividing cells would concur with this. This proposal would fit 
well with its likely intimate relation to endoplasmic reticulum ER. In normal cells ER 
partakes in a host of functions which range from biosynthesis of proteins and lipids, 
proper maturation and conformation of the proteins with its resident molecular 
chaperones, and synthesis of biomembranes which are destined for organelles and 
plasma membrane. This close link with ER would also be an avenue where BOB78 
antigen may be transported to the plasma membrane. 
The difficulty in synchronising the growth cycles of the cells has placed limitations on 
these kinetics studies and restrictions on the interpretations of the results. It had also not 
been possible to achieve near synchrony for apoptosis among the cells making it 
difficult to explore further queries of kinetics such as whether BOB78 antigen is 
actively synthesised or degraded during apoptosis. 
The tentative conclusions are thus: BOB78 antigen is not an oligosaccharide, and 
probably undergoes low basal turnover. The next series of experiments which follow 
were attempted in order to isolate the BOB78 molecule for a more defined identity of 
BOB78 antigen and its functions. These are detailed in Chapter 5. 
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Although results from the experiments using neuraminidase -X, tunicamycin and 
Brefeldin -A consistently suggested that the epitope recognized by BOB78 is not a 
carbohydrate, validity of the observations would be consolidated if control positive 
experiments had been performed. Positive controls using glycoproteins could be used 
to verify the effectiveness of treatments with various agents used in deglycosylation 
and metabolic disruption of endosynthetic pathways. Certain glycoproteins which are 
known to be associated with the cell lines used eg. CD44 and CD 15 would have been 
suitable candidates as positive controls, as they are likely to be affected by such 
treatments. Titrations of neuraminidase, tunicamycin, monensin and Brefeldin A would 
be guided by the loss of positive detection by appropriate antibodies directed against 
these glycoproteins in treated cells. 
The possibility that the BOB78 antigen may be secreted was studied using monensin to 
block secretion of intracellular stores of glycoproteins. However, this could have been 
evaluated more directly by detection of the BOB78 antigen within the supernatant of 
cell cultures, using Western blots or ELISA. 
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CHAPTER 5 
IDENTIFICATION OF BOB78 ANTIGEN AS A HEAT SHOCK PROTEIN 
Part I. Investigating if BOB78 identifies Calreticulin 
Part II. Purification and identification of the BOB78 antigen 
INTRODUCTION 
The results obtained so far indicate that BOB78 antigen is probably a protein, and 
likely a member of the house -keeping molecules integral to the normal functioning of a 
cell. The translocation of BOB78 antigen from the cytoplasmic pool to the plasma 
membrane may involve the endomembrane systems of endoplasmic reticulum, as 
plasma membrane is derived mainly from ER. Once positioned on the surface of an 
apoptotic cell BOB78 antigen remains stable until the cell undergoes late secondary 
lysis. The plasma membrane of a cell dying through apoptosis undergoes dynamic 
changes, amongst which include signals to mediate phagocytic recognition and 
engulfment. Externalised phosphatidylserine is an example of such changes. A possible 
role for BOB78 antigen which fits with the observations made in this project would be 
that of a molecular chaperone. Of the endoplasmic reticulum- associated chaperones, 
calreticulin (CRT) shares some striking similarities with the BOB78 antigen as 
elaborated below. 
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Calreticulin and BOB78 antigen: similarities 
Calreticulin was first isolated almost 3 decades ago (Ostwald and MacLennan, 1974). 
CRT is found in all eukaryocytic cells, and is highly conserved with 90% amino acid 
identity among human, mouse, rat and rabbit (Michalak, 1996). It is a 46 -kDa soluble 
protein, but has an apparent mobility on SDS -PAGE closer to 60 -kDa weight mark 
(Michalak et al., 1992; Nash, Opas & Michalak, 1994; McCauliffe and Sontheimer, 
1993). This is the calculated molecular weight of the BOB78 antigen on SDS -PAGE 
immunoblotting. Calreticulin is not found in erythrocytes (Krause & Michalak, 1997), a 
finding which matches that of BOB78. CRT has been shown to concentrate within the 
blebs of apoptotic cells. Keratinocytes induced to undergo apoptosis with ultra -violet 
irradiation generate discrete surface blebs which contain high concentrations of CRT 
(Casciola- Rosen, Anhalt & Rosen, 1994). CRT is an autoantigen prevalent in the 
autoimmune disease systemic lupus erythromatosus, SLE (Kishore et al., 1997). The 
CRT within the blebs possibly gets exposed to the adaptive immune system should the 
blebs be inadequately cleared following apoptosis. In fact, CRT had been found in 
these blebs together with other well- documented auto -antigens in SLE, the 
ribonucleoproteins (Staikou et al., 2003; Yang et al., 1999). Both BOB78 and CRT 
appear to share similar disposition within apoptotic cells. 
In normal cells calreticulin is a molecular chaperone which localises mainly as a 
luminal protein in the endoplasmic reticulum (Opas et al., 1996). Molecular chaperones 
in cells prevent accumulation and aggregation of misfolded proteins which represent a 
threat to the homeostasis and viability of cells. In general molecular chaperones are 
proteins which binds to hydrophobic surfaces exposed in unfolded but not native 
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protein conformers, stabilising the folding intermediates, thereby preventing incorrect 
interactions (such as aggregation) and increasing the yield of properly folded protein 
(Bukau & Horwich, 1998; (Grallert and Buchner, 1999). This binding is reversible and 
involves ATP -binding and hydrolysis. Calreticulin had been confirmed to demonstrate 
chaperone activities for both glycosylated and non -glycosylated proteins (Saito et al., 
1999). Observations from the experiments discussed in Chapter 4 have suggested that 
BOB78 may well be an endoplasmic reticulum -resident protein. 
Calreticulin in its role as endoplasmic reticulum- resident chaperone is linked to the 
management of membrane -bound protein groups destined for the plasma membrane. 
CRT associates with the MHC Class I loading complex prior to peptide loading 
(Sadasivan et al., 1996). CRT had been shown to recognise misfolded MHC Class I 
proteins, and to possibly stabilise the loaded peptides within the MHC loading complex 
(Gao et al., 2002; Mancino et al., 2002) for presentation on the cell surface. CRT has 
recently been reported as being expressed on the cell surface of lymphocytes (Arosa et 
al., 1999). Apparently there is an increased amount of misfolded MHC Class I proteins 
in activated lymphocytes. It is these misfolded protein groups that CRT was associated 
with at the surface. The increased translocation of CRT to the surface was reported by 
Arosa and colleagues to parallel the increase of misfolded MHC Class I proteins. The 
ability of endoplasmic reticulum- resident chaperones to escape to the plasma 
membrane has been reported in several cell types (Wiest et al., 1997; Zhang et al., 
1998). This traffic of calreticulin from its cytoplasmic (ER- membrane compartment) 
position to the plasma membrane of the cell is reminiscent of the translocation of 
BOB78 within a cell undergoing the dramatic changes of apoptosis. 
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RESULTS 
Part I. Investigating if BOB78 identifies Calreticulin 
5.1 Investigating if BOB78 antigen is Calreticulin 
The above observations prompted studies to investigate if BOB78 might be identifying 
calreticulin or an epitope closely related in structure to calreticulin. Purified 
recombinant calreticulin was used to test if the BOB78 antibody might identify it. This 
was compared with the ability of an anti -calreticulin antibody to recognise the CRT 
antigen. The purified CRT protein was run on SDS -PAGE gel and blotted onto 
nitrocellulose membrane for probing with the calreticulin and BOB78 antibodies as 
described in methods (Chapter 2). Immunocytochemistry with MEG -01 cells was also 
performed to investigate the possible relationship between BOB78 antigen and 
calreticulin. The ability of calreticulin antibodies and BOB78 antibody to identify 
platelets generated from the human megakaryocytic cell line MEG -01 was also 
investigated. The use of this cell line is discussed in detail later in this chapter (refer 
5.2). Briefly, it has been observed that platelet formation from MEG -01 cells involves 
the caspases which are employed in apoptosis (De Botton et al., 2002). The platelets are 
reminiscent of the blebs produced from the membranes of cells undergoing apoptosis 
(Stenberg and Levin, 1989). The results later in Chapter 5 detail the observation that the 
BOB78 antigen is being channelled into these platelets from the cytoplasm of the 
MEG -01 cells. 
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5.1.1. BOB78 does not identify Calreticulin 
The purified recombinant human calreticulin protein was run on a SDS -PAGE gel, 
together with total protein lysate from leukaemic THP -1 cells and molecular weight 
markers. The separated proteins were then blotted onto a nitrocellulose membrane for 
probing by IgM isotype control and BOB78 primary antibodies. This reaction was 
detected through peroxidase- conjugated anti -mouse secondary antibody as described 
previously (Chapter 2). The results indicated that the BOB78 antibody did not identify 
the calreticulin antigen (figure 5.1). However it reacted with THP -1 cell lysate with a 
band corresponding to a molecular weight of approximately 65 kiloDaltons. This would 
mean that BOB78 is not an antibody identifying calreticulin. 
5.1.2. The BOB78 antigen is not Calreticulin 
Immunocytochemical analysis of the presence of BOB78 antigen and calreticulin 
within the human megakaryocytic MEG -01 cells was performed next. The MEG -01 
cells were harvested and cytocentrifuged onto microscopic slides for 
immunocytochemistry as described (Chapter 2). Reactions of primary mouse anti- 
human BOB78 and IgM isotype control; and rabbit anti -human calreticulin and IgG 
isoytype control, were detected with FITC- conjugated and TRITC- conjugated 
fluorescent secondary antibodies. The nuclei were counter - stained with TO -PRO 3. The 
fluorescent staining was analysed using both fluorescence and confocal microscopy. 
The results confirmed conclusively that BOB78 does not recognise calreticulin (figure 
5.2). The most interesting feature was that BOB78 antigen was distributed in a location 
devoid of calreticulin. Their respective cytoplasmic distribution appeared mutually 
exclusive. The calreticulin present in MEG -01 cells was restricted to a band juxtaposed 
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Figure 5.1 Investigating if BOB78 identifies calreticulin 
(CRT). Total cell lysate from leukaemic THP -1 cells (lanes 2 and 3), and 
recombinant calreticulin (lane 1) were separated through SDS -PAGE and 
probed with BOB78 antibody. The immunoblot was developed with 
peroxidase- conjugated anti -mouse antibodies, and visualised through the 
ECL system. 
- 1701Da - 11610a - 76kDa 
4111111b. - 55kDa 
Lane: 1 2 3 U J 
CRT THP -1 
lysate 
BOB78 IgM 
BOB78 antigen is not calreticulin. The BOB78 antibody 
identified a 65 kDa antigen from the THP -1 cell lysate (lane 2). 
The purified calreticulin (lane 1) was not recognised by BOB78 
antibody. An appropriate control for this experiment would be 
immunoblotting with anti -calreticulin antibody. This could 
confirm the presence of calreticulin and enable the molecular 
weight of calreticulin to be compared to that of the BOB78 
antigen. The possibility of BOB78 identifying calreticulin was 
pursued further through immunocytochemistry with 
megakaryocytic MEG -01 cells. 
Figure 5.2 Localising BOB78 and calreticulin in MEG-01 
cells. Human megakary ocytic MEG -01 cells were cytocentrifuged into 
microscope slides and processed for immunocytochemistry . BOB78 
(mouse) was detected with FITC -conjugated secondary (green), and anti - 
calreticulin (rabbit) was detected with TRITC -conjugated (red) 
secondary antibodies. Nuclear counterstaining was effected with 
TOPRO -3. The images were obtained as 3 separate frames under 
fluorescence microscopy, and merged with Adobe photoshop. 
BOB78 does not identify calreticulin. BOB78 and calreticulin 
appear to be segregated to different intracellular locations. The 
BOB78 antigen is distributed to the outer cortex of the cytoplasm, 
whilst calreticulin is limited to the inner cytoplasm. This confirms 
the BOB78 monoclonal antibody is not recognising calreticulin. 
In addition BOB78 seems to be trafficked into the platelets 
budding off the cytoplasm. (Bar: lOn n) 
to the nucleus. There appeared to be no extension of the rim of CRT to any other 
cytoplasmic locale. Just beyond this peri- nuclear band was the main distribution of 
BOB78 antigen. The outer cortex of cytoplasm was filled with BOB78. And there was 
no identifiable BOB78 within the rim of distribution of CRT. In fact BOB78 antigen 
was transported into the platelets of MEG -01 cells. The packaging of BOB78 antigen 
into the platelets appeared to be initiated as the cell membrane developed outward 
protrusions. The mutually exclusive distribution of BOB78 antigen and CRT within 
separate locale within the MEG -01 cells confirmed that BOB78 antigen is not CRT. 
5.2 Studying BOB78 antigen in platelet production 
It has been demonstrated recently that caspases are involved in the generation of 
platelets from the human megakaryocytic MEG -01 cell line. Production of platelets 
arising from the terminal differentiation of MEG -01 cells was initiated by the activation 
of apoptosis- specific caspases (De Botton; 2002). Platelet production was inhibited by 
the (broad specificity) pan -caspase inhibitor z- VAD.fmk. However, once platelets 
began to form, such pan- caspase inhibition had no effect on the maturation and budding 
off of these platelets from the MEG -01 cells. This observation corroborates an earlier 
report that aged megakaryocytes undergo apoptosis and produce platelets (Zauli et al., 
1997). The parent polyploid megakaryocyte cell body appears to involute through 
apoptosis and be engulfed by phagocytes in the bone marrow (Radley and Holder, 
1983). Utilising human megakaryocytic MEG -01 cells which had been shown to 
produce functional platelets, Clarke and colleagues (2003) confirmed that these 
platelets were in fact generated through compartmentalised activation of caspases 
within the MEG -01 megakaryocytes. These platelets were devoid of caspase -9 although 
the lysate from these did contain caspase -3. These platelets undergo constitutive death, 
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displaying changes typical in apoptosis, leading to clearance through phagocytosis 
(Brown et al., 2000). The parent polyploid megakaryocytes proceeded to apoptosis after 
caspase -9 within them was activated. These various findings propose that the terminal 
differentiation of megakaryocytes leads to apoptosis of the parent cells, with activated 
caspases driving the dramatic cytoplasmic changes which culminate in platelets being 
budded off. Morphologically, a MEG -01 cell developing surface evaginations at the 
plasma membrane, which bud off into platelets, is reminiscent of an apoptotic cell 
developing membrane blebs (Takeuchi et al., 1998)(refer figure 5.3). This membrane 
blebbing in apoptosis has been shown to be an event which is dependent on, and 
consequential to, caspase activation (Coleman et al., 2001). Since the BOB78 protein 
has been demonstrated to be concentrated in the membrane blebs of apoptotic cells, it 
might also be found in the platelets derived from MEG -01 cells. This suspicion had 
been suggested by the immmunocytochemistry studies localising BOB78 and 
calreticulin in MEG -01 cells (refer figure 5.2). 
5.2.1. MEG -01 cells in the stages of terminal differentiation express 
BOB78 antigen on the surface 
Human megakaryocytic MEG -01 cells in culture constitutively undergo terminal 
differentiation with concomitant production of functional platelets (Clarke et al., 2003). 
MEG -01 cells were maintained in standard culture conditions and were noted to have 
platelets which were shed into the culture medium whilst the parent cell went through 
morphological changes resembling those of apoptotic cells. The MEG -01 cells were 
harvested and processed for analysis by flow cytometry to evaluate surface expression 
of BOB78 antigen. The viability and stages of cell death of the MEG -01 cells was 
confirmed with propidium iodide staining. 
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Figure 5.3 Platelet formation in megakaryocytic MEG-01 
cells in culture. Human megakaryocytic MEG -01 cells were 
maintained in standard cultures with RPMI /10% foetal calf serum. 
Photograph of cells in culture was taken through phase contrast 
microscope. 
Membrane evaginations of MEG-01 cells reminiscent of 
blebbing in apoptotic cells. Megakaryocytic MEG -01 cells 
undergo terminal differentiation with production of platelets 
through protrusions in the cell membrane. These resemble the 
`cytoplasmic boiling' observed in apoptotic cells where 
packages of cytoplasm would be delivered in membrane 
blebs. 
The pattern of expression of BOB78 antigen on MEG -01 cells is highly reminiscent of 
the surface expression of BOB78 antigen on apoptotic cells (figure 5.4). The population 
of MEG -01 cells which are viable do not express BOB78 antigen on the surface and do 
not stain with propidium iodide. A proportion of MEG -01 cells which are smaller in 
size express BOB78 antigen on the surface. These are probably terminally 
differentiating MEG -01 cells which, having produced platelets, are left with scanty 
cytoplasm enclosing a polyploid nucleus. These cells exclude propidium iodide in the 
early stages of cell death when surface expression of BOB78 antigen is pronounced. In 
the later stages of cell death the surface expression of BOB78 antigen persisted whilst 
the cells became progressively more permeable to propidium iodide. However, cells 
decaying into secondary necrosis do not express BOB78 antigen on the surface 
membrane whilst being fully permeable to propidium iodide. This pattern of expression 
is akin to that demonstrated in apoptotic leukaemic THP -1 cells. It appears that BOB78 
antigen is expressed by cells executing an inherent cell death programme. 
5.2.2. BOB78 antigen is concentrated in the platelets of megakaryocytic 
cell line MEG -01 
Megakaryocytic MEG -01 cells growing under normal conditions were harvested, cyto- 
centrifuged onto microscopic slides and processed for fluorescent 
immunocytochemistry as previously described (Chapter 2: Methods). The cells were 
stained for BOB78 antigen expression. Confocal microscopy revealed several striking 
features (figure 5.5). MEG -01 cells expressed BOB78 antigen within the cytoplasm. 
Closer scrutiny revealed the intracellular distribution of BOB78 antigen to be 
exclusively restricted to the outer cortex of the cytoplasm. The BOB78 protein from 
this outer rim of cytoplasm appeared to be trafficked into and sequestered within the 
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platelets as these pinched off from the parent MEG -01 cells. This phenomenon is 
highly reminiscent of the translocation of BOB78 antigen within blebbing apoptotic 
THP -1 cells (refer Chapter 3, figure 3.13). As discussed earlier, this movement of 
BOB78 antigen may be driven by the caspases which are activated during the terminal 
differentiation of MEG -01 cells. This observation corroborates the earlier observation 
that trafficking of BOB78 antigen within cells is linked to the initiation of the apoptosis 
programme. The MEG -01 cell bodies which remained after shedding of the platelets 
demonstrated absence of BOB78 antigen within the cytoplasm. The nuclei were also 
typically fragmented as in apoptosis (figure 5.5). 
5.3 Expression of BOB78 antigen in senescent platelets 
Platelets produced by the human megakaryocytic MEG -01 cells constitutively undergo 
senescence in culture (Brown et al., 2000). Effete platelets demonstrate externalisation 
of phosphatidylserine residues on the plasma membrane, just as apoptotic nucleated 
cells do. This membrane feature is a hallmark of senescence in platelets. These platelets 
contain caspase -3, caspase -9, Apaf -1 and cytochrome -c, at levels comparable to 
nucleated cells (Clarke et al., 2003). In addition the platelets also contain mitochondria. 
The MEG -01 platelets therefore carry an inherent programme of caspases and factors 
which may effect the intrinsic pathway of apoptosis. In other cells these caspases drive 
hallmark downstream events including flipping of phosphatidylserine to the outer leaf 
of the plasma membrane during apoptosis. Not surprisingly caspase- dependent DNase 
is absent from the platelets, as these are devoid of genomic nuclear material (Wolf et 
al., 1999). This key event of phosphatidylserine externalisation on the platelets was 
followed with Annexin -V binding and compared with BOB78 antigen expression on 
the surface to see if these are parallel events. 
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Figure 5.4 Expression of BOB78 in megakaryocytic MEG-01 
cells. Human megakaryocytic MEG -01 cells were pooled from several 
days in standard culture conditions and processed for flow cytometry. 
Primary IgM isotype control and BOB78 antibodies were used, with 
FITC -conjugated secondary antibody. Viability of the cells was verified 
through exclusion of prop idium iodide PI. 
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Apoptotic MEG-01 cells express BOB78 antigen on the 
surface. Terminal differentiation of MEG -01 cells culminates in 
apoptosis of the polyploidy parent cells, with the release of 
platelets. The remaining nuclei which had scant cytoplasm 
stained PI strongly in the late apoptotic stage. The differentiating 
MEG -01 cells which stain weakly for PI exhibit strong expression 
of BOB78 antigen on the surface, until the later stages of 
apoptosis. This profile is reminiscent of that with apoptotic THP- 
1 cells after treatment with cam ptothecin (CPT). 
Figure 5.5 Localisation of BOB78 antigen to membrane 
blebs and platelets of MEG-01 cells. Human megakaryocytic MEG - 
01 cells were cytocentrifuged into microscopic slides and processed for 
immunocytochemistry. BOB78 (mouse) was detected with TRITC- 
conjugated secondary (red), and anti -calreticulin (rabbit) was detected 
with FITC- conjugated (green) secondary antibodies. Nuclear 
counterstaining effected with TOPRO -3. Fluorescence was analysed 
through confocal microscopy. (Bar: 15 Mn) 
BOB78 antigen is concentrated in the MEG-01 membrane 
blebs and platelets. BOB78 antigen seems to be trafficked into 
the membrane blebs on the surface of MEG -01 cells (broken 
arrow). An apoptotic MEG -01 cell with chromatin clumps (blue 
arrow) appears to retain calreticulin in the cell body whilst the 
shed platelets (arrow) appear as subcellular particles with 
strong BOB78 staining. 
5.3.1 Senescent MEG -01 platelets express BOB78 antigen on the surface, 
as well as externalising phosphatidylserine residues 
The platelets retrieved from the MEG -01 cell culture were processed and analysed for 
BOB78 antigen expression on flow cytometry as described in Chapter 2 (Methods). 
The platelets in culture were positively staining for Annexin -V in about 20% of the 
population. The aging subpopulation was distinguishable by generally reduced cell size 
on flow cytometry (figure 5.6). This same subpopulation also expressed BOB78 
antigen on the surface (figure 5.7). The pattern of expression was not discrete, rather it 
appeared that the senescent platelets were at various stages of exposing BOB78 antigen 
over a continuum. The exposing of phosphatidylserine residues as detected by 
Annexin -V followed a similar pattern. It appears that the expression of BOB78 antigen 
on the membrane of these senescent platelets is concomitant with that of 
phosphatidylserine This was similar to the coincident expression of BOB78 antigen and 
phosphatidylserine on the surface of apoptotic cells (refer to Chapter 3). The use of a 
vital dye such as propidium iodide to separate viable platelets from the senescent or 
dying ones was precluded by the absence of nuclei from platelets. The reported 
proportion of platelets in culture undergoing senescence is about 20 percent. However 
it was difficult to synchronise the maturation of MEG -01 cells, even in culture systems 
commencing with CD34 megakaryocytes in primary culture (Choi et al., 1995). 
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Figure 5.6 Analysis for senescence of MEG-01 platelets with 
Annexin V. Platelets produced by megakaryocytic MEG -01 cells were 
harvested from standard cultures and processed for flow cytometry. 
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Senescent platelets (green) 
may not be distinguishable 
from normal platelets by 
changes in size on flow 
cytometry, although shrinkage 
of cytoplasm has been 
documented with electron 
microscopy. 
Aged platelets stain for 
Annexin V. Platelets from 
megakaryocytic MEG -01 cells 
undergo constitutive aging, 
with externalisation of 
phosphatidyiserine on the 
plasma membrane. This is a 
feature of apoptotic nucleated 
cells. 
The standard dye exclusion 
test for viability with propidium 
iodide however would not 
differentiate the platelets as 
there is no nuclear material 
within them. 
Figure 5.7 Expression of BOB78 in MEG-01 platelets. Platelets 
produced by megakaryocytic MEG -01 cells were harvested from 
standard cultures and processed for flow cytometry. The platelets were 
stained for surface expression of BOB78 antigen. Fluorescence from 









The population of cells 
expressing BOB78 antigen on 
the surface appear to be 
similar to the senescent 
Annexin V positive population 
(see figure. 5.6). 
Senescent platelets express 
BOB78 antigen on the surface. 
This profile is similar to 
nucleated cells surfacing 
BOB78 antigen on the plasma 
membrane during apoptosis 
(see figure. 3.7). 
Senescent platelets stained 
with IgM isotype control 
antibodies. 
Part II. Purification and identification of the BOB78 antigen 
5.4 Determining the molecular weight of BOB78 antigen with SDS - 
PAGE and immunoblotting 
The molecular weight of BOB78 was determined through mobility of the antigen in a 
SDS -PAGE gel compared with standard molecular weight markers. Lysate of human 
leukemic THP -1 cells was used in the SDS -PAGE as described in methods (Chapter 2). 
Briefly protein from a total cell lysate was loaded onto an acrylamide gel together with 
weighted molecular markers and driven through the gel by electrophoresis. The gel 
with the mass -separated proteins was blotted onto nitrocellulose membrane. This was 
incubated with control IgM isotype and BOB78 primary antibodies. Detection of the 
antigen by the BOB78 antibody was marked by a single specific band. The distance 
moved by the BOB78 band was compared with the distances moved by standardised 
molecular weight markers. The distances through which the molecular markers moved 
were plotted as an inverse linear relation ie. lighter proteins moved farther than the 
heavier proteins. The distance through which the BOB78 band moved was plotted off 
this curve to mark its weight. 
5.4.1 BOB78 antigen is 65 kiloDaltons and this is consistent amongst 
various cell lines 
The molecular weight of the BOB78 antigen on SDS -PAGE gel was calculated as 65 
kiloDaltons (figure 5.8). This weight was consistent when examined in other cell lines 
which included megakaryocytic MEG -01 cells, hepatoma HUH -7, HepG2 cells and 
pancreatic Mia cells. BOB78 antigen may be a highly conserved protein with a 
molecular of 65 kiloDaltons on a SDS -PAGE gel (figure 5.9). 
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Figure 5.8 The molecular weight of BOB78 antigen on SDS- 
PAGE Lysate from leukaemic THP -1 cells was loaded in equal amounts 
(2Oug per lane) onto a gel and the proteins were separated through SDS- 
PAGE. The proteins were then transferred onto a nitrocellulose 
membrane in semi -dry conditions. The BOB78 antigen amongst the 
proteins was probed with a titration of BOB78 monoclonal antibodies in 
decreasing concentration. Positive reaction was visualised through the 
ECL chemi- luminescence system. 
BOB78 monoclonal WI 
.. 410.. 011.. 
- 170kDa - 116kDa - 76kDa 
-- 65kDa - 55kDa 
The BOB78 protein weighs 65 kiloDaltons. From mobility on 
SDS -PAGE analysis with Western blotting the molecular 
weight of BOB78 antigen measured 65 kiloDaltons. This 
weight is calculated from a plot of the weights against the 
distances moved by the standard molecular weights. At 
titration of higher strengths, a band at a slightly lower 
molecular weight is apparent. This might represent non- 
specific reaction. Western blots were subsequently performed 
with BOB78 supernatant at 1: 100 dilution. 
Figure 5.9 Investigating lineage specificity of BOB78 
antigen. Total protein lysate from various cell lines were loaded in 
equal amounts and separated through SDS -PAGE and probed with 
BOB78 antibody. Western immunoblot was developed with peroxidase- 
conjugated anti -mouse antibodies, and visualised through ECL system. 
The numbered lanes were loaded respectively with proteins from MEG - 
01 platelets (lanes 1 and 2), MEG -01 cells (lane 3), THP -1 cells (lane 4), 
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- 55kDa 
Multi- lineage specificity of BOB78 antigen confirmed. The 
BOB78 antibody identified a 65kDa antigen from the various cell 
lines outlined above. Platelets generated from MEG -01 
megakaryocytic cell line appear to have BOB78 in amounts not 
very different from the nucleated cells. This observation 
suggests the MEG -01 platelets might be a useful source of 
BOB78 antigen. 
5.5 Isolation of BOB78 antigen through immunoprecipitation 
Earlier attempts at isolating BOB78 antigen from neutrophils might have been impeded 
by breakdown of the protein by the proteolytic enzymes in these leucocytes (Hart et al., 
2000). Having identified that platelets from the megakaryocytic MEG -01 cells were an 
enriched source of BOB78 antigen, these were used for isolating the BOB78 antigen 
through immunoprecipitation. To improve the capture of the BOB78 antibody which is 
a mouse IgM, an additional step using rabbit anti -mouse polyclonal antibodies to 
retrieve the BOB78 antibody- antigen complexes was employed. These secondary 
antibodies of IgG subclass were in turn bound onto Sepharose protein A, as described 
in Chapter 2 (Methods). The platelets were lysed to release the BOB78 antigen with a 
buffer containing Triton -X as membrane detergent. Triton -X had been noted to be less 
disruptive to the bond between the antibody and the antigen, which is non -covalent. 
The captured proteins as well as unreacted BOB78 antibody (hybridoma supernatant) 
were then separated on a SDS -PAGE gel under reducing conditions. One half of the gel 
was stained for proteins with Gelcode (colloidal Coomassie Blue, Pierce) whilst 
duplicate lanes on the other half were blotted and probed with BOB78 antibody in 
standard Western blot conditions. This was to confirm the specificity of the antigen 
capture from the platelet lysate. The weight of the band corresponding to BOB78 on 
Western blot was calculated from the standard molecular weights. The band on the 
stained gel which corresponded to this weight was then cut out for protein sequencing. 
5.5.1. The antigen captured from MEG -01 platelet lysate is approximately 
67 kiloDaltons 
The reaction between the MEG -01 platelet lysate and BOB78 supernatant yielded a 
unique band at weight 67 kiloDaltons on staining with Gelcode. This band 
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corresponded to the specific capture of the BOB78 antigen (refer results 5.5.2). This 
was the band that was cut out for sequencing through MALDI -TOF. 
5.5.2. Antigen captured from MEG -01 platelet lysate is BOB78 
The parallel half of the immunoprecipitation gel was probed with BOB78 antibody as 
per Western blot (described in Chapter; Methods). The residual non -specific activity of 
rabbit anti -mouse antibodies was quenched with an excess of mouse IgM isotype 
antibodies. The blot was then probed with BOB78 antibody. This showed a specific 
reaction at a weight of 67 kiloDaltons corresponding to the specific band antigen 
captured by the BOB78 supernatant from the MEG -01 platelet lysate. 
5.6 Sequencing of the BOB78 antigen by MALDI -TOF 
The immunoprecipitated proteins as well as the BOB78 antibody were separated 
through SDS -PAGE under reducing conditions. The SDS (sodium dodecyl sulphate) in 
the electrophoresis reagents would disrupt all non -covalent protein associations, 
thereby releasing the captured antigens from the antibodies. The separated proteins on 
the gel were stained with Gel -Code (Pierce), as this does not contain methanol which 
by reason of its chemical nature and reactions with the proteins and peptides, render 
mass spectometry sequencing inaccurate. A band specific to the reaction between the 
platelet lysate and the BOB78 supernatant was identified and its weight was calculated 
at 67kDa (figure 5.10). The other half of the gel containing identical proteins had 
confirmed the specific capture of BOB78 and it had a weight of 67kDa on SDS -PAGE 
under these conditions (figure 5.11). The band was cut out and sent for sequencing 
using MALDI -TOF mass spectrometry. This sequencing service is run by Dr Andrew 
Cronshaw at the Edinburgh Protein Interaction Centre (EPICs). Protein sequencing was 
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Figure 5.10 Immunoprecipitation of BOB78 antigen. BOB78 
antigen from the lysate of MEG -01 platelets was captured with the 
BOB78 IgM monoclonal antibodies. The immune complexes were then 
captured with rabbit anti -mouse antibodies, which in turn were captured 
by protein -A Sepharose beads. The captured proteins were released 
under reducing conditions and loaded into a gel for SDS -PAGE. The 
separated proteins were stained with Gel -Code (Pierce) and compared 
with the molecular standards in the same gel. 
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BOB78 antigen was precipitated from the MEG-01 platelets 
lysate. There was a band (arrowed) specific to the reaction 
between BOB78 monoclonal antibody and the platelets lysate, 
weighted at 67kDa. lane 2). This band was sent for sequencing 
with mass spectrometry (MALDI). Lanes 1, 3 & 4 represent 
control experiments. 
Lane 1: BOB78 antibody supernatant; beads 
Lane 2: BOB78 antibody, platelet lysate; beads 
Lane 3: IgM isotype control, platelet lysate; beads 
Lane 4: platelet lysate; beads 
Bands: A immunoglobulin light chain 
B: immunoglobulin heavy chain 
C: other proteins in supernatant 
Figure 6.11 Confirmation of capture of BOB78 at weight 
67kDa. Duplicate lanes from the immunoprecipitate gel was probed 
with BOB78 antibody and processed for Western blot. The residual 
rabbit anti -mouse activity from the bridging antibodies was first 
quenched through incubation with an excess of blank mouse IgM 
molecules. The band indicated specific BOB78 antigen captured on 





Lane 1 2 3 4 
- 170kDa - 116kDa 
76kDa - 55kDa 
- 30kDa 
The antigen BOB78 was captured at a band weighted at 67 
kiloDaltons. The antigens captured through 
immunoprecipitation were identified with reactivity for BOB78 
antibody. The lane of antigens captured from the reaction of 
BOB78 antibody with protein lysate yielded a band specific for 
BOB78 antibody, indicating specific capture of the antigen. A 
band of identical weight was identified on staining with Gel - 
code and was sent for MALDI -TOF mass spectrometry. 
Lane 1: *beads incubated with only BOB78 antibody 
Lane 2: lysate incubated with BOB78 antibody 
Lane 3: lysate incubated with 1gM isotype control antibody 
Lane 4: lysate incubated with beads *(conjugated to rabbit anti - 
mouse antibodies) 
performed on bands obtained from BOB78- platelet lysate immunoprecipitation on 3 
separate occasions. These returned with the captured antigen positively identified as 
chaperonin, also known as heat shock protein 60 (hsp60) in mammalian cells (figure 
5.12). 
5.7 Verifying the MALDI -TOF sequencing with recombinant human heat 
shock protein 60, and commercially available mouse anti -human hsp60 
antibody 
The putative identity of BOB78 antigen through MALDI -TOF sequencing was that of 
human heat shock protein 60, also known as chaperonin (figure 5.12). This 
identification of the antigen by BOB78 antibody was verified with commercially 
available recombinant human heat shock protein 60 (rh- hsp60, from StressGen). At the 
same time the reactivity of the BOB78 antibody was compared with commercially 
available mouse anti -human hsp60 antibody (Stressgen). Cell lysate from MEG -01 
platelets and rh -hsp60 were separated on a SDS -PAGE gel and blotted onto 
nitrocellulose membrane as described in Chapter 2. The separated proteins were then 
probed with anti -hsp60 (StressGen) and the BOB78 antibody. 
The Western blot showed that BOB78 identified rh -hsp60 at the molecular weight of 65 
kiloDaltons on SD -PAGE (figure 5.13). This is also the weight of the BOB78 antigen 
consistently identified by the BOB78 antibody. Among the proteins from the MEG -01 
platelets, the mouse anti -hsp60 antibody identified a band corresponding to a molecular 
weight of 65 kiloDaltons. This is the same weight for the band of purified recombinant 
human hsp60 identified by the anti -hsp60 antibody. 
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9 Nov BSA 69.3 28 1.6e+8 / 14 
15 Nov HSP60 61 23 4.0e+6 / 9 
(Chaperonin) 
19 Nov HSP60 61 29 2.3e+8 / 12 
(Chaperonin) 
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Figure 5.13 Verifying the reactivity of BOB78 against 
recombinant human (rh) heat shock protein 60. The reactivity of 
BOB78 for rh -hsp60 protein was compared with that of commercial anti - 
hsp60 monoclonal IgG. The lanes were loaded with either (recombinant 
human) rh -hsp60 (marked with thick line ) or lysate from MEG -01 
platelets (marked with interrupted line ). The proteins were 
separated on SDS -PAGE gel. Western blotting was performed with 
BOB78, anti -hsp60 monoclonal and isotype control antibodies. 
- 170kDa - 116kDa - 76kDa 
gap 
J - 55kDa 
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BOB78 identifies heat shock protein 60. The BOB78 antibody 
identifies rh -hsp60 as well as BOB78 from MEG -01 platelets, at 
the same molecular weight. The purified anti-hsp60 monoclonal 
antibody identifies recombinant hsp60 as well as the BOB78 
antigen, at the same weights as BOB78 detects these. No band 
of identification is detected with the IgM and IgG isotype controls. 
DISCUSSION 
Part I: BOB78 antigen and calreticulin 
Calreticulin is a well- studied molecular chaperone important for many homeostatic 
functions in the cell (Michalak et al., 1999). It also sequesters calcium, a capacity vital 
to its homeostatic functions. There appear to be several similarities between calreticulin 
and BOB78 antigen, including absence from red blood cells. Studies using the human 
megakaryocytic MEG -01 cells have conclusively distinguished calreticulin from 
BOB78 antigen. BOB78 antigen (hsp60) is not calreticulin. The mutually exclusive 
distribution of these entities suggests different functions served by calreticulin and 
BOB78 antigen in MEG -01 megakaryocytes. It is interesting to note that calreticulin 
remains with the parent MEG -01 cell body after it has undergone terminal 
differentiation, releasing platelets in the process. In vivo these remnant apoptotic bodies 
of megakaryocytes are disposed of through phagocytosis by stromal cells in the bone 
marrow (Radley and Haller, 1983). This finding agrees with the implication of 
calreticulin having a role in phagocytosis of apoptotic cells (refer Chapter 1, 
Introduction). It would be reasonable to speculate a role for calreticulin in the clearance 
of these apoptotic bodies when the MEG -01 megakaryocytes have completed 
differentiation. 
It is interesting how BOB78 antigen (hsp60) is exclusively concentrated within 
platelets whilst calreticulin is excluded from these. Both CRT and hsp60 are known to 
be cellular chaperones. Calreticulin has been implicated as a key moiety in recognition 
of apoptotic cells, being present on phagocytic cells (Ogden et al., 2001). Studies 
carried out in this research project have confirmed the expression of hsp60 on apototic 
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cells which may be important in the phagocytosis of apoptotic cells. It may be that, in 
megakaryocytes which are destined for apoptotic cell death, these chaperones with 
different functions are distributed according to the role they play with respect to the 
entities carrying them. Whilst calreticulin may be associated with the remnant cell body 
which is likely stationary within the bone marrow, the platelets which are due to be 
distributed within the circulation may be endowed with a predetermined life span. It is 
suggested that these two chaperones, calreticulin and hsp60, fulfill different functions 
within the same cell. 
The detection of hso60 on the surface of senescent platelets may have clinical 
implications. Currently platelets are kept at room temperature to prolong their shelf life. 
Interestingly it had been found that platelets are primed for activation when chilled 
(Hoffmeister et al., 2003). It had been noted that following activation, platelets undergo 
a clearance program driven by caspases, just like apoptosis. Quantifying the percentage 
of hsp60 positive platelets would allow an estimation of the amount of functional 
platelets. In addition such functional assays may allow various methods of storage to be 
investigated for optimal efficiency in prolonging shelf life. Such measure may also 
involve the use of caspase -inhibitors. 
Part II: Purification of the BOB78 antigen 
The megakaryocytic MEG -01 cell has been a fortuitous choice for characterising 
BOB78 antigen. Observations derived from the MEG -01 cells indicate that MEG -01 
platelets could be a potent source of BOB78 antigen. This assumption is supported by 
findings with SDS -PAGE analysis of protein lysate from various cell lines. The use of 
MEG -01 platelet lysate has allowed capture of the antigen with the BOB78 IgM 
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antibody, a reaction which otherwise would have been rather more difficult. IgM 
immunoglobulins are noted for their low avidity for antigens (Medzhitov and Janeway, 
2000). 
From the findings derived from MEG -01 cells and platelets, caspases used by cells to 
drive apoptosis appear to be creatively mobilised to sculpture platelets out of terminally 
differentiated MEG -01 cells (De Botton et al., 2002). It is possible that through 
compartmentalised activation of the caspases, which act on the cytoskeleton, the body 
of a polyploid MEG -01 cell may be cleaved into discrete packages of cytoplasm as 
platelets. However, activated caspases are not packed into these platelets. Instead the 
complement of caspases able to drive the intrinsic apoptotic pathway are stored in these 
platelets until senescence occurs (Clarke et al., 2003). Senescent platelets undergo 
apoptosis with changes similar to the hallmark membrane changes of apoptotic cells. 
One of these changes is the expression of phosphatidylserine on the membrane. The 
phosphatidylserine residues are important for the pro -coagulant activities of platelets 
(Heemskerk et al., 2002). Senescent platelets also express BOB78 [i.e. hsp60] much 
like the parallel expression of BOB78 antigen and PS on the surface of apoptotic cells 
(see Chapter 3). These membrane changes may then translate into signals for 
recognition and engulfment by phagocytes. As senescent platelets expose BOB78 
antigen on the plasma membrane, it may be inferred that the exposed hsp60 may form a 
component of the array of signals chemotactic to the phagocytes. 
The antigen recognised by the BOB78 antibody had been conclusively been identified 
as heat shock protein 60, also known as chaperonin. The significance of this 
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observation and the possible functions hsp60 may serve on the surface of apoptotic 
cells are discussed in Chapter 6. 
CONCLUSION 
The antigen identified by the BOB78 antibody is conclusively identified as heat shock 
protein 60. It is a highly conserved protein in eukaryotes with homologues among the 




The aim of the project has been to characterise the antigen BOB78 as comprehensively 
as possible. The monoclonal IgM antibody BOB78 identifies an antigen expressed on 
the surface of apoptotic cells which has been positively identified as heat shock protein 
60 (hsp60). The main conclusion derived from the studies arising from this project is 
that heat shock protein 60 is translocated to the surface of apoptotic cells. The 
significance of the findings and results detailed in previous chapters are discussed in 
three main contexts; 1) the nature of the antigen identified by BOB78; 2) the transport 
and the functions of BOB78 antigen on the membrane; and 3) the immunological 
significance of BOB78 antigen (hsp60) on apoptotic cells. 
BOB78 identifies heat shock protein 60 on apoptotic cells 
The antibody BOB78 was raised in our laboratory following immunization of mice 
with serum -deprived human monocytic leukaemic THP -1 cells. Hybridomas were 
created by fusing the mouse splenic cells with myeloma cells. Antibodies from the 
hybridoma clone coded as BOB78 were noted to bind to neutrophils in late apoptosis, 
as shown in earlier studies (Hart et al; 2000). Neutrophils aged in culture proceeded to 
apoptosis spontaneously. Whilst the surface expression of adhesion markers like CD 16 
was down -regulated, BOB78 appeared to be a prominent feature on the surface of 
apoptotic neutrophils. Interestingly, the BOB78 antigen was also demonstrated to be 
present in the cytoplasm of normal neutrophils. Isolation of BOB78 through immuno- 
precipitation however might have been rendered difficult by the inherent proteolytic 
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activities of the enzyme granules within the neutrophils, as Hart and his colleagues 
reported. The expression of BOB78 on the surface of neutrophils was suggested to be a 
late apoptotic event. 
My studies confirmed the ability of BOB78 to identify apoptotic cells and further 
characterised its behaviour in these cells. The epitope recognised by the BOB78 
antibody was successfully identified as belonging to heat shock protein 60. 
Surface expression of BOB78 antigen (hsp60) is downstream to initiation 
of apoptosis 
Analysis through flow cytometry marks the surface expression of BOB78 antigen as an 
event following the initiation of apoptosis. Using the lipophilic dye DiOC6, which is 
retained by functioning mitochondria, BOB78 has been shown to be expressed on the 
surface only after the mitochondria have depolarised (Ozgen et al., 2000). Functioning 
mitochondria maintain ionic polarity in the space between the inner and outer 
membrane, and the loss of this transmembrane potential is one of the key events in 
apoptosis. In the intrinsic pathway of cell death, this depolarisation initiates the 
activation of terminal caspases by releasing initiator caspases and other pro -apoptotic 
signals. Once the downstream effector caspases are activated cellular disassembly 
follows, with the substrates of the caspases including cytoskeleton proteins, DNAses, 
and nuclear laminins. 
When a cell is in established apoptosis another key feature is the loss of plasma 
membrane symmetry. This results from the externalisation of phosphatidylserine 
residues which are usually retained on the inner leaflet of the membrane. These 
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exposed phosphatidylserine residues can be identified through their binding for another 
phospholipid called Annexin -V (Martin et al., 1999; Martinez and Freyssinet, 2001). 
The surface expression of BOB78 antigen coincides with that of phosphatidylserine. 
The expression of BOB78 antigen (hsp60) on the surface of the plasma membrane 
therefore occurs after apoptosis is initiated. 
BOB78 antigen (hsp60) is expressed on membrane blebs of apoptotic 
cells 
Using flow cytometry and fluorescence microscopy BOB78 antigen was shown to be 
expressed in the membrane blebs which develop on the surface of apoptotic cells. 
During apoptosis the plasma membrane develops evaginations called blebs to 
accommodate portions of cytoplasm which are extruded from the dying cell. Membrane 
blebbing with apoptotic bodies budding off a dying cell form some of the most 
distinctive features of programmed cell death (Kerr, Wyllie & Currie, 1974). Hence the 
earlier description of `cytoplasmic boiling' of apoptotic cells, when these were studied 
with time -lapse photography. The membrane of an apoptotic cell maintains its semi - 
permeability, thereby sustaining the exclusive cellular environment where the cell death 
programme may proceed. Controlled deconstruction of the cell, with activities such as 
dramatic changes in cell shape, dissolution of the nuclear envelope, and degradation of 
DNA into small bundles, would not take place if the cellular integrity was disrupted. 
Apoptotic bodies are small subcellular entities carrying various organelles and 
chromatin clumps, and are probably rendered into bodies of suitable dimensions in 
order to facilitate clearance. Whilst BOB78 antigen is usually expressed in the 
cytoplasm of the cell, during apoptosis the molecule appears to translocate to the 
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plasma membrane where blebs are developing. The membranes of developing apoptotic 
bodies as well as free floating ones are strongly positive for BOB78 antigen. The 
surface expression of BOB78 appears to be a distinctive and consistent feature of cells 
dying through apoptosis regardless of the methods of apoptosis induction. The 
observations imply that BOB78 identifies cells which are disintegrating through 
apoptosis. 
Apoptotic cells are rapidly ingested by phagocytes in vivo. These may be neighbouring 
cells (non -professional phagocytes) or macrophages in the tissues (professional 
phagocytes). In vitro however apoptotic cells disintegrate or undergo lysis from 
secondary necrosis. This is expected from dying cells as most cellular mechanisms are 
shut down during apoptosis. Caspases which initiate and execute the cell death 
programme are not synthesised but are already present as precursors, ready to be 
activated, mobilised and recruited into action. Studies in this project with in vitro 
culture systems demonstrate that the surface expression of BOB78 antigen (hsp60) on 
dying cells persist up to the point where the cells begin to lose membrane integrity 
secondary to necrotic degeneration. When the membrane integrity is disrupted this 
surface feature is lost. This localisation of BOB78 antigen (hsp60) on the surface of 
cells throughout the apoptotic phase may have implications on the possible roles it may 
play in these cells and apoptotic bodies, for example, in recognition of apoptotic 
bodies. 
BOB78 antigen (hsp60) is expressed on aged platelets 
A creative deployment of caspases takes place in the generation of platelets from 
megakaryocytes (De Botton et al., 2001). In bone marrow precursors of 
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megakaryocytes fuse together to form multinucleated cells. Long and thin cytoplasmic 
extensions develop from the polyploid megakaryocyte during terminal differentiation. 
From these extensions cytoplasm is demarcated as packets which bud off as platelets. 
This process is apparently downstream to activation of caspases. The caspase- mediated 
disintegration of the megakaryocytic cytoplasm is followed by typical apoptotic 
involution of the nuclei; the platelets however do not show activation of caspases. 
Freshly produced platelets therefore do not exhibit membrane changes typical of 
apoptosis. Somehow the actions of the caspases are so compartmentalised that whilst 
the parent cell body dies, the progeny platelets remain as functional entities in that the 
hallmarks of apoptosis are absent. The platelets demonstrate the ability to undergo 
senescence during which they expose phophatidylserine (PS) and are readily taken up 
by phagocytes (Brown et al., 2000). Phagocytosis is intimately related to PS on the 
plasma membrane. Platelets contain energy -producing mitochondria which may be 
induced to depolarise initiating classical downstream caspases activation and attendant 
PS externalisation. Albeit being anucleate, circulating platelets apparently contain the 
substrates to effect cytoplasmic and membrane changes akin to apoptotic termination 
when they are effete. Platelets are therefore capable of undergoing cell death through 
classical caspase- dependent pathways. 
My studies with the megakaryocytic MEG -01 cells demonstrated that dying MEG -01 
cells express hsp60 on the plasma membrane. These dying MEG -01 cells represent 
those which are differentiating to produce platelets. It is likely that where platelets are 
budding off the cell body hsp60 is expressed on the membrane. This may be because 
some of the platelets produced by MEG -01 cells are proceeding towards constitutive 
cell death prematurely. The remnant apoptotic nuclei at the final phase of terminal 
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differentiation of MEG -01 cells are devoid of hsp60 as studied on confocal microscopy. 
In vivo remnant megakaryocyte cells are cleared within the bone marrow stroma 
probably through phagocytosis by resident marrow stromal cells (Radley and Haller, 
1983). In the bone marrow these apoptotic chromatin clumps may be disposed of 
differently from the way apoptotic bodies, containing organelles as well as nuclear 
material, are cleared from other tissues. 
It is interesting to find that BOB78 antigen (hsp60) is also expressed by senescent 
platelets. This agrees with the observation of membrane expression of hsp60 being an 
event downstream to activation of initiator caspases. Since hsp60 appears to be 
exclusively packaged into platelets upon differentiation of megakaryocytic MEG -01 
cells, it may be inferred that hsp60 forms part of the network of apoptotic machinery 
within the platelets. These hsp60 molecules are then mobilised to the plasma membrane 
when platelets undergo caspase- dependent cell death. The specificity demonstrated by 
BOB78 for hsp60 within the megakaryocytic MEG -01 platelets has made it possible to 
precipitate hsp60 from these. 
Translocation of hsp60 onto the surface of the cell membrane 
Heat shock proteins have been originally characterised for their up- regulated expression 
in bacteria exposed to heat shock. They are synthesised under other conditions of 
cellular stress, so are also known as stress proteins (Georgopoulos and Welch, 1993; 
Langer and Neupert, 1991). They are classified according to their molecular weights 
eg. hsp60, hsp70, hsp90. Heat shock proteins are highly conserved and human 
homologues are found in bacteria and yeasts. Most heat shock proteins are molecular 
chaperones, a large family of proteins whose functions are to prevent protein 
138 
aggregation, promote proper folding of non- native proteins, assist in the assembly of 
multi- subunit protein complexes, as well as target proteins for membrane translocation 
(Craig et al., 1994). Hsp60 is a molecular chaperone and deletion of it is lethal as 
protein assembly essential for normal cellular functions and growth is disrupted (Bukau 
& Horwich, 1998; (Fayet et al., 1989). Hsp60 binds misfolded proteins and newly 
synthesised protein intermediates, and facilitates their folding into native 
conformations. The misfolded proteins are sheltered from the cytosolic environment to 
prevent aggregation of similarly misfolded proteins into physical masses which would 
destabilise the cells functionally and physically. Proteins which cannot be refolded into 
their proper conformation are marked for degradation. 
When first isolated most hsp60 was found to be localised to the cytoplasm of 
prokaryotes and mitochondria in eukaryotes. In mammalian cells, hsp60 has been 
localised to various cytoplasmic and organelle related locations; including endoplasmic 
reticulum, peroxisomes, mitochondria (Itoh et al., 1995; Itoh et al., 2002; Soltys & 
Gupta, 1996). In normal cells hsp60 is assembled into a barrel- shaped hetero- oligomer. 
The hsp60 units react with proteins and polypeptides which have folded in tertiary 
formations. Misfolded proteins are ushered into the hsp60 barrel and the lid is provided 
by another stress protein, hsp10. The properly folded peptides are then released into the 
cytoplasm. Earlier works have suggested such actions form an important stress 
response generated within mitochondria, a key player in the initiation of apoptosis 
through the intrinsic pathway. 
The mechanism by which hsp60 associates with the cell membrane is not fully 
understood. The ability of hsp60 to be incorporated into membrane has been observed 
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(Torok et al, 1997). The highly conserved C- terminus of hsp60 is involved in 
membrane targeting. It was found that hsp60 could penetrate efficiently both 
monolayers and bilayers of phospholipids, and the hsp60 complexes retained ATPase 
and protein folding activity while bound to the reconstructed membranes. It has also 
been shown that hsp60 may attach itself to the plasma membrane through protein 
kinase A- catalysed phosphorylation (Khan et al., 1998). In addition hsp60 may 
participate in translocation of protein across the cytoplasmic membrane of E. coli. 
Bochkareva et al. (1988) demonstrate that hsp60 maintains newly synthesised pre -ß- 
lactamase in translocation- competent unfolded state for secretion, whilst Kusukawa et 
al. (1989) report that functionally defective hsp60 compromised such export. An 
essential role of hsp60 in export of other secretory proteins have also been reported by 
Lecker et al. (1989) and Battistoni et al. (1995). Translocation across the membrane 
requires Mg- ATP -promoted discharge of the protein from GroEL. 
Functions of hsp60 on the membrane 
Heat shock protein 60 translocating to the cell membrane of an apoptotic cell may serve 
certain functions. There is evidence that hsp60 when incorporated into the cell 
membrane exists as whole molecules (Ferrarini et al., 1992; Kaur et al., 1993). Surface 
hsp60 may be involved in processing of proteins for antigenic presentation (Belles et 
al., 1999; Blander and Horwitz, 1993). This suggests hsp60 may retain its chaperone 
functions in the membrane of apoptotic cells. It may be chaperoning peptide(s) targeted 
to the membrane when a cell undergoes apoptosis. These peptides might be secreted in 
apoptotic cell death, serving as a signal for phagocytes. Alternatively, hsp60 may be 
keeping certain peptide groups in the membrane properly constituted. 
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Heat shock protein 60 and immunological response 
Heat shock protein 60 (hsp60) has been noted to be released during cellular stress. It 
has also been identified as an autoantigen especially in patients with autoimmune 
disease. Elevated levels of anti -hsp60 antibodies have been detected in several auto - 
immune disorders including juvenile chronic arthritis and diabetes mellitus (de Graeff- 
Meeder et al., 1993). There have been reports of homology between hsp60 and many 
known auto -antigens (Jones et al., 1993). It was reported that hsp60 has the capacity to 
activate macrophages thereby stimulating the innate immune system (Chen et al., 1999; 
Kol et al., 1999). This observation was followed by reports that hsp60 activates the 
macrophages through CD14 (Kol et al., 2000), and that the putative receptor for hsp60 
is Toll -like receptor -4 complex, Tlr (Ohashi et al., 2000). These studies utilised purified 
recombinant hsp60 to activate macrophages. Hsp60- mediated activation was abrogated 
in the presence of blocking antibodies to CD14, and also in Tlr mutant mice.The 
authors suggest that these findings support an intimate link between tissue hsp60 and 
inflammation. However hsp60 homologues from Escherichia coli and Mycobacterium 
tuberculosis can also activate macrophages in a CD14- independent manner 
(Lewthwaite et al., 2001). 
Reports offering counter evidence have recently emerged. Classically the ligand 
activating CD14 in conjunction with Tlr has been lipopolysaccharide (LPS), an 
essential product of the bacterial cell wall. It has been suggested that in earlier studies, 
the effects attributed to recombinant hsp60 arose from contamination with bacterial 
LPS. Using polymyxin B- agarose column to deplete LPS and LPS- associated proteins, 
Gao and Tsan (2003) reported that purified recombinant hsp60 was not able to activate 
macrophages. It was shown that the LPS- contaminated hsp60 induced production of 
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tumour necrosis factor -alpha (TNF- alpha) from macrophages even at very low levels. 
The authors believed that contamination with LPS- associated factors, which are not 
sensitive to polymyxin B treatment, might also have accounted for the TNF -alpha 
inducing properties of preparations of recombinant hsp60. A similar finding has been 
put forward for recombinant hsp70, another stress protein previously shown to activate 
macrophages (Gao and Tsan, 2003). In the light of these studies further corroborative 
reports, utilising methods to assess LPS contamination and functional activities of 
hsp60, will be needed to clarify the interaction of hsp60 and the innate immune system. 
Significance of heat shock protein 60 on apoptotic cells 
I. Hsp60 may be required for a non -inflammatory response to apoptosis 
Our observations on the expression of hsp60 on apoptotic cells are supported by studies 
using different models. Extending an earlier observation that T lymphocytes infected 
with HIV -1 virus had increased cytoplasmic levels of hsp60 (Poccia et al., 1996), the 
authors tested the expression of hsp60 on infected T cells undergoing apoptosis. It was 
found that the subset of smaller and more granular lymphocytes detected by flow 
cytometry, probably representing late apoptotic cells, express hsp60 on the membrane 
(Poccia et al., 1996). It has also been reported that hsp60 probably translocated to the 
plasma membrane in cardiac myocytes undergoing apoptosis (Kirchhoff et al., 2002; 
Gupta and Knowlton, 2002). The authors found that total cellular hsp60 was unchanged 
during hypoxia, but that hsp60 translocated to the plasma membrane fractions in 
apoptotic cells. These studies also pointed to the association of hsp60 with Bax, a pro - 
apoptotic member of the bel -2 family of proteins. It was suggested that when Bax 
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dissociated from hsp60, it moved to mitochondria to induce release of cytochrome c 
initiating apoptosis whilst hsp60 moved to the plasma membrane. 
It is interesting that hsp60 is expressed on all apoptotic cells which have been examined 
during the course of this study. Although the potential of hsp60 to stimulate the innate 
immune system remains to be determined, the non -inflammatory property of apoptotic 
cells has been the defining nature of apoptosis. In fact uptake of apoptotic cells by 
macrophages is attended with production of anti -inflammatory cytokines (Fadok et al., 
1998; McDonald et al., 1999; Huynh et al., 2002). It appears logical that disposal of 
apoptotic cells occurring under physiological conditions, eg. development, or during 
resolution of inflammation is meant to be non -inflammatory. It is probably through 
defects in recognition and disposal of apoptotic cells that intracellular antigens are 
presented to the immune system in a stimulatory context. This might be the basis of 
autoimmune diseases such as systemic lupus erythromatosus (SLE) where apoptotic 
bodies form a distinctive feature of the histological landscape (Potter et al., 2003). 
It is very likely that the potential to stimulate immune cells depends very much on the 
context in which hsp60 is presented to them. Studies reporting the immunostimulatory 
properties of hsp60 have so far relied on feeding the macrophages free molecules of 
purified recombinant hsp60 in culture systems. Most of these studies were designed to 
simulate situations where tissue damage releases cytoplasmic hsp60, such as hypoxia or 
in infections. It is hypothesised that infections with Chlamydia bacteria sensitises the 
innate immune system to hsp60 and where cardiac myocytes release hsp60, an 
inflammatory reaction is set up leading to further damage and local inflammation 
eventually leading to atherogenesis (Kol et al., 1998; Libby et al., 1997; Xu et al., 
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1992). However the responses elicited when macrophages encounter hsp60 molecules 
on the membrane blebs of apoptotic cells would probably be very different from those 
stimulated when hsp60 is freely released into the circulation in tissue necrosis. 
Il. Heat shock protein 60 may be used by intracellular bacteria as 
molecular mimicry 
Surface expression of hsp60 is a consistent feature of many intracellular bacteria. 
Difference in the surface expression of hsp60 has been noted among strains of 
Legionella pneumophila, a gram negative, facultative intracellular bacterium which 
causes the pulmonary infections called Legionnaire's disease. It infects through the 
lungs and is taken up by alveolar macrophages (Cianciotto, 2001). This has to do with 
its ability to subvert the immunological response of macrophages. The virulent strains 
of L. pneumophilia have been shown to be expressing higher levels of surface hsp60 
(Fernandez et al., 1996). Once inside the host macrophages the synthesis of hsp60 is 
reduced. Surface hsp60 accounts for the difference in invasiveness of intracellular 
Legionella pneumophila (Garduno, Garduno & Hoffman, 1998). Using HeLa cells as a 
model for invasion, the authors found that surface hsp60 promoted binding and 
internalisation of L. pneumophila by HeLa cells. The invasiveness of virulent L. 
pneumophila might be suppressed through the antagonistic action of purified hsp60 or 
substratum -bound hsp60. It had been noted that when taken up by host macrophages 
bacterial hsp60 is released into mature or newly formed phagosomes, events which 
correlate with the ability of virulent L. pneumophila to abrogate the fusion of 
phagosome with lysosome (Fernandez et al, 1996). The avirulent strains however do 
not show this up- regulated expression of surface hsp60. 
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It had been previously reported that the heat shock proteins hsp70 and hsp90 share a 
common receptor (Basu et al, 2001).The receptor was identified as the alpha -2M 
receptor. Hsp60 however does not share this receptor. Certain features of the 
macrophage receptor for hsp60 have been demonstrated (Habich et al, 2002). The 
putative receptor is specific for hsp60, and is not antagonised by hsp70 or hsp90. In 
addition Toll -like receptor (TLR) does not mediate binding of hsp60, as macrophages 
lacking TLR could bind hsp60. A specific ligand- receptor interaction probably exists 
for hsp60 and macrophages. Recently hsp60 has been identified as the factor used by 
the fungus Histoplasma capsulatum to target entry into macrophages via phagocytosis 
(Long et al., 2003). This had been demonstrated in surface staining on flow cytometry 
and confocal microscopy, as well as immunoblotting. The uptake of Histoplasma 
capsulatum is enhanced by the presence of surface hsp60 As with L. pneumophila, the 
endocytosed H. capsulatum is not degraded in the lysosomes. It was however difficult 
to confirm if the fungal hsp60 was instrumental in preventing phago -lysosomal fusion 
(Long et al., 2003). 
In summary, it appears that phagocytosis of cells or organisms by macrophages may be 
significantly influenced by surface hsp60 on these entities. Membrane -bound hsp60 
appears to target a specific receptor on the macrophages. Recognition by this receptor is 
linked to phagocytosis, and the degree of uptake appears proportionally related to the 
level of hsp60 expression on the surface. Intracellular organisms also rely on the hsp60 
to prevent fusion of the phagosome and lysosome thereby averting digestive breakdown 
by the macrophages. The setting in which the membrane hsp60 is presented to the 
macrophage receptor is likely to be vital to this escape from immune activation, 
allowing organisms which express surface hsp60 to reside within the macrophages. 
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The platelet is another entity which possibly uses membrane hsp60 in a similar manner. 
Platelets undergoing senescence execute a caspase- driven programme. The membrane 
changes on aged platelets are reminiscent of those on apoptotic cells. Aged platelets 
express hsp60 on the surface. In vitro it had been shown that aged platelets are avidly 
taken up by macrophages. In vivo, during remodelling of a platelet plug covering a 
defect in the blood vessel, platelets are actively phagocytosed by macrophages 
(Diegelmann and Evans, 2004). The surface hsp60 on platelets may therefore serve as a 
membrane marker to facilitate uptake by macrophages. 
It may be possible that the manner in which hsp60 is presented by these intracellular 
organisms is similar to the way hsp60 is displayed on apoptotic bodies. It may be 
conjectured that displaying hsp60 on the surface serves as an advantage for these 
microbes. These microbes may be using molecular mimicry. The microbes may be 
using membrane hsp60 as a disguise for apoptotic bodies. The hsp60 moieties on the 
membrane would enhance the uptake of these microbes into the macrophages. 
Subsequent to that important changes emerge. Apoptotic bodies get degraded, whereas 
intracellular microbes do not. There are probably other factors on the membranes of 
microbes which prevent degradation. The membrane hsp60 however may serve another 
important function. The hsp60 moieties carried on the apoptotic bodies may generate a 




Heat shock protein 60 is expressed on the membrane of cells, apparently of all lineages 
except red cells, dying through apoptosis. This surface expression of hsp60 is an event 
following the initiation of apoptosis, with a major component of the cytoplasmic pool 
of hsp60 being translocated to the cell membrane in the process. Hsp60 is also 
expressed on surface of platelets which are undergoing senescence through the same 
caspase- driven programme. Intracellular microbes utilise surface hsp60 to gain entry 
into macrophages. Molecules of hsp60 expressed on the surface may well be a 
recognition marker for macrophages, with important immuno -regulatory functions. 
FUTURE WORK 
A major investigation of the role of hsp60 in macrophage clearance of senescent cells 
would have added considerably to the work if time had permitted. Cell surface hsp60 
expression may be a general macrophage recognition mechanism for apoptotic cells. 
(Mevorach, 2000). 
The results obtained from the studies presented in the thesis may be extended in several 
meaningful directions. The main areas which I would like to develop would be along 
the following themes, 1) assessing the functional significance of surface hsp60 in 
phagocytosis, 2) isolating the receptor for hsp60, and 3) tracking the movement of 
hsp60 in cells during apoptosis using reporter protein. 
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Functional assessment of the role of surface hsp60 on apoptotic cells may take the form 
of inhibition studies. Apoptotic THP -1 cells may be co- cultured with untreated THP -1 
cells or macrophages, and competitive binding of the putative hsp60 receptor may be 
effected with saturating the culture medium with recombinant hsp60 protein. In 
addition competitive binding may also be effected with liposomes bearing purified 
hsp60. The inhibition of phagocytosis may be compared between hsp60 and 
phosphatidylserine (PS) on apoptotic cells. 
The receptor of hsp60 may be isolated using MEG -01 platelets. Platelets may be aged 
or induced to undergo apoptosis using calcium ionophore 23827. These may then be 
fixed (eg. using glutaraldehyde) and presented to macrophages. The reaction mixture 
will then be lysed, and the proteins diiferentiated on a SDS -PAGE gel. There may be 
bands specificto the reaction between the macrophages and the platetlets, when 
compared with control experiments and these bands may be sequenced using MALDI- 
TOF. 
The movement of hsp60 may be tracked using fluorescent reporter proteins eg. GFP 
(Green Fluorescent Protein), and analysed using time -lapse confocal microscopy. The 
movement of hsp60 from the time of induction of cell death, translocation from the 
cytoplasm to the membrane, through to the uptake and engulfment into phagocytes may 
be followed. 
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Figure 6.1. Capturing apoptosis. Human hepatoma HUH -7 cells 
were incubated with 2511M monensin for 18 hours. The monolayers of 
cells were fixed and stained for BOB78. Secondary anti -mouse antibody 
was TRITC- conjugated (red), with TO -PRO 3 (blue) for nuclear 
staining Analy sis was effected through confocal microscopy. 
Phagocytosis and apoptosis. A human HUH -7 cell was seen 
developing a phagocytic cup around an apoptotic body marked 
by its intense staining for BOB78. The distribution of BOB78 
within the cell is not different from that within other normal 
appearing HUH -7 cells. This scenario is reminiscent of cells 
taking in membrane bound entities under physiological 
conditions. 
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MATERIALS FOR CELL BIOLOGY 
Cell Culture 
Cell lines 
THP -1 (human acute monocytic leukaemia; Tshuchiya et al., 1980) 
MEG -01 (human megakaryocytic leukaemia; Ogura et al., 1985) 
HuH -7 (human hepatoma; Nakabayashi et al., 1982) 
MIAPaCa -2 (human pancreatic carcinoma; Yunis, Arimura & Russin, 1977)) 
Standard culture medium 
Dulbecco's Modified Eagle Medium/ Nutrient Mix F12 (1:1), without L- glutamine 
(DMEM /F12, no. 11880 -028 GibcoBrl) 
RPMI 1640 Medium 
(RPMI, no. 10100 -147 GibcoBrl) 
10% foetal bovine serum 
(no. 14200 -059) 
2mM L-glutamine 
(stock: 100X (200mM) L-glutamine, Gibcobrl) 
100 units /ml penicillin + 100µg /m1 streptomycin 
(stock: 10 000 units of penicillin + 100001.1g of streptomycin, GibcoBrl) 
Trypsinization 
Trypsin -EDTA (0.25% trypsin, 1mM EDTA.4Na) (1X), liquid 
(Gibcobrl) 
Dulbecco's Phosphate Buffered Saline,1X, liquid 
(Gibcobrl) 
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Metabolites used in culture 
Thymidine (Sigma, product no. T 1895) 
Camptothecin (Sigma, product no. C 9911) 
Tunicamycin (Sigma, product no. T 7765 ) 
Monensin sodium salt (Sigma, product no. M 5273) 
Brefeldin -A (BFA) 
y,4-dihydroxy-2- [6-hydroxy-1 -heptenyl] -4-cyclopentanecrotinic acid X- lactone 
from Penicillium brefeldianum (Sigma. product no. B 7651) 
Plastic ware 
Flasks 
Costar 25cm2 culture area flasks 
(Corning cat no. 3055) 
Costar 75cm2 culture area flasks 
(Corning cat no. 430725) 
Plates 
Costar 6 well (9.5cm2 culture area/well) plate 
(Corning cat no. 3506) 
12 well (3.8cm2 culture area/well) plate 
(Corning cat no. 3512) 
96 well (0.32cm2 culture area/well) plate 
(Corning cat no. 3585) 
Costar Cell scraper 
(Corning cat no. 3011) 
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APPENDIX B 
MATERIALS FOR IMMUNOCHEMISTRY 
A. Immunochemistry for flow cytometry 
Washes and cell fixative 
PBS - 1% BSA (w /v): lg bovine albumin in 100m1 PBS 
(Bovine albumin fraction V, Sigma N 8159) 
PBS - 1% formalin (v /v) 
Fixation 
4% paraformaldehyde (w /v) 
(prepared from 10% stock with H2O) 
Permeabilisation 
100% cold methanol 
(stored at -20 °C) 
Blocking serum 
20% normal rabbit serum in PBS 
(rabbit serum from Diagnostics Scotland) 
Isotype control primary antibody 
Mouse IgM negative control (DAKO code no. X 0942) 
Antibody specificity for Aspergillus niger glucose oxidase, an enzyme neither present 
nor inducible in mammalian tissues 
Secondary antibody 
Sheep anti -mouse F(ab')2 fragment -FITC (fluoro- isothiocyanate) 
(Sigma F 2883) 
Goat anti -mouse IgM: RPE 
(R. Phycoerythrin (RPE)- conjugated goat IgGs (0.2mg /m1) purified from antisera to 
mouse IgM, Serotec) 
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Propidium iodide (Sigma product no. P 4170) 
PE-conjugated Annexin V 
(Cat no. 65875X, BD Pharmingen) 
Annexin V binding buffer 
10mM Hepes buffer/NaOH (pH 7.4), 140mM NaC1, 2.5mM CaCl2 
Nuclear staining mixture 
Nuclear Staining Solution (NSS) 
5mg propidium iodide, 0.1mg sodium citrate and 0.3ml Nonidet P40; in 100m1 distilled 
water (protected from light) 
RNAse A solution 
10mg /m1 RNAse A in 1.12% sodium citrate (diluent) 
Flow cytometry instruments and accessories 
Immunocytometry 
Coulter EPICS XL -MCL Cytoineter 
Analytical software for Flow Cytometry 
ExpoTM 32 ADC Analysis for Coulter EPICS XL cytometers 
(Beckman Coulter) 








Fixation & Permeabilisation 
100% Methanol (BDH) 
Blocking serum 
20% normal rabbit serum in phosphate buffered saline (PBS) 
(serum from Diagnostics Scotland) 
Primary antibodies 
BOB78 (clone 1) 
Rabbit anti -human calreticulin IgGs 
(Sigma; catalogue no. C4606) 
Mouse IgM negative control (DAKO code no. X 0942) 
(Antibody specificity for Aspergillus niger glucose oxidase, an enzyme neither present 
nor inducible in mammalian tissues) 
Fluorescent secondary antibodies 
Polyclonal rabbit anti -mouse immunoglobulins /TRITC 
(tetramethyl- rhodamine isothiocyanate R isomer ; DAKO code no. R 0270) 
Polyclonal goat anti -mouse immunoglobulins /FITC 
(Fluoresceine isothiocyanate isomer 1; DAKO code no. F 479) 
Polyclonal swine anti -rabbit immunoglobulins / TRITC 
(tetramethyl- rhodamine isothiocyanate R isomer; DAKO code no. R 0156) 
Alexa Fluor 546 goat anti -rabbit IgG (H +L) (2 mg /ml) 
(Molecular Probes) 
Alexa Fluor 546 goat anti- rabbit IgG (H +L) (2 mg /ml) 
(Molecular Probes) 
Aqueous slide mountant 
DAKO 
Chamber slides 
Lab -Tek II chamber slide with cover (8 well) 
(Nalge Nunc International) 
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Microscopes and camera for fluorescence visualization 
Leica DMRB upright microscope (connected to digital camera for imaging) 
Leica DC 200 digital camera 
Confocal microscopy 
Leica DMRE upright microscope with Leica TCS NT confocal system 
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20mM Tris, pH 8.0 
2mM EDTA 
150mM NaC1 
1% Triton -X 100 
Triton -X (Sigma product no. T 8532) 
*proteases inhibitors mix added before use 




Rabbit anti -mouse immunoglobulinsIgGs (anti -serum) (3.5mg /m1) 
(Affinity -purified rabbit anti -mouse IgM, DAKO code no. Z 0259) 
Washing solution ie. extraction buffer without Triton -X 




*proteases inhibitors mix added before aase 
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Protein electrophoresis and Western blotting 
RIPA cell lysis buffer 
1% Nonidet NP40, 0.5% sodium deoxycholate, 0.1% sodium dodecylsulphate (SDS) in 
phosphate buffered saline (PBS) 
Determination of protein concentration 
BCA Protein Assay Reagent kit 
(Pierce, catalogue number 23227) 
Running buffer 
Per 2 Litre solution (5x, pH 8.3) 
Glycine 144 g 
Tris base ( Tris(hydroxymethyl)methylamine) 30g 
Sodium docecyl sulphate SDS l Og 
ddH2O 2000m1 
Transfer buffer 
Per 2 Litre solution 
Glycine 5.86g 
Tris base ( Tris(hydroxymethyl)methylamine) 11.625g 
Sodium docecyl sulphate SDS 0.75g 
Methanol 400m1 
ddH2O 1600m1 
Washing buffer (TBS) 
Per 5 Litre solution (10x, pH 7.4) 
Tris base ( Tris(hydroxymethyl)methylamine) 121g 
Sodium chloride 438.5g 
ddH2O 5000m1 
Blocking buffer 
TBS, 0.1% Tween, 5% Marvel (dried skim milk) 
Blotting 
Nitrocellulose membrane (Biorad transblot 0.451.im cat. no. 162 -0115) 
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Protein staining on nitrocellulose membrane 
Ponceau's solution 
(Sigma, product no. B 6008) 
Secondary antibody 
Polyclonal rabbit anti -mouse immunoglobulins, horseradish peroxidase -linked whole 
antibodies (DAKO code no. P0260) 
Chemiluminescent detection 
Enhanced Chemiluminescent detection kit: 
ECL Western blotting analysis system 
(Amersham Pharmacia Biotech, RPN 2108: 
X -Ray film 
Kodak X -Omat 
(Sigma, catalogue 8532665) 
Accessories for Western blotting 
Protein assay 
Dynaex plate reader 
Semi -dry blotting system 
Pharmacia LKB Multiphor II electrophoresis unit 
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APPENDIC C 
MATERIALS FOR ELISA 
Antibodies for ELISA 
Rabbit anti -mouse IgM (specific for µ- chains) (1 mg /ml) 
(affinity -isolated rabbit anti -mouse IgM, DAKO code no. Z 0457) 
Rabbit anti -mouse immunoglobulins, horseradish peroxidase -linked whole 
antibodies (DAKO code no. P0260) 
Buffers for ELISA 
Coating buffer 
0.O1M phosphate buffer, 0.145M NaC1, pH 7.2 
NaH2PO4.H2O 0.345 g 
Na2HPO4.12H2O 2.680 g 
NaC1 8.474 g 
In 1000m1 of distilled H2O, pH 7.2 
Washing buffer 
0.01M phosphate buffer, 0.5M NaC1, 0.1% Tween 20, pH 7.2 
NaH2PO4.H2O 0.345 g 
Na2HPO4.12H2O 2.680 g 
NaC1 29.220 g 
Tween 20 (Sigma cat. no. P7949) lml 
In 1000m1 of distilled H2O, pH 7.2 
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0.1M citric acid -phosphate buffer pH 5.0 
citric acid. H2O 7.30 g 
Na2HPO4.12H2O 23.87 g 
In 1000m1 of distilled H2O, pH 5.0 
Chromogenic substrate, pH 5.0 
OPD tablets (2mg /tablet) 4mg (Dakoplatts, code no. 52000) 
Citric acid buffer 12ml 
30% H2O2 5µ1 
Chromogenic substrate solution protected from light, stable for 2 hours 
1 M Sulphuric acid 
55m1 95 -97% H2SO4 
900m1 distilled water 
Volume adjusted to 1000m1 
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SURFACE HEAT SHOCK PROTEIN -60 (CHAPERONIN) IS A SPECIFIC MARKER OF 
APOPTOTIC CELLS 
*YC Goh, ±S Hart, PBS Lai, ±I Dransfield, to Cronshaw, *JA Ross 
*Tissue Injury & Repair Group, ±Centre for Inflammation Research; University of Edinburgh, 
¡Edinburgh Protein Interaction Centre 
Introduction 
Cells undergoing apoptosis demonstrate distinctive changes in the plasma membrane. Expediency in 
removal of apoptotic cells has been proposed to be an essential nature of programmed cell death. One of the 
best characterised is phosphotidylserine (PS), a membrane phospholipid otherwise restricted to the inner 
leaflet of the plasma membrane. Externalised PS residues have been implicated as key signal for binding 
and engulfment of apoptotic bodies by phagocytes. Other pro -engulfment participants include CD36, 
thrombospondin, mer- family receptors, CD32, and CD14. With the myriad of putative factors involved, it 
remains unclear which play pivotal roles. A monoclonal IgM antibody raised by JA Ross has consistently 
identified apoptotic cells. It identifies an intracellular antigen (BOB78) which translocates to the surface of 
plasma membrane when cells undergo apoptosis (Goh et al, ELSO, 2003). 
Methods 
Visualisation of BOB78 on apoptotic cells has been effected through fluorescent immunocytochemistry. 
The captured BOB78 antigen was detected through SDS -PAGE and identified through mass spectrometry. 
Reactivity of BOB78 was verified with purified heat shock protein 60. 
Results 
The BOB78 antigen is multi -lineage and highly conserved. It is concentrated on the membrane blebs of 
apoptotic cells. Surface expression of BOB78 is coincident with that of PS, but is lost upon necrotic 
degeneration. The antigen identified by BOB78 is heat shock protein 60 ( chaperonin). 
Discussion 
We conclude that heat shock protein 60 (chaperonin) is a consistent surface feature of cells undergoing 
apoptosis. It remains to be studied if hsp60 may be chaperoning molecules which are essential as 
recognition markers for apoptotic cells. 
The following companies have procured the monoclonal antibody BOB78 for commercial 
purposes based on the findings elaborated in my thesis. 
Sigma- Aldrich 
3050 Spruce Street 
St Louis 
MO 63103 
e -mail: sigma -aldrich.com 
ALEXIS Corporation 
Industriestrasse 17 
CH -4415 Lausen 
Switzerland 
e -mail: alexis -ch @alexis- corp.com 
HyCult Biotechnology 
